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Recent history suggests that malaria can be eliminated in low-endemic countries, and there 
is a growing interest among key stakeholders from Peru to plan accordingly and achieve malaria 
elimination with a comprehensive programmatic goal.  In support of this interest, this dissertation 
integrates a course of studies to inform and support such goal, by accounting for the two most 
important malaria transmission patterns that currently characterize Peru, the one affecting the 
Peruvian north coast and the other affecting the Peruvian Amazon basin.  The first study will 
determine the impact of reactive case detection with focal mass drug administration (RCD/FMDA) 
as compared to passive case detection on reducing the regional annual parasite incidence in 
Tumbes, Peru (Paper 1).  The second study will determine the impact of the malaria elimination 
program implemented in Tumbes on interrupting the transmission of malaria beyond the 
intervention area and along the Peruvian north coast (Paper 2).  And the third study will determine 
whether further understanding the patterns of malaria incidence in Loreto, the main human malaria 
reservoir in Peru, may offer a variety of strategical targets for the malaria elimination program that 
was launched in Loreto, influencing as well the nearby regions at the Peruvian Amazon basin in 
2017 (Paper 3).  
It has been observed that the malaria elimination program implemented in Tumbes, which 
was based on replacing passive case detection with RCD/FMDA strategy, had a significant effect 
on reducing the regional annual parasite incidence in Tumbes within the intervention areas (2/13 
districts) during the first two years of the program (pilot project).  When the strategy was scaled 
up across the entire Tumbes region, malaria transmission was halted with no endogenous cases for 
the following three years.  Additionally, data suggest that the Tumbes intervention indirectly 
helped to interrupt malaria transmission in the nearby region of Piura.  During the intervention in 
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Tumbes, nearby Piura districts also observed a decrease of their malaria weekly parasite incidence, 
ultimately reporting zero autogenous malaria symptomatic cases at the end of the study period.   
Based on the evidence generated by the two previous studies we explored the pattern of 
malaria transmission across the Loreto Region through riverine networks where the RCD/FMDA 
strategy may have a substantial effect on interrupting the transmission of malaria.  Our data showed 
that the distribution of malaria cases does follow the Amazon river tributaries, which are areas 
competent to sustain the transmission of malaria from one season to the following.  Furthermore, 
we observed that the main predictors of malaria in the region are low altitude and the density of 
the vegetation and that there are some differences in the distribution of falciparum malaria which 
seems to be more associated with the density of the vegetation than the distribution of vivax 
malaria.  Among the different riverine networks, we identified some that appear to behave like 
independent foci of malaria transmission with only select communities demonstrating indices 
consistent with a year-round transmission, each of them representing potential targets for the 
RCD/FMDA strategy with a high likelihood to have a substantial effect on interrupting the 
transmission of malaria. 
Based on this information, achieving malaria elimination in Peru therefore appears 
feasible; however, it will require strongly epidemiological and data-driven approaches to optimize 
the effect of existing preventing interventions strategies.  This will need to target well-
characterized human malaria reservoirs in low endemic settings in order to maximize the effect of 
transmission-blocking drugs and effectively interrupt malaria transmission in limited-connected 
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Chapter 1. Introduction  
In the year 2014, the World Malaria Report announced that the number of children who 
die from malaria each year had fallen more than 50% since 2000 (1).  This significant achievement 
in the fight against one of the leading causes of death for children under five in Africa and Asia 
was a source or major optimism about the ultimate goal, malaria eradication.  And it was right; 
such achievement showed that when committed towards a common goal, global partners can 
achieve big goals and overcome the major health disparities that continue to deny millions of 
children in developing countries a healthy start in life.  These partnering efforts included the Global 
Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), the U.S. President’s Malaria 
Initiative, the UK’s Department for International Development, and their strong partnership with 
many endemic-country governments.  However, only three years later, the World Malaria Report 
2017 raised concerns about the latest progress in the path towards malaria eradication, which 
appeared to have stalled.  Latest data analyzed showed that many of the countries with ongoing 
transmission are currently on track for reductions in the burden produced by malaria (2).  This a 
matter of great concern, particularly because the overall progress in the path towards malaria 
eradication have been halted and several countries and regions are beginning to see reversals in 
their progress and in the gains achieved (2).  As a consequence, the World Health Organization is 
currently pushing to boost funding for malaria programs, increase access to currently available and 
effective interventions, and increase investment in the research and development of new 
intervention tools.  Peru has certainly answered the call and, in April 2017, launched a long-term 
malaria elimination program ("Plan Malaria Cero 2017-2021"), in which the first stage included 
funding for the first five years of the program.  Such a challenge, although accepted, demands a 




species.  This is particularly important because most of the interventions available were developed 
focused primarily on controlling malaria in regions where P. falciparum is the predominant 
species.   
This dissertation aims to explores the epidemiology of malaria in the main malaria-endemic 
regions in Peru, the North coast (Tumbes and Piura) and the Amazon basin (Loreto), and to assess 
the effect of a reactive case detection with focal mass drug administration (RCD/FMDA) based 
malaria elimination program at and beyond the intervention areas — along the north coast as well 
as its potential utility at the Amazon basin.  In the intervention areas of Tumbes region, we assessed 
RCD/FMDA effect on interrupting the transmission of malaria and, later on, its potential effect 
boosting the elimination of malaria across the Tumbes region and beyond, at the Piura region.  We 
hypothesized that the reason why such an intervention would be effective is due to the strong 
connectivity between the two regions and we can identify some riverine networks with similar 
characteristics that could be influenced as well in the Loreto region.   
 
1.1 Background 
Malaria eradication as the ultimate goal 
Despite extensive efforts made to date, malaria continues to exert a significant burden of 
disease worldwide (3).  To address this public health threat, several local and regional malaria 
elimination campaigns have been attempted since the last Global Malaria Eradication Program 
(1955–1969) (4).  Following the announcement at the Gates Malaria Forum in October 2007 (5) 
several key international organizations, including the World Health Organization (WHO) and the 
Roll Back Malaria, debated the pros and cons of shifting the goal of the malaria control efforts 




launched, including countries in southern Africa (6) and Pacific Island states (7).  These efforts 
together with the WHO’s Global Malaria Program agenda and field manuals for malaria 
elimination (8, 9) have pointed out the path towards another global attempt at eradication. 
The proportion of the population at risk that now lives in malaria-free areas had increased 
from 30% to over 50% from 1950 to 2001 (10, 11), contributing to increasing spatial heterogeneity 
of the malaria distribution worldwide (12, 13).  Currently, malaria is affecting primarily the hard 
to reach populations - often located in the rural and most resource limited regions of each country-
, representing an increasing programmatic challenge for the control and later elimination of malaria 
(14).  Furthermore, due to the increasing cost of case detection in the elimination phase and the 
consequent decrease in programmatic efficiency, funding exhaustion on the part of stakeholders 
commonly fosters reemergence of malaria in late phases (15).  Therefore, there is a need for novel 
and efficient strategies and tools that can prudently select from currently available interventions to 
maximize program efficiency (16), but so far these have not been discovered.   
 
The Peruvian path towards malaria elimination  
In the past, Peru has on two separate occasions progressed to a degree in disease control to 
demonstrate that malaria elimination is feasible in the country (Figure 1).  First, after a peak of 
over 90,000 cases in 1944, the malaria burden fell to under 1,500 cases (98% reduction) in 1965 
and remained at similar levels for approximately two decades (17).  Such success was primarily 
due to the introduction of DDT and other insecticides, capacity building, and the shift of the focus 
from clinical treatment to transmission control within the National Malaria Service, an effort that 
was initially sponsored by the Rockefeller Foundation and later by the Interamerican Public Health 




country were chemical control using DDT (which later was replaced by different families of 
insecticides, including pyrethroids such as cyfluthrin) for domiciliary residual spraying and spatial 
fogging with malathion, and source control by community participation on identifying and filling 
the larval sites.  Yet DDT use was halted initially in Loreto in 1988 and then banned in the rest of 
the country because of its effect on the ecosystem, an event that may explain why malaria started 
increasing four-fold in Peru and fifty-fold in Loreto in the following decade (17).  After peaking 
in 1998 with 250,000 cases, the malaria burden fell to 87,800 cases in 2005 (65% reduction) and 
25,300 cases (90% reduction) in 2011.  During years 2006-2010 Peru received funds from the 
Global Fund to restart the project of malaria control in the borders within the Andean region 
(PAMAFRO), enhancing passive surveillance, implementing rapid diagnostic tests, insecticide 
residual spraying, and distributing over 250,000 long-lasting impregnated bed nets in Loreto (19), 
but in the absence of a control arm we may never know if this project contributed or not to the 
reduction in malaria cases reported during that period.  Currently, the total number of falciparum 
and vivax malaria cases increased from 3,920 to 12,978 and from 27,324 to 41,328 cases, 
respectively between 2012 to 2017 (20).  Contradictorily, the main contributing factor to this 
reemergence was the increase of malaria transmission in the Loreto region (Figure 2).  The reasons 
for the increasing burden of malaria in Loreto remains unclear; however, it is believed to be related 
the overlapping of the latest Dengue outbreak, which apparently, early in the epidemic, forced the 
local authorities to divert the Public Health budget away from malaria towards urban populations 
to control dengue (21).  Regardless, all these ups and downs have changed the epidemiology of 
malaria in Peru, to a point where malaria has become a heavily seasonal disease, transmitted by 
two predominantly peridomiciliary biting vectors - Anopheles darlingi and An. benarrochi (22), 




farmers and other laborers who often travel to these areas (23).  This epidemiological pattern of 
transmission of malaria is similar in other endemic Amazonian regions such as San Martin and 
Ucayali, which vary slightly as compared to Loreto where malaria transmission is more intense 
and perennial.  However, in other malaria-endemic regions such as in Tumbes, Piura, Lambayeque, 
and La Libertad, all of them located along the Peruvian north coast, malaria occurs with epidemic 
and sporadic outbreaks, probably related to stochastic factors such as malaria importation and 
relapses (24).  In the north coast malaria cases are largely due to P. vivax, with only occasional P. 
falciparum malaria cases reported since 2010.  In this region the predominant malaria vector is An. 
albimanus (25) and malaria is highly concentrated within peri-urban communities (26).  Across 
the region, only counted imported malaria cases have been reported since 2014 (27) up to 2017 
(20).  Accounting for this heterogeneity in the patterns of transmission is highly relevant for 
malaria control and the prospect of elimination in Peru. 
 
The challenges towards malaria elimination in Peru 
Several interventions could be implemented in the Peruvian Amazon to interrupt malaria 
transmission and support the current malaria elimination efforts.  However, most of these 
interventions may not be particularly effective in the Amazon region given its specific 
epidemiological and cultural characteristics.  For example, indoor residual spraying (IRS) is an 
intervention that is effective when the vector has an indoor biting behavior like in African 
countries, an intervention that has been demonstrated to reduce malaria transmission by up to 50% 
(28).  Though, in the Amazon where vectors (predominantly An. darlingi) have both intra and 
peridomiciliary biting behavior and the household’s architecture is predominantly open instead of 




Similarly, insecticide-treated nets (ITN) have been reported as a highly effective intervention for 
malaria control globally.  Nonetheless, that is not always the case of the Peruvian Amazon where 
ITNs have been reported to be significantly underused (>60% of households not using any of the 
distributed LLINs), which is due mostly that ITNs do not fulfill some “basic” architectural and 
social functions, such as providing privacy and warmth as compared to other traditional non 
impregnated tocuyo nets provide more adequately (29).  Another critical factor to take into 
consideration when implementing malaria control interventions is the temporal and spatial 
variability of malaria, which are highly correlated with a variety of climate (precipitation, 
temperature, humidity, surface pressure, solar radiation, etc.) (30) and land conditions (soil 
moisture, deforestation, vegetation, and others) indicators (31).  However, as recently Feingold et 
al. reported, there are two parameters that showed the highest correlation, among the many 
indicators used to characterize the climate and the conditions of the land surrounding the Peruvian 
Amazon communities: these are precipitation and soil moisture, respectively (32).  Finally, the 
effectiveness of case detection and proper case management interventions also might be different 
in the Peruvian Amazon, as compared to the Africa scenario, given the high likelihood of relapses 
due to P. vivax (>70% of Peru’s malaria burden) (33), the differences in the sensitivity of the 
surveillance systems as Peru is still microscopy-based, instead of being based on Rapid 
Diagnostics Test (RDTs) as is done in Africa, and the different first-line therapeutic schemes used 
in the case of P. falciparum (Artesunate/Mefloquine in Peru) (34).  
Another important reason why malaria elimination is so difficult to achieve is the key role 
played by the asymptomatic carriers in its transmission and our inability to diagnose them 
accurately (35).  As a significant fraction of the human malaria reservoir, identifying and treating 




malaria eradication campaign (36).  In Peru, like in most of the Amazon basin, most malaria cases 
are due to P. vivax (≈80% of all malaria infections), which are predominantly (≈75%) 
asymptomatic (37, 38).  As a consequence, malaria transmission might be largely maintained by 
relapses from dormant liver parasite stages (i.e., hypnozoites), which are beyond the detection 
threshold of the diagnostic test currently available (39).  In such a scenario, little can be done from 
the perspective of diagnosing and treating cases approach, so there is an increasing need for better 
diagnostics and more effective therapies that empower us to interrupt transmission more 
effectively. 
 
The opportunities for achieving malaria elimination in Peru 
To implement a strategy that accounts for all of the many challenges in the path towards 
malaria elimination it is particularly relevant to shift the malaria policies from control towards 
local elimination, as recommended by the current malaria eradication campaign (40).  Based on 
this paradigm, current elimination efforts rely on the hypothesis that by testing, treating, and 
tracking malaria cases and simultaneously performing vector control through the distribution of 
insecticide-treated nets and indoor residual spraying, malaria could be controlled and later 
eliminated (41-43).  However, this paradigm has proven to be extremely challenging due several 
implementational factors or which some of the most relevant includes: 1) the difficulties to locate 
and target the human malaria reservoir; 2) the operational, technical, and financial challenges of 
implementing sustainable interventions; and, 3) the lack of cost-effective methods and strategies 
to detect the asymptomatic malaria cases.   
One alternative to overcome these three caveats and accelerate the path towards malaria 




instead on the traditional passive case detection.  As proposed, reactive case detection, 
presumptively, is a more effective and sustainable method to target the human malaria reservoir, 
given that focuses in a very well-defined population subset at an increased risk of parasitemia 
(largely asymptomatic), instead of searching for malaria in all carriers across the whole population, 
as in traditional active case detection methods where community-wide sampling is done (44).  To 
do so, under reactive case detection, field teams are deployed to test for malaria in all the members 
of the households where at least one subject tested malaria positive within the previous six months, 
considering all of them as the population at high-risk, regardless of the absence of malaria-like 
symptoms.  As a consequence, reactive case detection might represent a more efficient strategy, 
optimizing the time of the field workers in the field, allowing them to increase the coverage, and 
contributing to the sustainability and success of each malaria elimination campaigns (45-47).  
Nevertheless, considering the particular characteristics of the epidemiology of malaria in the 
Amazon, it is strongly recommended that we first assess the effectiveness of reactive case detection 
before recommending its broad implementation.  This is precisely the reason why I have chosen 
this topic of interest as the primary aim of this study.  
Reactive case detection is different from traditional active case detection methods in that 
reactive case detection searches for malaria carriers only within a defined sub-population at high-
risk instead of among the whole population at risk (47).  To do so, field teams first identify the 
high-risk malaria households by using as a signal the malaria cases that were previously reported 
within a certain period of time (often within the last malaria season) and then test all the inhabitants 
of these households under the assumption that it is more likely to detect malaria carriers among 
them than within the households where no malaria cases were reported during the same period 




Swaziland (49), Zambia (50, 51), Senegal (45), Bhutan (52), Mauritius (53), Peru (37), and Brazil 
(54, 55), using similar but different operational definitions and diagnostic methods, and as a 
consequence showing different results.  Furthermore, according to a 2013 malaria control program 
managers survey, reactive case detection has also been implemented in countries like China, 
Cambodia, Democratic People's Republic of Korea, Indonesia, Malaysia, Nepal, Philippines, 
Republic of Korea, Solomon Islands, Thailand, Vanuatu, and Vietnam.  Sadly, very little is known 
about the impact of these experiences yet.  Experiences from Sri Lanka (48) and Swaziland (49), 
where reactive case detection was implemented using a 1 km radius from an index case household 
as the criteria to define the population at risk, although initially reported as successful experiences 
in time they prove to be very hard sustain given its relatively high cost (47).  As an alternative 
Searle et al. assessed reactive case detection in southern Zambia using a 500 m radius reporting 
similar results to those achieved with a 1 km radius and identifying 77% of all households with an 
RDT positive resident and 76% of all RDT positive individuals (46).  In the Peruvian Amazon, 
Branch et al reported that given primarily to the high clustering of malaria carriers screening 
subjects within 100 m radius around the household of the malaria cases passively detected, using 
molecular diagnostic methods, allowed them to detect 4.3 and 1.8 more cases of P. falciparum and 
P. vivax, respectively, than passive case detection alone (37).  According to Stressman et al., in 
Zambia by screening subjects for subpatent malaria within the household of a malaria case 
passively detected, they detected a malaria prevalence that was 11 times higher as compared to 
randomly selected control households (8% vs. 0.7%, respectively) (50).  Littrell et al. assessed a 
similar strategy.  In northern Senegal, who reported that even using RDTs and focusing only within 
the members of a malaria case household they found a 3.2-fold increase in the incidence of malaria 




detected through passive case detection (the “index case”) to trigger additional case detection 
activities, there were several key differences in terms of screening inclusion criteria for malaria 
blood testing (fever, recent history of fever, or none), the criteria used to define the population at 
risk (1 km, 500 m, 100 m around the malaria cases household, limited to the people living within 
the household of the index case, or by targeting a specific number of proximate people or 
households around the household index case) (56).  Based on the current understanding of the 
epidemiology of malaria in the Peruvian Amazon and available infrastructure, I do believe that a 
reactive case detection strategy that test every member within the household of each of the malaria 
cases that were detected passively in the previous six months (our proposed criteria to define the 
high-risk population of malaria), regardless of the absence of symptoms, that uses microscopy as 
the method for diagnosis, and that them follow them at intervals of two months for six months 
represent a sustainable and effective alternative to reduce the transmission of malaria in 
Amazonian riverine communities.  This reactive case detection strategy could contribute to 
optimizing the time, cost, and sustainability of future malaria regional elimination campaigns. 
Regardless of the methods used to target the human malaria reservoir we know very little 
about factors regarding individuals' conceptualization of treatment and factors affecting 
compliance with antimalarial treatments, which are a matter of great concern because implies 
treating asymptomatic individuals.  Currently, the evidence behind asymptomatic subjects 
contributing to the transmission of malaria is very consistent, even at submicroscopic parasitemia, 
so there is an increasing need for a strategy to ensure that a large majority of the individuals 
identified receive full courses of treatment and achieve parasitologic cure, otherwise these people 
will constitute a reservoir for reinfection (57).  There at least two perspectives to take in 




malaria like symptoms, there is any reason why they should seek or complete treatment for malaria 
when identified by the program.  And second, from the healthcare providers' perspective, even 
when those malaria carriers were tested, we still might fail to diagnose and treat a large fraction of 
malaria infections due to subpatent infections (infections with parasitemias below 
microscopy/rapid diagnostic tests threshold of detection) (58).  These are two reasons why it is so 
important to actively search for those cases to effectively reduce transmission (59).  Once 
diagnosed, two activities should be considered as important ones to ameliorate the risk that those 
human malaria reservoirs continue behaving like a parasite source for vectors and subsequent 
malaria transmission.  These behaviors are: (i) to receive and complete a malaria course treatment, 
which is highly relevant to prevent secondary cases (60); and, (ii) perceiving themselves at risk 
(greater than that of others around them) to drive seeking for formal healthcare early at the onset 
of fever in the future (61).  However, in order to be able to enhance these behaviors, we need to 
understand the decision-making processes behind them.  To do so a good initial step might be to 
identify the main social determinants that influence complete treatment adherence, which has been 
investigated intensively among symptomatic malaria-infected subjects (62), but not among the 
asymptomatic malaria cases.  So subsequently, explore which are the decision-making processes 
behind health care seeking behavior in subsequent febrile illnesses.   
 
The Feasibility of malaria elimination in Peru 
In February 2014, a conference was organized in the city of Iquitos, the capital of Loreto, to 
review the agenda of malaria elimination in Peru.  During the meeting, representatives from 
national and regional organizations, as well as from the Ministry of Health and international 




achieve control and further elimination of malaria in Peru.  After discussing the latest body of 
evidence and sharing their country-specific experiences, the group resolved that the feasibility of 
malaria elimination in the Peruvian Amazon was a real possibility, though its success would 
require a clear financial and political commitment from Peru’s government.  This is to launch a 
comprehensive regional plan to guide this initiative, as well as encouraging introducing new tools 
and strategies to purposely eliminate malaria as they are developed.  The consensus highlighted 
that, in order to prevent early failures, the implementation of these measures should be integrated, 
culturally appropriate, and politically and economically sustainable; incorporate regional and local 
authorities (such as provincial governors and local leaders at the city and village levels), to collect 
adequate reliable data on malaria incidence, and focus on interrupting malaria transmission by 
targeting the human malaria reservoir.  
Decision makers should consider adopting targeted parasite elimination strategies that are 
appropriate to the region to overcome the limitations of passive case detection and the hard-to-
reach populations (either remote communities or sub-populations such loggers and gold miners 
that spend large amounts of time away from health infrastructures).  To do so effectively critical 
knowledge, currently unavailable, should be developed to allow program officers to decide where 
to intervene first.  During the meeting, some criteria where proposed to select such sites, including: 
i) have a large population with low incidence of malaria (IPA<1); ii) being cultural and political 
accessible; ii) being close to each other (either within the same river basin or region); and, iv) have 
some capacity to implement control measures as a unit so as to respond efficiently to predictable 
reintroduction events.  However, none of these criteria has been backed up with proper analytics 





The Peruvian malaria elimination program 
In April 2017, Peru launched its latest malaria elimination program, under the name of the 
Zero Malaria Program 2017-2021 ("Plan Malaria Cero 2017-2021") (63), whose overall goal Is to 
eliminate malaria from Peruvian Amazon using a culturally sensitive community based approach.  
Such program represents a major opportunity for the country and an excellent challenge for science 
due to the many knowledge gaps in to fill out to achieve that critical goal.  Hence, this study was 
designed to support this important initiative by identifying the main challenges for the initiative 
and some key opportunities to overcome them.   
 
1.2 Organization of the dissertation 
The dissertation is presented in seven chapters.  Chapter 1 introduces the background and 
specific aims of the research.  Chapter 2 provides a review of the current literature on the 
challenges and opportunities for pursuing malaria elimination in Peru.  Chapter 3 provides details 
on the study area and an overview of the methods for each specific aim. Chapters 4, 5, and 6 
describes a course of three substantive research papers, each aligned with one of the above three 
aims.  Chapter 4 focuses on assessing the malaria elimination program that was implemented in 
Tumbes, which was based on based on RCD/FMDA and compared to PCD.  Chapter 5 investigates 
the impact of this program on interrupting the transmission of malaria beyond the intervention 
areas and along de Peruvian north coast.  Chapter 6 explores whether a further characterization 
and understanding of the different patterns of the transmission of malaria in Loreto may help to 
offer a set of strategic targets for the Peruvian malaria elimination program.  The final chapter 




The Appendices includes the tools and guides used for data collection, institutional approval 
letters, and supplementary tables and figures.  
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1.4 Figures for Chapter 1 
Figure 1. The historical trend of reported malaria incidence in Peru: 1939-2014 
 
 
Legend: Annual Parasite Index (total of subjects that tested smear positives to malaria per 1,000 
inhabitants per year) in Peru since 1939 to 2014.  Here, the red dash shows that the threshold of 1 
case per 1,000 inhabitants has been overcome only twice (in the latest 1960’s and in the latest 
2010’s), but malaria is increasing again.  During this whole period, several important interventions 
were introduced in the country. In 1944, the Rockefeller Foundation (RF) sponsored the 
introduction of Indoor residual spraying (IRS) with dichlorodiphenyltrichloroethane (DDT), but 
after several years of continuous spraying and malaria-burden decline, such funding ceased in 
1970.  In 1988, DDT use was halted first in Loreto and later in the rest of the country. In 1996, 
sulphadoxine–pyrimethamine (SP) replaced chloroquine (CQ) as the first-line treatment of 
uncomplicated falciparum malaria, but after several clinical trials, Peru decided to adopt 
artemisinin-based combination therapies (ACTs) to replace SP in 2001, remaining as such to date 




Figure 2. Annual Parasite Index distribution by surveillance units in Loreto: 2009-2013  
 
Legend: (a) Location of Loreto and (b-f) Annual Malaria Parasite Incidence per Health Center 
for 2009-2013 period.  




Chapter 2. Methods 
 
2.1 Specific Aims 
Primary Aim 1 
To determine the impact of reactive case detection with focal mass drug administration 
(RCD/FMDA) as compared to passive case detection (PCD) on reducing the regional annual 
parasite incidence in Tumbes, Peru.  This was a non-randomized community trial designed to test 
a malaria elimination program based on RCD/FMDA as compared to PCD in Tumbes, Peru. 
 
Primary Aim 2  
To determine the impact of the malaria elimination program implemented in Tumbes on 
interrupting the transmission of malaria beyond the intervention area and along de Peruvian north 
coast.  This was a time series analysis designed to assess the effect the Tumbes malaria elimination 
program on interrupting beyond the intervention areas. 
 
Primary Aim 3  
To characterize the different patterns of the malaria incidence in Loreto and offer a set of 
strategical targets for the Malaria Zero Program.  This was a time series analysis designed to 
characterize the regions of Loreto that exhibits similar or different patterns of malaria incidence, 
looking for specific communities which are reservoirs for prolonged parasitemia and thus potential 





2.2 Summary of studies 
Study 1 (Chapter 3). “Reactive case detection with focal mass drug administration for 
malaria elimination in northwestern Peru”.  
This was a non-randomized community trial that was implemented in Tumbes, Peru.  The 
goal was to determine the impact of reactive case detection with focal mass drug administration 
(RCD/FMDA) on reducing the regional annual parasite incidence in Tumbes.  The effect for both 
interventions was evaluated as their effect on reducing the mean annual parasite incidence during 
the pilot study (2009-2010) across the surveillance reporting units from the two intervention 
districts compared to the surveillance reporting units from the eleven non-intervention districts 
that utilized passive case detection only.  To complement this analysis, we also described the trends 
of the annual parasite incidences in the department in the five years following the RCD/FMDA 
scale-up (2011-2015).  In both analyses, we used the regional surveillance data and included the 
reporting units that report at least one malaria case during 2000-2009. 
   
Study 2 (Chapter 4). “Reactive case detection with targeted mass drug 
administration: Interrupting malaria transmission and achieving elimination beyond 
intervention areas in northwestern Peru”.  
This was a follow-up study of the non-randomize community trial previously described 
that aims to assess the impact of malaria elimination program implemented in Tumbes beyond the 
intervention areas and along the Peruvian north coast.  The effect of the intervention was measured 




In this analysis we the weekly parasite incidence as the outcome and the regional surveillance data 
from both regions, Tumbes and Piura. 
 
Study 3 (Chapter 5). “The patterns of malaria incidence in the Peruvian Amazon and 
the opportunity of interrupting malaria transmission with focal interventions”.  
This study was a Time-Series Cross-Sectional Analysis that explores whether a further 
characterization and understanding of the different patterns of the transmission of malaria in Loreto 
may help to offer a set of strategical targets for the Peruvian malaria elimination program.  The 
third study develops the hypothesis that the reactive case detection with focal mass drug 
administration may have a role in the path towards eliminating malaria from the Peruvian Amazon, 
particularly in the riverine networks that have some communities that behave like malaria foci that 
boost the sustainability of malaria transmission from one malaria season to the next one. 
 
2.3 Study Population 
The thesis research was conducted in three different regions in Peru, the Tumbes and Piura 
regions on the north coast, and the Loreto region in the north of the Peruvian Amazon.  Study 1 
was carried on in the northern region of the Peruvian north coast at the border with Ecuador, while 
the study 2 was carried on in the nearby region of Piura.  Study 3 was carried on in the Loreto 
region, which is the largest region in the country and is located on the borders with Ecuador, 
Colombia, and Brazil. 
The Peruvian north coast is comprised of four regions (From north to south: Tumbes, Piura, 




bordering with Ecuador, and consequently are very important geopolitically, economically and 
epidemiologically for both countries (Figure 3).  Malaria transmission along the north coast has 
historically progressed from north to south giving tropical weather and greater endemicity in the 
north (Tumbes and Piura) and the connectivity provided by the Pan-American Highway that 
connects them to the capital city of Lima.  Most malaria cases in northern regions of Peru have 
been consistently due to P. vivax, but occasionally P. falciparum.  In the year 2000 the north coast 
regions reported 21,985 malaria cases, with ~20% of those cases secondary to P. falciparum; 
however, in the year 2015, those regions reported only 50 cases (4 in Piura and 46 in La Libertad), 
with all of those cases secondary to P. vivax.  The principal malaria vectors in the region are An. 
albimanus, An. calderoni, and An. pseudopunctapenis (1), unlike in the Amazon region, where An. 
darlingi mosquitoes predominate (2).  The majority of infections are asymptomatic, although we 
reported several but uncommon severe vivax malaria cases in Piura (3).  Malaria along the north 
coast is strongly seasonal, peaking during the rainy season (February-June) and plunging during 
the dry season (July-January).  Such strong variability might be explained by regional 
characteristically fluctuations in the climate parameters such as rainfall and temperature, which 
determine the ability of the environment to support the development of mosquito larvae (4).   
Tumbes, the smallest region of the all the four north coast regions, is divided into 13 districts, 
encompasses roughly 230,000 people, and have a total surface of 4,670 km2.  In the late 1990s, 
malaria was transmitted by both P. vivax and P. falciparum, but early in the 2000s, the incidence 
of malaria was drastically reduced due to the introduction of artemisinin-based combination 
therapy (ACT) in the country.  Consequently, the parasite predominance shifted towards P. vivax, 




falciparum malaria outbreak reported in years 2010-2012 due to malaria imported cases from 
Loreto, the last autochthonous case of P. falciparum was reported in the region in 2006 (5).   
Peru is divided into 24 regions (Figure 4), of which nine are situated along the Peruvian 
Amazon basin, including (From north to south): Loreto, Amazonas, San Martin, Ucayali, 
Huánuco, Pasco, Junin, Madre de Dios y Cusco.  Each of these nine regions has been malaria 
endemic in the past two decades, with a strong seasonal pattern, peaking consistently between 
March and August.  That been said, it is important to highlight that Loreto represents by far the 
largest human malaria reservoir in the Peruvian Amazon basin, contributing historically to the 
spread of malaria across the nearby Amazon basin regions.  Most malaria cases in Loreto, as in 
the rest of the country, have been consistently reported as due to P. vivax, but the region is currently 
facing a substantial increment of P. falciparum malaria cases.  In the year 2010 Loreto reported 
25,927 malaria cases, with ~15% of those cases due to P. falciparum; however, in the year 2014 
Loreto reported 60,566 malaria cases, with ~17% of those cases due to P. falciparum.  The 
principal malaria vectors in the region are An. darlingi and An. bennarrochi (6), the majority of 
infections are asymptomatic (7), and severe malaria cases are uncommon  with very few deaths 
reported in the literature (8). 
 
2.4 Malaria Surveillance data 
Malaria counts 
Malaria is a condition that requires mandatory weekly reporting from all health facilities 
countrywide according to the surveillance guidelines of the Peruvian Ministry of Health (MoH). 




Regional Health Directorates (DIRESA's), where their epidemiology units analyze the data and 
report it to the central government using an Electronic Online Surveillance System named NOTI. 
The process of data collection begins with registering every febrile illness that needs to be 
tested for malaria at each reporting unit by the designated health personnel in charge of the local 
malaria program. Then the designated personnel proceeds with the notification process by 
summarizing the data and sending two types of reports: collective cases reported including both 
fever cases and malaria cases, and the individual cases reports.  Once the data is received at each 
DIRESA, the data is entered into the NOTI system.  During the data entry, a monitoring process 
takes place, checking quality control and optimizing the database.  At this point, a weekly 
surveillance report is generated to allow the local epidemiologist to follow the malaria trend. Once 
the data entry process and quality control are finished, the NOTI system is collected online at the 
Peruvian Center of Diseases Control, where the country data is analyzed and examined for 
indications of outbreaks or other trends.  The information is returned to the DIRESA stakeholders 
as epidemiological bulletins to inform their decision making with a 1-2 weeks delay since the cases 
are initially documented.  Overall the data allows the public health officers to assess the 
distribution and trends of malaria at the regional scale, but rarely is used to inform decision making 
at the reporting units scale.  
 
Population data 
The annual population estimates per health center were obtained from the Tumbes, Piura 
and Loreto’s Ministry of Health Directorates.  Moreover, the weekly population estimates were 
calculated based on linear interpolation from the annual population estimates assigned to each 






Malaria incidences were estimated annually and weekly at each health center using the 
formula for the annual parasite incidence (API), as defined in equation 1, and the weekly parasite 
incidence (WPI), as defined at the equation 2:  
Annual Parasite Incidence = !"#$%&'(	*+	(',*(-'.	/01'1	.$(2#3	0	4'0(	,'(2*.
,*,$50-2*#	.$(2#3	0	4'0(	,'(2*.
6 ∗ 1000:     (1) 
 
Weekly Parasite Incidence = !"#$%&'(	*+	(',*(-'.	/01'1	.$(2#3	0	;''<	,'(2*.
	,*,$50-2*#	.$(2#3	0	;''<	,'(2*.
6 ∗ 1000:     (2) 
The APIs are reported per region at the Epidemiological Bulletins published by the 
Epidemiology General Directorate (http://www.dge.gob.pe/portal/).  And despite it only depicts a 
rough picture of the regional malaria trends is commonly used by MoH decision makers as the 
main metric to guide public health spending and resources allocation.  Consequently, those regions 
with the highest burden receive more budget to manage their malaria cases and those with less 
malaria cases more budget to fight the most important competitive risks at the moment.  
 
2.5 Remote Sensing Data 
The methods used to analyze the remote sensing data and estimate the climate and 
environmental variables at each health center were described in a separate publication (Table 2) 
(9).  Briefly, as described in the manuscript “temperature, humidity, and surface pressure were 
calculated based on the outputs from the NASA MERRA (Modern-Era Retrospective analysis for 




Mission (TRMM) Multisatellite Precipitation Analysis (TMPA); vegetation products from the 
moderate-resolution imaging spectroradiometer (MODIS) instrument; and elevation data from the 
Advanced Spaceborne Thermal Emission and Reflection Radiometer (ASTER) Global Elevation 
Model (GDEM)” (9). 
The MERRA model provided us with a historical time series of temperature, humidity, and 
surface pressure.  The model run off since 1979 and incorporates remote sensing observations from 
different modern satellites providing estimates for other variables also such precipitation, 
radiation, as well as land surface variables like soil moisture.  Data from MERRA products are 
available hourly with a spatial resolution of 1/2° (latitude) × 2/3° (longitude).  For the studies, we 
obtained from MERRA the following variables: specific humidity at 2 m above the displacement 
height (QV2M), the temperature at 2 m above the displacement height (T2M), and soil moisture 
content in the top soil layer (SFMC). 
Like MERRA the TRMM TMPA dataset also provides precipitation estimates, but with a 
higher resolution.  To do so, it merges information from multiple satellite sensors and ground-
based gauges to produce a more precise one (10).  These include several passive microwave 
sensors (PMW) that are onboard Low Earth Orbit Satellites and sensors that are on board platforms 
of the Defense Meteorological Satellite Products and NOAA (11).  The TMPA product is created 
by using the PMW rain rates from each sensor through the Goddard Profiling algorithm and is 
available for the 50°N–S latitude band since 1998 with 0.25° × 0.25° resolution at 3-hourly time 
steps (12).  The TMPA product is available in a real-time version (TMPA 3B42RT) and in gauge-
adjusted post real-time research version (TMPA 3B42), which use of rain gauge data for bias 
adjustment (13).  So, to prevent such bias, the studies will use the TMPA 3B42V7, as strongly 




Vegetation indices for the studies were obtained from the global 16-day composite of 
MODIS vegetation indices.  Although MODIS produces two indices, the normalized difference 
vegetation index (NDVI) and the Enhanced Vegetation Index (EVI), for the purpose of the studies 
the selected index will the NDVI (15).  NDVI is available from the MOD13C1 Product at 0.05° x 
0.05° resolution (~ 5,6 km2) and is derivate from the reflectance in the near-infrared (N) and red 




	                                                             (2) 
 
Elevation data for the studies was obtained from the ASTER GDEM model, which provides 
elevation data globally at 30 m resolution.  The ASTER instrument produces the ASTER DEMs 
by using near infrared spectral band and nadir-viewing and backward-viewing telescopes to 
acquire stereo image data (16).  Such data, then is processed automatically and comprehensible by 
including cloud masking, stacking all cloud-screened DEMs, removing wrong values, and 
averaging selected data to create final pixel values.  The ASTER GDEM is available with a 
resolution of 1° × 1° tiles for land surface regions between 83o N-S (16).  
 
2.6 Surveillance Data Modeling 
To account for the limitations proper of surveillance data as well as for its multilevel 
structure each of the studies assessed potential confounders using a mixed-effects Poisson 
regression model.  The overall notation for these models is the following: 




2IU2V                (3) 





WXYGK2IJ − WXYGL2IJ = N′2IR + T′2IU2                  (5) 
 
WXYGK2I L2I⁄ J = N′2IR + T′2IU2                         (6) 
 
WXYGK2I L2I⁄ J = N′2IR + T′2IU2                       (7) 
 
Where:  ] = 1,… ,`	aXbcd]L]Me,  f = 1,… , d2	gMMhe, and U2~`(0, klm) 
 
 
In the study 1, we estimated the adjusted incidence rate ratio (IRR) attributable the 
RCD/FMDA by fitting a two-level mixed-effects Poisson regression for the weekly malaria 
incidence adjusting for potential environmental and climate confounders.  These variables 
included temperature, humidity, soil moisture, elevation, precipitation, as well as the normalized 
difference vegetation index (NDVI) and the enhanced vegetation indexes (EVI). 
In the study 2, we used similar approach, but here we focused in the association between the 
weekly malaria incidence and the road proximity to the intervention districts during the pilot of 
study 1.  Here, we use road distances estimated from each surveillance unit to the Aguas Verdes 
international bridge over the Zarumilla river, which connects Peru with Ecuador, as a proxy of 
indirect exposure.  
And in the study 3, we use a two-level mixed-effects Poisson regression model to assess the 
variability of the malaria counts and characterize the different patterns of malaria transmission 
across the main riverine networks of Loreto.  However, giving a large number of zeros in the 
malaria counts across Loreto, we ultimately fitted a mixed negative binomial regression model to 
compensate for the over-dispersion of the count data.  In all data sets examined, the negative 
binomial model fitted much better than the Poisson regression model and other alternatives like 




decided to report the negative binomial regression model giving it is a much simpler model to 
estimate and interpret.  
At each study we used the forward selection, the Akaike Information Criteria (AIC) and the 
likelihood ratio test (LRT) to determine the variables for the multivariate model comparing nested 
models.  And to assess and prevent multicollinearity we used the correspondent Pearson’s 
correlation coefficients for each analysis.  All the mixed-effects regression analysis was conducted 
with Stata/MP 14.0 (Stata Corporation, College Station, TX) using the "meqrpoisson" command 
for the Poisson regression model and the "membreg" command for the negative binomial Poisson 
regression model. 
 
2.7 Seasonality component  
There are several alternatives about how to assess or to define malaria seasonality, resulting 
in a wide range of alternatives reported in the literature.  Choosing one is essential to model malaria 
cases because, like in Peru, malaria distribution in time shows seasonal peaks in most endemic 
settings.  However, it is also important to understand that such choice may vary across settings for 
optimal malaria control and seasonality characterization.  In study 3, we decided to address 
seasonality by using a trigonometric solution, which is a simple approach to describe and compare 
the seasonality of malaria across settings (17).  To do so, we incorporated sine and cosine terms in 
our mixed effects regression models.  These terms will be included in pairs to satisfy boundary 
conditions and orthogonality.  This is important because the predictions from a regression on sine 
and cosine terms are automatically identical at the beginning and the end of the interval to deal 
with the periodicity of each interval without discontinuity.  And because an attractive property of 




To produce the necessary set of trigonometric predictors we used Stata and forvalues loop.  
Following Cox et al recommendations we set the loop over the integers 1/3 (i.e., 1, 2, and 3) and 
the counter (strictly, a local macro) “j” to 1, which represents the first time around the loop. 
Consequently, in Stata we used the following commands: 
. generate t = week_n / 52 
. forvalues j = 1/3 { 
.  gen sin`j' = sin(`j' * 2 * _pi * t) 
.   gen cos`j' = cos(`j' * 2 * _pi * t) 
. } 
By running the previous coding in Stata, we certainly can describe the seasonal pattern of 
malaria as two sine and one cosine functions within a regression model, and more importantly, we 
can adjust our predictor of interest by its main confounders of interest. 
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2.9  Tables for Chapter 3 
Table 1. Annual Parasite Incidences (API) by region during years 2000-2014 
Region 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Loreto 26.4 37.9 58.2 52.4 47.5 59.2 45.6 39.2 26.2 26.6 11.6 11.8 25.0 42.9 57.3 
Tumbes 15.3 17.5 9.8 7.8 5.3 2.1 2.2 5.5 13.0 6.8 8.2 3.0 0.4 0.0 0.0 
Piura 9.0 8.9 6.1 1.5 0.5 0.2 0.1 0.3 2.3 1.6 1.2 0.1 0.0 0.0 0.0 
Madre de Dios 5.8 4.4 9.1 6.3 21.5 50.2 45.0 41.3 39.1 18.1 25.1 14.1 5.2 2.0 0.1 
Ayacucho 4.0 2.5 3.8 4.3 7.9 8.5 4.4 1.4 0.6 0.7 1.7 3.4 3.8 2.4 1.0 
San Martín 2.8 7.5 9.2 14.9 14.8 6.8 2.1 1.3 1.1 1.1 1.0 0.3 0.2 0.1 0.9 
Junín 2.1 2.1 0.1 3.8 5.1 4.6 2.3 2.7 2.0 1.5 5.6 3.5 1.4 1.7 1.5 
Ucayali 1.9 3.9 8.1 8.5 8.4 6.3 1.5 0.3 0.7 0.5 0.6 0.1 0.1 0.2 0.1 
Lambayeque 1.8 0.4 0.5 0.9 0.2 0.3 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 
Amazonas 1.6 0.8 1.8 1.6 2.3 3.4 0.9 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.2 
Cusco 1.3 1.5 2.0 2.0 3.9 2.8 1.4 0.6 0.5 0.2 0.8 0.8 0.3 0.5 0.3 
La Libertad 1.2 1.4 0.6 0.8 0.7 0.5 0.7 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 
Cajamarca 1.0 0.5 0.4 0.3 0.7 0.8 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 
Ancash 0.8 0.9 0.5 0.5 0.6 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Pasco 0.6 0.5 0.8 1.4 1.1 1.8 1.3 0.7 0.8 0.1 0.5 0.2 2.0 0.1 0.0 
Huancavelica 0.5 0.1 0.2 0.1 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Apurímac 0.3 0.0 0.1 0.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Huánuco 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Puno 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Loreto 26.4 37.9 58.2 52.4 47.5 59.2 45.6 39.2 26.2 26.6 11.6 11.8 25.0 42.9 57.3 
Tumbes 15.3 17.5 9.8 7.8 5.3 2.1 2.2 5.5 13.0 6.8 8.2 3.0 0.4 0.0 0.0 
Piura 9.0 8.9 6.1 1.5 0.5 0.2 0.1 0.3 2.3 1.6 1.2 0.1 0.0 0.0 0.0 
Madre de Dios 5.8 4.4 9.1 6.3 21.5 50.2 45.0 41.3 39.1 18.1 25.1 14.1 5.2 2.0 0.1 
Ayacucho 4.0 2.5 3.8 4.3 7.9 8.5 4.4 1.4 0.6 0.7 1.7 3.4 3.8 2.4 1.0 
San Martín 2.8 7.5 9.2 14.9 14.8 6.8 2.1 1.3 1.1 1.1 1.0 0.3 0.2 0.1 0.9 




Table 2. Malaria counts and weekly parasite incidences (WPI) in Loreto by provinces 
during years 2010-2017 
Region  2010 2011 2012 2013 2014 2015 2016 2017 
Alto Amazonas Cases 457 508 1079 1090 2286 2520 2419 3739 
 Mean WPI 11 17 39 35 65 82 72 111 
Datem del Marañon Cases 611 884 1921 4955 11559 11357 14925 17483 
 Mean WPI 14 11 28 74 192 325 838 1171 
Loreto  Cases 1356 876 2360 6359 11842 12997 12756 9243 
 Mean WPI 41 17 53 139 313 369 544 457 
Mariscal Ramon Castilla Cases 1735 1356 7216 9380 5427 8442 2565 3269 
 Mean WPI 52 34 140 221 104 185 69 95 
Maynas City Cases 3496 4152 7065 13487 17810 12379 11205 7616 
 Mean WPI 41 71 154 225 228 173 146 125 
Maynas Periphery Cases 2131 3011 3524 5373 6484 9117 7871 9588 
 Mean WPI 43 45 60 101 114 190 161 204 
Requena  Cases 796 330 791 1071 1069 717 556 414 
 Mean WPI 87 29 94 131 113 70 73 52 
Ucayali Cases 166 107 59 132 73 132 91 51 





Table 3. Annual Parasite Incidences (API) by region during years 2000-2014 
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2.10  Figures for Chapter 3 
Figure 3. Peruvian north coast and its four malaria endemic regions 
 
Legend: From north to south: Tumbes, Piura, Lambayeque, and La Libertad 






Figure 4. Peruvian Amazon and its elevation variability 
 
Legend: Notice that the Peruvian Amazon encompass about two thirds of Peru´s territory 
including nine administrative regions.  Peruvian Amazon basin regions from north to south: 
Loreto, Amazonas, San Martin, Ucayali, Huánuco, Pasco, Junin, Cusco, and Madre de Dios. 




Figure 5. Scatterplot matrix of the first three pairs of sine and cosine terms 
 
 





Chapter 3.  “Reactive case detection with focal mass drug 
administration for malaria elimination in 
northwestern Peru”  
3.1 Abstract 
Reactive case detection (RCD) with focal mass drug administration (FMDA) represent a 
novel and efficacious strategy for malaria elimination, although little is known about its 
effectiveness.  In this study, we assessed the effectiveness attributable to the RCD/FMDA strategy 
as compared to passive case detection (PCD) in reducing the incidence of malaria to zero in 
Tumbes, Peru.  From 2009 to 2010 we piloted a malaria-elimination program based on 
RCD/FMDA in the two districts with high burden of malaria in Tumbes; then, from 2011 to 2014 
we scaled the program up in the other 11 districts in Tumbes.  Under RCD each malaria case that 
was passively detected was followed-up within the first 24 hours by enumerating and treating each 
of their household contacts, excluding pregnant women, elders (>65 years old), and chronically-
ill subjects.  Then every eligible subject was treated with oral chloroquine (25mg/kg, total dose) 
for 72 hours plus oral primaquine (0.5mg/kg) for seven days.  The primary study endpoint was a 
50% reduction in the annual parasite incidence (API =total malaria cases/1,000 inhabitants) at the 
surveillance-reporting unit level, and the data were analyzed by the intention to treat method.  The 
Peruvian Ministry of Health sponsored the study, and the Ecuadorian government donated 20,000 
vivax malaria treatments.  During the pilot study, we treated a total of 8,243 subjects, including 
7,376 household contacts.  The estimated reduction in the mean API across intervention reporting 
units was 86% (95% Confidence Interval: 72−100) at 12-months and 98% (93−100) at 24 months 




months and -19% (-87− 49) at 24-months, respectively.  The reductions in the mean API were 
statistically significantly higher in the intervention group at both 12-months (p =0.02) and 24-
months (p =0.04) compared to baseline.  These findings were verified using mixed-methods 
Poisson regression analysis when adjusting the RCD/FMDA effect by seasonality and climate and 
environmental parameters of soil moisture, surface pressure, and vegetation.  Based on this 
multilevel multivariate analysis we observed that RCD/FMDA significantly contributed to 
decreasing the weekly parasite incidence (Beta= -0.53; CI 95%: -0.91, -0.15; IRR=0.59) in the 
intervention areas as compared to the comparison areas.  After scaling up, the API throughout 
Tumbes dropped to 3.1 and 0.4 in the years 2011 and 2012, with zero cases found in 2013, and 
one imported case in the year 2014.  As a result of this, we concluded that RCD/FMDA represents 
an effective strategy to support malaria elimination initiatives in regions with high predominance 
of vivax malaria, strong but limited connectivity between communities, with a long track record 
using primaquine as is found in northwestern Peru and the Peruvian Amazon. 
 
3.2 Introduction 
Malaria control has proven to represent a formidable challenge despite the latest investments 
and innovations proposed to tackle the burden of such threatening disease (1).  Currently, the 
burden of malaria has steadily declined since 2000, but still represents one of the top ten leading 
causes of death in children aged 1-59 months worldwide (2).  This progress certainly can be 
attributable to the significant political and financial commitment invested in scaling up of 
prevention, diagnosis, and treatment during the 2000-2015 period (3).  During this period, the 
increasing trend in malaria incidence was halted and reversed, putting the world on track to 




has been somewhat uneven.  For example, in 2015 the WHO European Region has reported zero 
indigenous cases for the first time while in the WHO African region - mainly in Sub Saharan Africa 
- fifteen countries reported 80% of the malaria cases and 78% of malaria deaths globally (4).  
Similar uneven progress had been observed within each WHO region and within each country, 
showing that malaria control efforts must be flexible using macro- and micro-level approaches.  
One of the reasons for this variability is that the main reservoir of malaria parasites is often over-
dispersed (5, 6).  As we progress towards malaria elimination, delivering interventions becomes 
progressively more difficult and expensive, mainly because the malaria map now is concentrated 
in the hardest to reach populations (7).  Furthermore, because antimalarial medication is not free 
from adverse events and the threat of drugs resistance is not trivial, it is critical to use them wisely 
(8).  In recent years, several new strategies have been proposed to overcome both considerations.  
Among them, reactive case detection (RCD) with focal mass drug administration (FMDA) appears 
to be a promising alternative to mass drug administration (9).   
RCD is different from traditional active case detection methods in that it searches for malaria 
carriers, with individuals with asymptomatic parasitemia as the primary target, only within a 
defined high-risk sub-population instead of treating the whole population (10).  First, field teams 
identify high-risk malaria households, often by identifying and index case detected either passively 
or previously reported within a specified period (often within the last malaria season).  Then, all 
the inhabitants of these households are tested and treated if testing positive (11).  Several countries 
have used RCD in the past (11-17), including Peru (18) and Brazil (19, 20) in the Americas, using 
similar but different operational definitions and diagnostic methods, and as a consequence showing 
different results (21).  Focal mass drug administration (FMDA), also known as targeted mass drug 




high-risk population instead of the whole population at risk, regardless of the presence or absence 
of malaria-like symptoms and without diagnostic testing.  China (22), Greece (23, 24), Tanzania 
(25), Zambia(26), and Kenya (27) have tested FMDA with relative success, reporting it as a cost-
effective alternative to MDA in low malaria-endemic settings (28).  By limiting the number of 
subjects receiving malaria drugs, we can avoid large numbers of unnecessary treatments, limit the 
risk of severe adverse events and drug resistance, and even with imperfect diagnostics target a 
more substantial fraction of human malaria reservoir than those covered with screen-and-treat 
strategies (25).  Hence, it is critical to differentiate those that are at high risk of malaria from the 
rest of the population to correctly implement such a strategy.  To do so, researchers have proposed 
RCD as an alternative to precisely do that. Using RCD, we can detect more malaria by actively 
screening subjects for malaria within the areas surrounding the households of every symptomatic 
malaria case that is passively detected (often with parasite densities detectable with microscopy or 
rapid diagnostic tests [RDT]).  Recently China (22) and Greece (23, 24) have reported successful 
experiences using the RCD/FMDA strategy controlling the burden of malaria in regions where 
vivax was the predominant species.  
In Peru, since the introduction of Artemisinin-based Combination Therapy in 2001-2003 
(29), the number of cases of P. falciparum has decreased, particularly in the North Coast of Peru.  
Tumbes, which borders Ecuador, sustained its negative trend until achieving zero local 
transmission of P. falciparum malaria in the year 2005 (30).  With the exclusion of an outbreak of 
P. falciparum malaria that occurred within a military base in 2008, nearly all malaria cases reported 
after the year 2005 were due to P. vivax.  However, during the same period, P. vivax malaria in 
Tumbes begun to increase, to the point that Tumbes became a significant source of the malaria 




Pan-American highway.  These changes provided a unique opportunity for binational collaboration 
and to pilot a strategy based on the RCD recently implemented by the regional health directorate 
in the region and the FMDA experience from Ecuadorian peers (31).  In this study, we reported 
the results of this experience, including initial piloting in two districts and followed by scaling up 




The study design is a non-randomized community trial followed over time.  In Tumbes, we 
piloted an RCD/FMDA strategy at the two most malaria endemic districts − Aguas Verdes (3°28´S 
80°14´ W, population ~13,000) and Zarumilla (03°49´S 80°27´W, population ~22,000) −.  We 
selected the remaining eleven districts (population ~167,000) as controls, given that they continue 
using passive case detection as established by the Peruvian malaria guidelines.   
To assess the strategy, we determined the effect on the mean annual parasite incidence 
across each the reporting units from the two intervention districts compared to the reporting units 
from the eleven non-intervention (control) districts that utilized passive case detection only.  To 
complement this analysis, we also described trends in annual parasite incidence in the region in 
the five years following the RCD/FMDA scale-up (2011-2015).  In both analyses, we included the 






Tumbes, one of the 24 regions of Peru, is located in northwestern Peru on the border with 
Ecuador.  The region has a warm climate due to its location nearby the Equator, with beaches 
considered among the finest in Peru.  Despite its small area, the region contains a wide variety of 
ecosystems.  Politically, Tumbes is divided into 13 districts with a total surface of 4,670 km2 and 
a population of ≈237,685 inhabitants.  In the late 1990s, P. falciparum was highly endemic in the 
region (Annual Parasite Incidence >10 x 1,000 inhabitants, with 36% of cases due P. falciparum 
in 1998) (32), but since year 2000 the parasite predominance shifted to P. vivax to the point that 
autochthonous falciparum transmission was reduced to zero in the year 2006.  However, during 
October 2010-June 2012 Tumbes reported an outbreak of P. falciparum malaria (n =210 cases).  
The index case was identified as a military that traveled from Yurimaguas, a small town in the 
Peruvian Amazon, where P. falciparum remains endemic (33).  In Tumbes, contrary to the 
Amazon region where An. darlingi is the main vector, the most predominant Anopheles species 
was Anopheles albimanus.  Malaria endemicity of malaria in Tumbes is low and seasonal, peaking 
during the rainy season (February–June).  Figure 6 displays the map of Tumbes with the 
distribution of the health centers within each district, the rivers, and roads, as well as the boundaries 
of the Tumbes regions and its 13 districts.  Some health centers are clustered along the Peruvian 
border with Ecuador, some along the Tumbes River, while other health centers are more dispersed 






For this study, we selected Aguas Verdes and Zarumilla to pilot an RCD/FMDA strategy 
considering that both represented the two most malaria endemic districts in Tumbes.  We used as 
controls the remaining 11 districts, which continue using PCD as the strategy recommended by 
the Peruvian National Malaria guideline (34).  At the intervention sites, subjects were considered 
as eligible for FMDA if they: (1) had his/her legal residence registered at their intervention 
districts; (2) resided at the household of a subject that was diagnosed as malaria positive within 
the previous 24 hours (index case) or resides outside the index case household but is identified 
during the census by him/her as a close social contact (either because of work or study in close 
contact on daily basis); and (3) assented to complete the malaria treatment regardless of the 
absence of symptoms.  Exclusion criteria included children under five years old, elders (65 years 
of age or older), pregnant women, and chronically ill subjects.  
 
Study interventions 
The study intervention was RCD/FMDA, where every malaria case that was passively 
detected was immediately followed within the first 24 hours in order to census and treat each of 
his/her household/social contacts, excluding children under 5 years old, elders (adults 65 years of 
age or older), pregnant women, and chronically ill subjects (Figure 7).  The “control” (or 
comparison) was PCD, where only the subjects that tested positive for malaria during passive case 
detection activities received treatment.  In both cases, following national guidelines, subjects were 
treated uniformly and free of charge for uncomplicated vivax malaria cases.  To ensure that passive 




collaborated with local authorities to train malaria officers at each of the regional reporting units.  
We developed a capacity building system (combining in-class active learning methods with Pre-
Post assessments) to train the personnel responsible for the malaria program annually, as well as 
to procure the administrative and laboratory supplies necessary to ensure a continual provision of 
care.   
 
Treatment for Vivax Malaria 
As described in the Peruvian malaria treatment guidelines all patients received treatment 
uniformly and free of charge at each of the MoH health care facilities (35).  Briefly, the treatment 
of choice for uncomplicated vivax malaria cases in adults and children consist in oral chloroquine 
(10 mg/kg/day) daily for three days, plus primaquine oral (0.5 mg/kg), daily, for seven days.  
Pregnant women receive chloroquine (10 mg/kg/day) daily for three days and then a weekly dose 
of 5 mg/kg upon delivery.  Immediately after, they receive primaquine phosphate (0.5 mg/kg) daily 
for seven days.  Infants under six months of age were treated with only chloroquine, while the 
unconscious patients were treated with clindamycin (20 mg base/kg/day) and quinine sulfate (10 
mg salt/kg/day) intravenously, three times daily, until they start to tolerate oral standard treatment. 
 
Study outcomes 
As a primary outcome, we assessed and compared the malaria annual parasite incidences 
at baseline (2008) with the second year (2011) post-intervention between the reporting units from 
the two intervention districts and the 11 non-intervention districts in the study.  As secondary 




following five years.  Annual parasite incidence was calculated by dividing the total count of 
malaria cases, as reported by the national surveillance system, over the total population as 
estimated by the Peruvian Ministry of Health, at each of their surveillance reporting units.  Those 
subjects that tested positive and did not report malaria-like symptoms (fever, chills, sweating, 
headache or any other kind of symptoms that the subject interpreted as indicating malaria) during 
RCD/FMDA activities were diagnosed with asymptomatic malaria and included in the API 
calculations. 
 
Climate and environmental variables 
A specific set of climate and environmental variables were obtained for the purpose of 
adjusting our estimates of the effect of RCD/FMDA by assessing different satellite remote sensing 
products.  These variables included temperature, humidity, soil moisture, elevation, precipitation, 
as well as the normalized difference vegetation index (NDVI) and the enhanced vegetation indexes 
(EVI) (Figure 6).  Each of these variables was assessed using their weekly averages estimated at 
the coordinates of each the health centers for the 2008–2014 period.  Temperature (T2M or 
temperature at 2m above the displacement height), humidity (QV2M or specific humidity at 2 m 
above the displacement height), and soil moisture (SFMC or soil moisture content in the top soil 
layer) estimates were obtained from the NASA MERRA (Modern-Era Retrospective analysis for 
Research and Applications) model; elevation data from the Advanced Spaceborne Thermal 
Emission and Reflection Radiometer (ASTER) Global Elevation Model (GDEM); precipitation 
data from the Tropical Rainfall Measuring Mission (TRMM) Multisatellite Precipitation Analysis 
(TMPA); and NDVI and EVI estimates from the Moderate-Resolution Imaging Spectroradiometer 




by averaging their hourly estimates using the standardized protocols for each of the satellite 
products.  MERRA data was available at hourly steps and at 1/2°×2/3° spatial resolution in latitude 
and longitude; TMPA data was available for the at 3-hourly time steps and 0.25°×0.25° resolution; 
while MODIS data was available at 0.05° resolution.  
 
Data Collection 
Annual parasite incidence (malaria cases per 1,000 inhabitants) was estimated based on 
surveillance malaria counts and government population estimates, so we extensively reviewed the 
regional malaria surveillance registries from each of the reporting units during the study period.  
For the study, we took advantage of the national surveillance system (implemented in 2001), which 
provides a confidential and secure database with accurate data recording.  All reporting units report 
their malaria counts on a weekly basis to the regional health directorate, which was in charge of 
the data entry by using the surveillance software NOTI.  The software was designed to minimize 
data entry errors, such as including field range limits and logic checks, as well as to allow 
systematic checks for consistency and completeness.  The primary data source for each positive 
malaria cases was the data recorded by the malaria program officers at each reporting unit, 
complemented by available data from the regional laboratory.  We confirmed each case by 
microscopy at a primary laboratory (located at each reporting unit) and sent a random 10% fraction 
of these samples to the regional laboratory for quality control purposes.   
We maintained the main datasets at a secure computer system, save weekly backups on 
local hard drives and monthly backups on the Regional Health Directorate computer systems, as 
prevention to avoid loss of data.  All databases were password protected.  We maintained 




locked filing cabinets separate from all other information and limit their access to only the study 
data managers.  Then, we translated the data into CSV files ready to be imported with STATA/MP 
v14.0 (Stata Corporation, College Station, TX, 2011) for further editing and checks, reviewing the 
data for consistency and completeness.  
 
Data Analysis 
First, we performed an exploratory analysis to describe and compare the baseline 
characteristics within and between study arms.  Baseline characteristics and primary and secondary 
outcomes were described with summary statistics, using frequency and percentage for categorical 
variables and mean and standard deviation for continuous variables.  To estimate the effect of the 
RCD/FMDA during the pilot study we compared the mean API across reporting units between the 
two study arms, those from the two intervention districts with those from the eleven non-
intervention comparison districts, from years 2008 (baseline) to 2010.  This and further 
multivariate analysis were performed by using a mixed-effects Poisson regression model to adjust 
for potential confounders and to account for the structure of the data.  The following variables 
were assessed as potential confounders: seasonal trend, year, week, precipitation, vegetation, 
temperature, surface pressure, humidity, and soil moisture.  Forward selection was used to 
determine the variables selection for the multivariate model using the Akaike Information Criteria 
(AIC) and the likelihood ratio test (LRT) to compare nested models.  Pearson’s correlation 
coefficients are also computed for each variable to assess and prevent multicollinearity.  All the 
analyses were conducted with Stata/MP 14.0 (Stata Corporation, College Station, TX) using a 






During study planning, the study protocol was presented by the Tumbes Regional Health 
Directorate authorities to the National Ministry of Health authorities, which approved the study as 
a pilot demonstrative project of public health relevance.  During RCD/FMDA activities eligible 
subjects were invited to participate, instructed about the study risks and benefits, and only those 
whom consented received the treatment for vivax malaria.  The Regional Health Directorate 
covered the costs for all the interventions related activities, including the training and retraining of 
the Ministry of Health personnel and the laboratory and administrative supplies.   
 
3.4 Results 
Malaria cases at baseline 
From 2001 to 2008, Tumbes reported a total of 10,146 malaria cases of which 8,168 (81%) 
were due to P. vivax, for a mean API across each of its reporting units of 64 malaria cases per 
1,000 inhabitants.  During this period, the malaria cases due to P. falciparum cases dropped from 
902 cases in 2001 down to zero in 2007, without any autochthonous P. falciparum malaria cases 
since 2006.  However, an outbreak of 210 P. falciparum cases was reported in October 2010 (18 
cases in 2010, 156 in 2011, and 36 in 2012) as secondary to an index case (an army recruit of 19 
years of age) imported from a small town in the Amazon basin named Yurimaguas.  The last case 
from this outbreak was reported in June 2012, without further P. falciparum malaria cases reported 




At baseline (2008) a total of 2,479 malaria cases, all P. vivax, were reported in Tumbes.  
The average age of the malaria positive cases was 29±17 years of age, being most of the cases men 
(69%).  That year 43% of the annual cases were reported from Aguas Verdes (population, 17,635) 
and Zarumilla (population, 22,280), the two most malaria endemic districts in the region.  At these 
two districts, the mean API across their reporting units was significantly higher than among 
reporting units from the eleven non-intervention districts (42±44 cases per 1,000 inhabitants vs. 
7±9 cases per 1,000 inhabitants; p=0.001). 
 
Pilot study 
From 2009 to 2010 we treated a total of 8,243 subjects, including 867 malaria cases and 
7,376 contacts (1:8.5 cases/contact ratio).  During the pilot study, we estimate a mean API 
reduction across intervention units of 86% (95%CI: 72−100) at 12-months and 98% (93−100) at 
24-mo, respectively.  Moreover, across non-intervention reporting units, we estimated a mean API 
reduction of -231% (95%CI: -395−-66) at 12-months and -19% (-87−49) at 24-mo, respectively 
(Table 1).  The reductions in the mean API were statistically significantly higher in the intervention 
group at both 12-months (p=0.02) and 24-months (p=0.04).   
During the pilot study the variability of the climate and environmental conditions across 
the Tumbes region was low (coefficient of variation [CV]:  <100%) for variables like pressure 
(CV=0.02), temperature (CV=0.07), humidity (CV=0.14), soil moisture (CV=0.38), and 
vegetation (CV=0.42), and high (CV >1.00) for precipitation (CV=2.94).  Table 2 summarized the 




2010 but lagged 10 weeks to reflect better represent the malaria seasonality, including the wet 
months (November to April) and the dry months (May to October). 
 
Scale-up study 
During scaling up, the APIs dropped to from 7.4 (95%CI: 3.6−11.2) cases per 1,000 
inhabitants in the year 2010 to 1.5 (95%CI: 0.6−-2.4) in the year 2011, to 0.23 (95%CI: 0.04−0.42) 
in the year 2012, and to zero autochthonous cases in years 2013/2016 (Figure 7).  In 2014, Tumbes 
reported one malaria case imported from Iquitos; in 2015, three malaria imported cases, one from 
Ecuador, one from Iquitos, and one from Amazonas; and 2016, two malaria imported cases, one 
from Amazonas and one from Iquitos.  
 
Adverse events 
During both study phases participants did not report any antimalarial adverse events, and 
despite our specific protocol, the Tumbes hospital did not state any case of antimalarial adverse 
events neither.  Also, during both study phases, Tumbes did not report any fatal malaria case. 
 
Bivariate analysis 
The results of the correlation analysis between our variables of interest are summarized in 
Table 3.  Based on the estimates of the Pearson’s correlation coefficients we concluded that 
temperature was highly correlated (r>0.5000) with pressure (r=-0.6328; p<0.0001); that soil 




moderately correlated with humidity (r=0.4233; p<0.0001) and soil moisture (r=0.4547; 
p<0.0001); and that vegetation (NDVI) was moderately correlated with humidity (r=0.3575; 
p<0.0001) and soil moisture (r=0.3291; p<0.0001). 
 
Mixed-effects Poisson Regression Analysis for the Weekly Parasite Incidence during 
the pilot period 
The results from the mixed-effects Poisson regression analysis of the weekly parasite 
incidences of P. vivax cases across the 37 surveillance units from the Tumbes region are 
summarized in the Tables 4 and 5.  First, a basic two-level model was fixed to account for the 
distribution of the data and the effect of our intervention of interest (RCD/FMDA).  Second, a 
series of models were fixed to adjust for potential environmental and climate confounders.  To do 
so, the predictors were selected using the forward method and the AIC to decide which variables 
entered the model first.  Table 4 summarizes the rationale behind the variable selection, while table 
5 summarizes the final model, which includes the following covariables as predictors of the 
malaria vivax counts:  RCD/FMDA, season's trend, soil moisture, pressure, and vegetation.  Based 
on this model we can conclude that the RCD/FMDA significantly contributed to decreasing the 
weekly parasite incidence, with a risk reduction of ~41% (Beta=-0.53; CI 95%: -0.9172, -0.1478; 
IRR=0.5866).    
 
3.5 Discussion 
We reported the first successful malaria elimination initiative based on RCD with FMDA in 




able to reverse malaria incidences among the intervention districts when malaria actually was 
increasing across the Tumbes region.  Such a particular scenario powered the pilot study to detect 
differences, despite the small sample size of reporting units (9 vs. 23) included in the study.  
Additionally, we found high acceptability within the population at risk been able to treat 8 to 9 
contacts per each index case detected passively, which included in nearly every case 1 to 3 social 
contacts, predominantly co-workers and classmates of the index case.  And last but not least 
through this experience we learned that regardless of the report of a small P. falciparum outbreak 
during the second year of the pilot study malaria could be achieved without significant adverse 
events.  
In our study, we found that ~90% of the total impact attributable to the RCD/FMDA at 24-
months of the pilot study occurred during the first year.  This finding was of high interest because 
it was surprisingly high as compared with our initial expectation of reducing it by 50% after the 
first year.  One explanation that may help to understand such high impact is that Tumbes is a small 
and very well-connected region with good roads such as the Pan-American Highway connecting 
the intervention districts.  So is plausible that the impact of the RCD/FMDA strategy in one the 
nearby intervention and non-intervention district has had a synergic or indirect or effect over the 
other respectively.  Another plausible explanation is that given that both intervention districts were 
the two most malaria endemic in the region that allowed to distribute more doses of primaquine, a 
moderate transmission blocking antimalarial, covering a significant fraction of the human malaria 
reservoir (including both symptomatic and asymptomatic malaria cases) and hence interrupting 
transmission more effectively.  
Another essential reflection about the findings of our study is that by using RCD, we were 




scope of traditional RCD methods and also included the social contacts (mostly co-workers and 
classmates of the index case) that voluntary agree to complete the malaria treatment.  Based on 
previous reports it was estimated that through RCD, we could identify ~4-5 additional secondary 
infected subjects among the people living near the index case and people who share the same 
occupational risk factor.  Common occupational risk in the area includes driving taxis (including 
cars and three wheeled motorcycle taxis), micro commerce (bodegas, small markets stores, and 
street vendors), selling gas and farmers.  Moreover, through FMDA, it was described that we could 
effectively clear a significant fraction of the human malaria reservoir that lives near the index case 
(24).  However, both assumptions seem to vary with a wide range depending on a variety of factors.  
In example, RCD although it was a case detection method tested in several countries, including 
Sri Lanka (12), Swaziland (13), Zambia (14, 15), Senegal (11),  Bhutan (17), Mauritius (16), Peru 
(18), and Brazil (19, 20), is a method that has been implemented using similar but different 
operational definitions and diagnostic methods, and as a consequence showing different results 
(Table 2).  Furthermore, according to a 2013 malaria control program managers survey, reactive 
case detection has also been implemented in countries like China, Cambodia, Democratic People’s 
Republic of Korea, Indonesia, Malaysia, Nepal, Philippines, Republic of Korea, Solomon Islands, 
Thailand, Vanuatu, and Vietnam (21).  Sadly, very little is known about the impact of these 
experiences yet.  Experiences from Sri Lanka (12) and Swaziland (13), where reactive case 
detection was implemented using a 1 km radius from an index case household as the criteria to 
define the population at risk, although initially reported as successful experiences in time they 
prove to be very hard sustain given its relatively high cost (10).  As an alternative Searle et al. 
assessed reactive case detection in southern Zambia using a 500 m radius reporting similar results 




resident and 76% of all RDT positive individuals (36).  In the Peruvian Amazon, Branch et al 
reported that given primarily to the high clustering of malaria carriers screening subjects within 
100 m radius around the household of the malaria cases passively detected, using molecular 
diagnostic methods, allowed to detect 4.3 and 1.8 times more cases of P. falciparum and P. vivax, 
respectively, than passive case detection alone (18).  Now, according to Stressman et al., in Zambia 
by screening subjects for subpatent malaria within the household of a malaria case passively 
detected, they detected a malaria prevalence that was 11 times higher as compared to randomly 
selected control households (8% vs.  0.7%, respectively) (15).  Littrell et al. assessed similar 
strategy in northern Senegal, who reported that even using RDTs and focusing only within the 
members of a malaria case household they found a 3.2 fold increase in the incidence of malaria as 
compared to the neighbor households (11)  Although each of these experiences used cases detected 
through passive case detection (the “index case”) to trigger additional case detection activities, 
there were several fundamental differences in terms of screening inclusion criteria for malaria 
blood testing (fever, recent history of fever, or none), the criteria used to define the population at 
risk (1 km, 500 m, 100 m around the malaria cases household, limited to the people living within 
the household of the index case, or by targeting a specific number of proximate people or 
households around the household index case) (37).   
Regarding the FMDA of our strategy it is important to mention that local officers were not 
concerned with G6PD deficiency related adverse events because through the years thousands of 
primaquine were delivery in the region without major adverse events so it was considered safe in 
Tumbes, which might not be the case in other malaria-endemic regions with P. vivax 
predominance.  Another important aspect to be considered when implementing FMDA initiatives 




the high-risk (Table 3).  In our experience, we do it by using RCD methods under the assumption 
that inhabitants of the household of any malaria case that is passively detected (often with parasite 
densities detectable with microscopy or RDTs) significantly represent the subpopulation at the 
high-risk.  However, in Tumbes, such strategy might work so effectively mainly because of 
Tumbes it a low endemic region a high-risk population adequately identified as near each index 
case.  Such condition might vary significantly in most rural settings and not necessarily is the case 
of the Amazon basin in an example.  As a consequence, we considered as very important to pilot 
every proposed malaria elimination strategy before scaling up and if possible, perform formative 
research to adapt the strategy and maximize its likelihood to succeed properly. 
Similar strategies to the one we tested in Tumbes have been reported in vivax endemic 
regions from China and Greece with relative success.  In the Kiangsu province in China, after 
failing to achieve coverage rates of over 50% with large-scale MDA, several different 
RCD/FMDA strategies were implemented in various vivax-predominant malaria settings (22).  
During years 2000-2006 an RCD/FMDA strategy was applied at the villages with malaria 
incidences <1% by treating the families of every malaria case detected within the previous two 
years at the Sihong and Xuyi counties.  In 2007, this strategy was expanded to address also the 
immediate neighbors surrounding the index case households, but in 2008 the index case was 
redefined as every malaria case detected in the previous year instead of in the last two years.  
Finally, in the year 2009, when malaria cases were rare, the RCD/FMDA strategy was limited to 
the villages with over 2-3 cases reported yearly.  Overall, treatment (chloroquine 400 mg × 3d + 
primaquine 22.5 mg × 8d) compliance at the intervention villages ranged from 60% to 99% and 
the median number of individuals who completed FMDA by each index case was 16 (range 5 to 




0.79 and 0.29 per 1,000 inhabitants in Sihong and Xuyi, respectively, annual percent changes in 
Sihong ranged from -36% to -17% in Sihong and from -2% to -67% in Xuyi.  Similar results were 
reported in the municipality of Evrotas, in Greece, where most malaria cases were imported (~62% 
in the year 2012) and due to P. vivax (24).  In the year 2013, an RCD/FMDA strategy was 
implemented defining as the population at high-risk every family of migrants from malaria-
endemic countries that resided in Evrotas.  From 972 eligible subjects, 93.1% migrants initiated 
the treatment course, while 1.8% did not initiate it due primaquine contraindications (such as 
positivity for severe G6PD deficiency), 4.8% abandoned the study before starting the treatment, 
and 0.3% (3 cases) refused the treatment.  Among those that started the treatment, 95.2% 
completed the treatment, 4.6% cases were lost to follow up, and 0.2% (2 cases) stopped the 
treatment due to severe side effects (one due to rash and one due to hemolytic anemia) but recover 
eventually.  Although malaria baseline incidence was low (1.5 malaria cases per 1,000 inhabitants) 
after the intervention malaria cases drop down to zero with only one imported case reported in 
early 2015.  Both experiences are technically and financially different from our strategy but 
certainly add to the body of knowledge that supports its value as a tool to implement malaria 
elimination initiatives in settings with P. vivax malaria predominance.  Other experiences with 
FMDA such as the ones collected in Tanzania (25), Zambia (26), and Kenya (27), although of high 
value as antecedents cannot be used to contrast our results due they were deployed in settings with 
P. falciparum malaria predominance.  Regardless it is important to highlight that these studies 
suggest that the RCD/FMDA strategy might not be the most effective strategy for falciparum 
malaria as it might be for vivax malaria. 
In summary, RCD/FMDA represent an effective strategy to support malaria elimination 




history of using primaquine without severe adverse events due to G6PD deficiency.  Further 
studies will be required to scale-up the RCD/FMDA program to areas with a long-term history of 
using primaquine, without severe adverse events due to G6PD deficiency, and significant 
endemicity of P. falciparum, and moderate to high endemicity.  In the specific case of Peru, we 
recommend adopting the RCD/FMDA strategy, within the national malaria control guideline, to 
sustain malaria elimination by containing imported cases along the north coast. 
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3.7 Tables for Chapter 4 
Table 4. Annual parasite incidence by year and districts 
District Population * 
Annual Parasite Incidence ** (95% CI) 
2008 2009 2010 2011 2012 
Intervention 36,231 32.1 
(-0.8 - 65.0) 
13.4 
(2.5 - 24.4) 
4.2 
(0.6 - 7.9) 
0.8 
(-0.9 - 2.6) 
0.3 
(-0.4 - 0.9) 
Aguas Verdes 17,636 44.9 
(-5.6 - 95.5) 
18.9 
(3.5 - 34.4) 
1.9 
(-0.8 - 4.6) 
0.1 
(0.0 - 0.2) 
0.0 
(0.0 - 0.1) 













(3.6 - 12.8) 
2.3 
(0.7 - 3.9) 
8.7 
(3.5 - 13.8) 
1.8 
(0.6 - 2.9) 
0.2 
(0.1 - 0.3) 
Tumbes 101,734 4.5  
(-0.2 - 9.2) 
2.8  
(0.7 - 5.0) 
6.1 
(0.4 - 11.7) 
2.5 
(-0.4 - 5.3) 
0.4 
(0.0 - 0.8) 
Corrales 22,053 9.3 
(-5.1 - 23.8) 
3.4 
(-2.6 - 9.4) 
12.6 
(-4.9 - 30.0) 
2.1 
(-1.4 - 5.7) 
0.5 
(-0.6 - 1.6) 
Papayal 5,047 18.8 
(0.1 - 37.6) 
2.3 
(1.2 - 3.4) 
18.0 
(-7.8 - 43.9) 
0.0 
(0.0 - 0.0) 
0.1 
(-0.2 - 0.4) 
Zorritos 9,334 0.2 
(-0.6 - 1.0) 
0.1 
(-1.0 - 1.1) 
0.0 
(0.0 - 0.0) 
0.2 
(-1.8 - 2.1) 
0.0 
(0.0 - 0.0) 










Pampas de Hospital 4,751 1.7 
(-0.1 - 3.4) 
0.8 
(-2.7 - 4.2) 
13.9 
(-127 - 155) 
8.0 
(-24.5 - 40.6) 
0.0 
(0.0 - 0.0) 
San Juan de la Virgen 3,976 6.5 
(-12.5 - 25.4) 
2.4 
(-1.0 - 5.9) 
8.9 
(-3.3 - 21.1) 
2.4 
(-6.9 - 11.8) 
0.9 
(-2.9 - 4.7) 
San Jacinto 8,282 3.4 
(-3.6 - 10.3) 
0.1 
(-0.2 - 0.5) 
3.4 
(-0.9 - 7.6) 
1.3 
(-0.9 - 3.6) 
0.2 
(-0.2 - 0.6) 
* Population estimated at baseline (year 2008); ** Annual Parasite Incidence = Total malaria cases/ 1,000 inhabitants; 95% CI = 95% 




Table 5. Weekly Means ± SD (95% CI) of the Environmental and Climate Parameters during the Pilot Study by Districts* 
Districts Pressure (kPa) 
Humidity 
(kg vapor * 









All 99.6 ± 1.8 
(99.5 - 99.6) 
13.6 ± 1.9 
(13.5 - 13.6) 
25.9 ± 1.8 
(25.8 - 25.9) 
0.125 ± 0.047 
(0.123 - 0.126) 
10.1 ± 29.6 
(9.1 - 11.1) 
0.4 ± 0.2 
(0.4 - 0.4) 
Intervention 99.5 ± 1.8 
(99.3 - 99.6) 
13.5 ± 1.9 
(13.4 - 13.6) 
25.9 ± 1.8 
(25.8 - 26.1) 
0.125 ± 0.001 
(0.122 - 0.128) 
9.9 ± 30.0 
(7.8 - 12.0) 
0.4 ± 0.2 
(0.4 - 0.4) 
Aguas Verdes 99.4 ± 2.0 
(99.3 - 99.6) 
13.6 ± 1.9 
(13.4 - 13.8) 
25.9 ± 1.9 
(25.7 - 26.0) 
0.124 ± 0.047 
(0.120 - 0.127) 
9.9 ± 30.0 
(7.3 - 12.5) 
0.4 ± 0.2 
(0.4 - 0.4) 
Zarumilla 100.9 ± 0.1 
(100.9 - 100.9) 
13.9 ± 1.6 
(13.7 - 14.1) 
24.9 ± 1.5 
(24.7 - 25.1) 
0.122 ± 0.039 
(0.122 - 0.133) 
11.0 ± 33.4 
(6.4 - 15.6) 
0.5 ± 0.1 
(0.5 - 0.5) 
Non-intervention 99.6 ± 2.0 
(99.5 - 99.6) 
13.5 ± 1.8 
(13.5 - 13.6) 
25.6 ± 1.8 
(25.8 - 25.9) 
0.125 ± 0.045 
(0.123 - 0.127) 
10.1 ± 30.6 
(9.0 - 11.2) 
0.4 ± 0.2 
(0.4 - 0.5) 
Tumbes 99.7 ± 2.0 
(99.6 - 99.8) 
13.7 ± 1.8 
(13.6 - 13.8) 
25.6 ± 1.8 
(25.5 - 25.7) 
0.125 ± 0.045 
(0.122 - 0.128) 
10.5 ± 30.6 
(8.6 - 12.3) 
0.5 ± 0.2 
(0.5 - 0.5) 
Corrales 98.9 ± 1.9 
(98.8 - 99.1) 
13.3 ± 2.0 
(13.2 - 13.5) 
26.4 ± 1.8 
(26.2 - 26.5) 
0.123 ± 0.051 
(0.119 - 0.128) 
10.2 ± 28.9 
(7.7 - 12.7) 
0.4 ± 0.2 
(0.4 - 0.5) 
Papayal 97.8 ± 1.1 
(97.7 - 97.9) 
12.9 ± 2.1 
(12.7 - 13.1) 
27.4 ± 1.2 
(27.3 - 27.5) 
0.121 ± 0.059 
(0.115 - 0.126) 
7.9 ± 21.9 
(5.8 - 10.1) 
0.3 ± 0.2 
(0.3 - 0.4) 
Zorritos 100.9 ± 0.1 
(100.9 - 100.9) 
13.9 ± 1.6 
(13.6 - 14.2) 
24.9 ± 1.5 
(24.6 - 25.1) 
0.128 ± 0.039 
(0.120 - 0.136) 
8.9 ± 28.5 
(3.3 - 14.4) 
0.5 ± 0.2 
(0.4 - 0.5) 
Pampas de Hospital 100.9 ± 0.1 
(100.9 - 100.9) 
13.9 ± 1.6 
(13.7 - 14.1) 
24.9 ± 1.5 
(24.7 - 25.1) 
0.128 ± 0.039 
(0.122 - 0.133) 
11.0 ± 33.4 
(6.4 - 15.6) 
0.5 ± 0.2 
(0.4 - 0.5) 
San Juan de la Virgen 99.7 ± 1.3 
(99.5 - 99.8) 
13.3 ± 1.9 
(13.0 - 13.5) 
26.1 ± 1.8 
(25.9 - 26.4) 
0.125 ± 0.051 
(0.118 - 0.132) 
10.1 ± 27.0 
(6.4 - 13.7) 
0.6 ± 0.1 
(0.5 - 0.6) 
San Jacinto 100.9 ± 0.1 
(100.9 - 100.9) 
13.9 ± 1.6 
(13.6 - 14.2) 
24.9 ± 1.5 
(24.6 - 25.1) 
0.128 ± 0.039 
(0.120 - 0.136) 
11.0 ± 33.5 
(4.5 - 17.5) 
0.5 ± 0.2 
(0.4 - 0.5) 
Canoas de Punta Sal 100.9 ± 0.1 
(100.9 - 100.9) 
13.9 ± 1.6 
(13.6 - 14.2) 
24.9 ± 1.5 
(24.6 - 25.1) 
0.128 ± 0.039 
(0.120 - 0.135) 
11.0 ± 33.5 
(4.5 - 17.5) 
0.5 ± 0.2 
(0.5 - 0.6) 
* Weekly estimates averaged at year 2009-2010; SD, Standard deviation; 95% CI = 95% Confidence Interval; Pressure (kPa), kilopascals 




daily at 2 m above the displacement height; Temperature (°C), degree Celsius of temperature at 2 m above the displacement height; Soil 
moisture (m3*m-3), cubic meters of water per square meter of soil; Precipitation (mm * m-2), mm of rain per square meter per hour; 




Table 6. Correlation Matrix of variables used in the multivariate analysis for the P. vivax-weekly parasite counts model 
  WPI* RCD/FMDA Pressure Humidity Temp. Moisture Precip. 
RCD/FMDA Pearson (r) 0.0062*  1.0000     
 p value 0.7154       
Pressure Pearson (r) -0.1094* -0.1310* -1.0000     
 p value -<0.0001 <0.0001      
Humidity Pearson (r) 0.0885* -0.0480* 0.1260* 1.0000    
 p value <0.0001 0.0049 <0.0001     
Temperature Pearson (r) -0.0464* -0.1117* -0.6328* 0.0424* 1.0000   
 p value -0.0065 <0.0001 -0.0000 0.0131    
Moisture Pearson (r) 0.1007* 0.0119 0.0757* 0.8087* 0.0582* 1.0000  
 p value <0.0001 0.4849 <0.0001 <0.0001 0.0006   
Precipitation Pearson (r) -0.0289 -0.0006 -0.0174 0.4233* 0.0728* 0.4547* 1.0000 
 p value -0.0909 -0.9717 -0.3085 -<0.0001 -<0.0001 -<0.0001  
Vegetation Pearson (r) 0.0601* -0.0709* -0.1173* 0.3575* 0.1113* 0.3291* 0.1462* 
 p value 0.0004 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
* Weekly Parasite Incidence (WPI)= Total malaria cases per week/ 1,000 inhabitants; RCD/FMDA = Reactive case Detection with 




Table 7. Forward selection of variables for the Mixed-Effects Poisson Regression Model 
Models AIC 
I. Setting the basic model  
Empty Model 2980.1 
Empty Model + RCD/FMDA 2949.3 
Empty Model + RCD/FMDA + Week 2951.1 
Empty Model + RCD/FMDA + Season’s year 2949.5 
Empty Model + RCD/FMDA + Season’ trend  2927.1 
Empty Model + RCD/FMDA + Season’ trend + Year  2927.3 
Empty Model + RCD/FMDA + Season’ trend + Week 2925.7 
II. Modeling the effect of RCD/FMDA  
Basic model 2925.7 
Basic model + Precipitation 2927.3 
Basic model + Vegetation 2912.9 
Basic model + Temperature 2901.7 
Basic model + Pressure 2788.6 
Basic model + Humidity 2879.4 
Basic model + Moisture 2879.3 
Basic model + Moisture + Vegetation 2879.6 
Basic model + Moisture + Precipitation 2879.8 
Basic model + Moisture + Humidity 2879.4 
Basic model + Moisture + Temperature 2838.6 
Basic model + Moisture + Pressure 2755.6 
Basic model + Moisture + Pressure + Precipitation 2757.0 
Basic model + Moisture + Pressure + Temperature 2756.0 
Basic model + Moisture + Pressure + Humidity 2755.6 
Basic model + Moisture + Pressure + Vegetation * 2741.6 
Basic model + Moisture + Pressure + Vegetation + Precipitation 2743.0 
Basic model + Moisture + Pressure + Vegetation + Humidity 2741.6 
Basic model + Moisture + Pressure + Vegetation + Temperature 2741.2 
*  Final model; AIC = Akaike's information criterion; RCD/FMDA = Reactive case Detection 





Table 8. Mixed-Effects Poisson Regression Model for the P. vivax weekly Parasite Incidence 
 
Estimate 95% CI IRR-Fixed 
Effects 
95% CI 
Constant -49.7878 -58.786, -40.790 2.38E-21 2.95E-26, 1.93E-18  
RCD/FMDA -0.5325 -0.9172, -0.1478 0.5871 0.3996, 0.8626 
Season’s trend a -0.3587 -0.5663, -0.1512 0.6986 0.5676, 0.8597 
Soil moisture b 0.1237 0.0603, 0.1871 1.1317 1.0622, 1.2057 
Pressure c 0.4602 0.3707, 0.5497 1.5843 1.4487, 1.7327 
Vegetation d 1.1582 0.5880, 1.7284 3.1842 1.8004, 5.6316 
RE (Network) 0.4886 0.1111, 2.1489   
* IRR = Incidence-Rate Ratio; AIC = Akaike's information criterion; 95% IC = 95% Interval of 
Confidence; RE = Random effects; RCD/FMDA = Reactive case Detection with Focal Mass Drug 
Administration (positive/negative); a, Season´s trend with a value of zero for wet season and a 
value of one for the dry season; cubic meters of water per square meter of soil (units of soil 
moisture); c, kilopascals (units of surface pressure); d, NDVI or normalized difference vegetation 






































Year of implementation 1998 1998 2003 2003 2009 2009 2010 2012 2013 2014 
Named RCD ✓ 
   
✓ 
  
✓ ✓ ✓ 
Trigger by index cases (PCD) ✓ 
 
✓ ✓ ✓ ✓ 
 
✓ ✓ ✓ 
Screening around index case ✓ ✓ ✓ ✓ ✓ 
 
✓ ✓ ✓ ✓ 
Test for asymptomatic malaria 
 
✓ ✓ ✓ ✓ ✓ 
  
✓ ✓ 









✓ ✓ ✓ ✓ ✓ ✓ 
Use PCR  


















Focus on P. vivax malaria also 
 





* MAU, Mauritius; BRA, Brazil; SRI, Sri Lanka; PER, Peru; SWA, Swaziland; ZAM, Zambia; BHU, Bhutan; SEN, Senegal; PCR, 















Included within national guidelines ✓ ✓ 
  
  
Year of implementation 2000-9 2013 (Simulation) 2009 2013-4 2011-12 
Named explicitly as targeted or FMDA ✓ ✓ ✓ ✓ ✓ ✓ 
Focused on P. vivax malaria only ✓ ✓ 
 
✓   
Trigger by incident cases 
 
✓ ✓ ✓ ✓ ✓ 
Trigger by prevalent cases (PCD) ✓ 
   
  
Excluded infants, pregnant women, & chronically ill subjects  ✓ ✓ ✓ ✓ ✓ ✓ 
Included DOT with primaquine ✓ ✓ ✓ ✓  ✓ 
Included G6PD testing ✓ ✓ ✓ ✓  ✓ 
Included adverse events surveillance ✓ ✓ ✓ ✓   
* CHI, China; GRE, Greece; TAN, Tanzania; PER, Peru; FMDA, focal mass drug administration; MDA, mass drug administration; 
PCD, Passive case detection; DOT, Direct observation treatment; G6PD; glucose-6-phosphate dehydrogenase.  
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3.8 Figures for Chapter 4 
 
Figure 6. Tumbes malaria surveillance reporting units in northwestern Peru 
* Red circles mark the location of each surveillance unit across the Tumbes region with both 





Figure 7. Passive case detection vs. Reactive case detection 
 
Legend: A) Passive case detection, where only the infected but symptomatic cases have the chance 
to access antimalarial drugs when voluntary visit the near health facility and tested positive for 
malaria; B) Reactive case detection with target mass drug administration, where additional to the 
cases passively detected their households’ cohabitants and their immediate coworkers/student 





Figure 8. Weather parameters on a weekly level during the period 2003-2015 in Tumbes Peru. 






* The precipitation value in mm is referring to the amount of rain per square meter per hour 
averaged per week; the soil moisture value of m3/m-3 is referring to the mean quantity of cubic 
meters of water per square meter of soil averaged per week; the precipitation value in kPa is 
referring to the number of kilopascals of pressure estimated per km2 averaged per week; the 
humidity value in kg/kg is referring to the number of kg of water vapor per kg of air measured 
daily at 2 m above the displacement height; the temperature value in degrees centigrade is referring 
to the temperature at 2 m above the displacement height averaged per week; and, NDVI is referring 




Figure 9. APIs at each of the surveillance reporting units from Tumbes, 2001-2015 
 
Legend: Annual parasite incidences (APIs) were calculated by dividing the total count of malaria 
cases, as reported by the national surveillance system, over the total population at each surveillance 


































Figure 10. APIs across the surveillance reporting units from Tumbes during the study period (2009-2014) 
 
Legend: During the pilot study (2009-2010), the mean APIs across the intervention surveillance reporting units reduced by 98% 
(93−100), while increased by 19% (-49−87) at the non-intervention surveillance reporting units.  During scaling up, malaria cases 




Chapter 4.  “Reactive case detection with targeted mass drug 
administration: Interrupting malaria transmission 
and achieving elimination beyond intervention areas 
in northwestern Peru” 
4.1 Abstract 
Reactive case detection (RCD) with focal mass drug administration (FMDA) was previously 
reported as an effective strategy to support malaria elimination initiatives in Tumbes Peru, a region 
with a strong predominance of vivax malaria.  We assessed the effect of RCD/FMDA beyond the 
intervention areas in Tumbes along the nearby region of Piura, assuming an “spillover effect” of 
the treatment beyond the focal area.  Briefly, a pilot malaria elimination program based on 
RCD/FMDA was rolled out from 2009-2010 in the two districts with the highest annual parasite 
incidence of malaria in Tumbes.  And then, due its apparent success, from 2011-2014, the 
intervention was scaled up to the other 11 Tumbes districts.  In this study we focus on evaluating 
the effect of such intervention in the non-intervention communities in Piura during the 2011-2016 
period.  The primary study endpoint was a temporo-spatial reduction in weekly parasite incidence 
(WPI = total malaria cases per week/ 1,000 inhabitants) across all the surveillance units, analyzed 
by proximity to the intervention areas from Tumbes during the pilot project.  During the pilot 
program we estimated a mean reduction in WPI across the Tumbes intervention areas of 99% 
(97−100) and 85% (77−94) at 12 and 24 months (m), respectively; and a reduction in the non-
intervention areas of 34% (27−40) and 86% (76−93) at 12m and 24m, respectively.  During the 




of 63%, -73%, and -420% at 12m, and 91%, -126% and 91% at 24m, respectively.  After scale-
up, we found a similar association between the mean WPI reduction and proximity to intervention 
area across the Piura districts, at both 24m (p=0.04) and 48m (p<0.01).  The closer to Tumbes the 
greater the reduction in the WPI among the Piura districts.  During years 2015 and 2016, neither 
Tumbes nor Piura reported any autochthonous malaria cases.  Thus, the RCD/FMDA strategy may 
represent the main reason why malaria was eliminated from the region of Piura and, consequently, 
represents a valuable intervention to support malaria elimination initiatives in other settings with 
a high predominance of vivax malaria with a similar epidemiology. 
 
4.2 Introduction 
The world has experienced major progress towards malaria eradication in the last 15 years.  
Malaria mortality has plunged by 48% between 2000 and 2015 with an estimate of over 6.2 million 
lives saved, most of them children under five years of age (1).  Regardless, malaria continues to 
represent a major cause of global morbidity and mortality with more than 3 billion people at risk 
(1).  More worrisome, such progress appeared to have stalled in the recent years, with 2016 being 
the first year since 2000 were there were reports of an increase in the global morbidity, with five 
million malaria cases in the previous year (2).  This scenario has raised a significant concern about 
why many countries are beginning to shift their negative trends and reversing the gains achieved.  
While more countries are assuming the challenge of shifting their national policies from control 
towards elimination, new approaches are needed to supplement existing tools (3).  One of these 
approaches that has gained popularity in recent years is embracing the heterogeneous nature of 
malaria transmission at the community level and implementing malaria control interventions 




Hotspots are theoretically defined as those areas where estimates exceed those from other 
areas and may fuel transmission to surrounding areas (5).  However, operationally hotspots have 
many different definitions with some commonalities like using the malaria burden as a proxy for 
transmission, and many differences like using various metrics to assess its size, location, and 
stability (6, 7).  Regardless of the chosen definition, the detection of malaria hotspots has become 
increasingly relevant for planning national policies and pursuing local malaria elimination 
initiatives (8-12).  However, the questions about how to target them remain controversial.  Options 
range from mass diagnosis and treatment to mass drug administration strategies, from single to 
packages of combined interventions, and from one time visit to more regular ones, each with their 
own strengths and limitations (13).  Among all these options, one that is gaining support due its 
proven impact on reducing malaria transmission in low endemic settings is the combination of 
reactive case detection (RCD) with focused mass drug administration (FMDA) (14).  The 
RCD/FMDA strategy is commonly described as complementing the treating of every subject that 
tests positive for malaria with all his/her household members, irrespective of each person’s result 
obtained by diagnostic testing (15).  
Previous experiences with RCD/FMDA have documented that this strategy may help to 
overcome the limitation of currently available diagnostics to detect subpatent asymptomatic 
malaria infections, which are a large fraction of the human malaria reservoir and consequently is 
less expensive and more effective than the standard mass diagnose and treatment strategies (14).  
Due to its potential, a large trial is currently underway in Zambia, with promising short-term results 
in what is a low endemic malaria setting with a high predominance of P. falciparum malaria (15, 
16).  Furthermore, in the study 1 of this thesis we are reporting that the RCD/FMDA may also 




high predominance of P. vivax, if we use primaquine as the drug for interrupting malaria 
transmission and take advantage of the long-term history of using it without adverse events due 
glucose-6-phosphate dehydrogenase (G6PD) deficiency (17).  Furthermore, during this 
experience, we observed a possible “spillover effect” of the RCD/FMDA intervention beyond the 
intervention areas.  So, in this follow up study, we aim to determine the impact of the malaria 
elimination program implemented in Tumbes on interrupting the transmission of malaria beyond 




The study design corresponds with the follow up of a non-randomize community trial.  In 
Tumbes, after piloted an RCD/FMDA strategy in the districts of Aguas Verdes (3°28´S 80°14´ W, 
population ~13,000) and Zarumilla (03°49´S 80°27´W, population ~18,000) in years 2009 and 
2010 the intervention was scaled up during the years 2011-2015 to the remaining eleven districts 
(population ~167,000), while the nearby region of Piura continued to use passive case detection 
(PCD) as established by the Peruvian malaria guidelines.  To assess the “spillover effect” of the 
intervention to the surrounding non-intervention areas, we determined the effect of the 
RCD/FMDA intervention on the mean weekly parasite incidence across the reporting units from 
Piura using road distances to the Aguas Verdes international bridge over the Zarumilla River that 






Tumbes and Piura are northwestern regions located along the border with Ecuador.  Both 
regions are known for their warm beaches and tropical climate due to its location in proximity to 
the Equator.  The coast is divided by the Peruvian subtropical desert of Sechura on the south and 
the savanna-like scrub dry forests on the center and north of the region.  Politically, Piura is divided 
into eight provinces and 64 districts, has a total surface of 35,892 km2 and an estimated population 
of ≈1,844,000 inhabitants; Tumbes is divided into 13 districts, has a total surface of 4,670 km2 and 
an estimated population of ≈238,000 inhabitants.  The Pan-American highway connects both 
regions from north to south, which favors the propagation of anopheline vectors (primarily An. 
albimanus) as well as human migration for labor-intense agricultural activities (18).  The region 
typically has hot and humid summers with moderate rains that intensify from December to March 
and cold and dry winters from April to November.  However, this seasonal climate pattern can 
change drastically due to the El Niño phenomenon, which manifests with torrential rains and 
strong winds that often are associated with major flooding and landslides.  Such events have been 
associated with different malaria outbreaks in the past (e.g., the malaria epidemic in 1997–1998), 
while its counterpart, La Niña phenomenon, have behaves as a protective factor against malaria as 
it draws strong dry weather (19).  Malaria endemicity of malaria in Tumbes and Piura is low and 
seasonal, peaking during the rainy season (February–June).  Figure 10 displays the map of Tumbes 
and Piura with the distribution of the health centers within each district, the rivers and roads, as 
well as the boundaries of both regions and its districts.  Some health centers are clustered along 
the Peruvian border with Ecuador, some along the Tumbes River, while other health centers are 






For this study, we analyzed the totality of surveillance reporting units in Tumbes and Piura 
using the road proximity to the communities that were intervened during the pilot RCD/FMDA 
strategy in Tumbes as a proxy for exposure intensity.  Considering that the RCD-FMDA pilot ran 
off during years 2009-1010 and the scale-up during the years 2011-2015, we hypothesized that 
Piura reporting units nearby Tumbes experimented an “spillover effect” of the intervention in 
Tumbes, that could be detected by progressively decreasing their WPI. 
In Tumbes, communities that were exposed to the RCD/FMDA intervention were subjects, 
with the exception of children under five years old, elders (65 years of age or older), pregnant 
women, and chronically ill subjects, were considered eligible if they: (1) has his/her legal residence 
registered at their intervention districts; (2) resided in the household of a subject that was diagnosed 
as malaria positive within the previous 24 hours; and (3) assented to complete the malaria treatment 
regardless of the absence of symptoms.  In Piura, the Ministry of Health continued providing 
subjects health care using the PCD as recommended by the Peruvian National Malaria guideline 
(20).   
 
Study interventions 
The interventions were the same as previously described.  Briefly, (1) under PCD, only the 
subjects that tested positive for malaria received treatment.  Alternatively, (2) under RCD/FMDA, 
every malaria case detected under PCD was immediately followed within the first 24 hours to 
census and treat each of his/her household contacts (excluding children under 5 years old, adults 




national guidelines, subjects were treated uniformly and for free for uncomplicated P. vivax 
malaria cases.  In Tumbes the care surveillance protocols and case management were standardized 
across regional reporting units, so we collaborated with local authorities to train malaria officers 
at each regional reporting units, trained the personnel responsible for the malaria program 
annually, and procured the administrative and laboratory supplies necessary to ensure a continual 
provision of care.  In Piura, PCD was provided under normal circumstances without further 
interventions from the researchers.   
 
Treatment for Vivax Malaria 
As previously reported and according to the Peruvian malaria treatment guidelines every 
malaria cases received treatment uniformly and for free (21).  The treatment of choice for 
uncomplicated vivax malaria cases in adults and children was oral chloroquine (10 mg/kg/day) 
daily for three days, plus oral primaquine (0.5 mg/kg), daily, for seven days.  In the case of 
pregnant women, the treatment of choice was oral chloroquine (10 mg/kg/day) daily for three days 
followed by a weekly dose of 5 mg/kg until delivery, and then primaquine phosphate (0.5 mg/kg) 
daily for seven days, while in the case of Infants under six months of age the treatment was 
chloroquine only.  For unconscious patients, the treatment of choice was intravenously 
clindamycin (20 mg base/kg/day) and quinine sulfate (10 mg salt/kg/day) three times daily until 






As a primary outcome, we assessed and compared the variability of the malaria weekly 
parasite incidences at each of the Piura reporting units according to their proximity to the two 
intervention districts initially intervened in Tumbes before the intervention was scaled up across 
the Tumbes reporting units.  Road distances were estimated from each surveillance unit to the 
Aguas Verdes international bridge (the bridge that which connects Peru with Ecuador over the 
Zarumilla River), as a proxy of indirect exposure.  Weekly parasite incidence was calculated by 
dividing the total weekly count of malaria cases, as reported by the national surveillance system, 
over the total population as estimated by the Peruvian Ministry of Health at each surveillance 
reporting unit.   
In order to assess FMDA safety, we implemented a surveillance protocol for severe adverse 
events by training malaria officers to derivate patients to the Regional Hospital if any study subject 
present with at least one symptom compatible with a potential severe adverse event.  Once admitted 
patients were subject of clinical assessment by the study coordinator to confirm whether such 
symptoms correspond without any of the severe adverse events under surveillance.  The 
chloroquine severe adverse events under surveillance included retinopathy (as diplopia or bilateral 
loss of vision), cardiotoxicity (as breathlessness with exertion or even at rest, syncope or swelling 
of the legs, ankles and feet), myopathy (as symmetric weakness affecting proximal muscles of the 
legs and arms), and neurotoxicity (as seizures, insomnia or paresthesia). The primaquine severe 






Climate and environmental variables 
A specific set of climate and environmental variables were assessed as potential 
confounders of the effect of RCD/FMDA.  As previously described these variables included 
temperature (MERRA-T2M), humidity (MERRA-QV2M), soil moisture (MERRA-SFMC), 
elevation (ASTER-GDEM), precipitation (TRMM-TMPA), and NDVI (MODIS) (Figure 11).  
Each of these variables was assessed using their weekly averages estimated at the coordinates of 
each of the reporting units for the 2011–2014 period.  Due to the different resolution, each variable 
was estimated by averaging their hourly estimates using the standardized protocols for each of the 
satellite products.  In the case of the MERRA products data was available at hourly steps and with 
a 1/2°×2/3° resolution, TMPA data was available at 3-hourly time steps and with a 0.25°×0.25° 
resolution; while the MODIS data was available at 0.05° resolution.  
 
Data Collection 
Weekly parasite incidence (malaria cases per 1,000 inhabitants) was estimated based on 
surveillance malaria counts and government population estimates, so we extensively reviewed the 
regional malaria surveillance registries from each of the reporting units during the study period.  
Data was provided by the Regional Health Directorates as reported to the national surveillance 
system (implemented in 2001), which provides a confidential, and secure database with quality-
controlled data entry.  Briefly, each surveillance reporting unit reports their malaria counts on a 
weekly basis to the regional health directorate, which managed the data entry and data quality 
control by using the surveillance software NOTI.  For this study, the data was downloaded from 
the NOTI system without identifiers in the password protected CSV files for the study analysis.  




confidentiality and avoid loss of data.  Then, we directly analyzed the CSV files using STATA/MP 
v14.0 (Stata Corporation, College Station, TX, 2011) with the Excel import command for data 
management, including further checks and reviewed for consistency and completeness.  
 
Data Analysis 
First, we performed an exploratory analysis to describe and compare the baseline 
characteristics within and between reporting units by region.  Baseline characteristics and 
outcomes were described with summary statistics, using frequency and percentage for categorical 
variables and mean and standard deviation for continuous variables.  To estimate the effect of the 
RCD/FMDA strategy on interrupting malaria transmission in Piura, we first estimated the fit of a 
bivariate model with the WPI as a function of the road proximity to the closest intervention district 
during the pilot study.  Then, we fit a multivariate model using a mixed-effects Poisson regression 
model to adjust for the climate and weather variables as potential confounders and to account for 
the structure of the data.  The forward selection was used to determine the variables for the 
multivariate model using the Akaike Information Criteria (AIC) and the likelihood ratio test (LRT) 
to compare nested models.  Pearson’s correlation coefficients were also computed for each variable 
to assess and prevent multicollinearity.  All the analyses were conducted with Stata/MP 14.0 (Stata 
Corporation, College Station, TX) using a significance level of p<0.05. 
 
Ethical considerations 
During study planning, the study protocol was approved by the Tumbes and Piura Regional 




for their regions.  Both regions designated a leading epidemiologist to collaborate during data 
collection.  Both Regional Health Directorate epidemiologists participated actively in all the 
interventions related activities, so they have broad knowledge about the quality and limitations of 
the data, and where the first recipients of the study results for local decision-making purposes.   
 
4.4 Results  
Malaria cases before and at baseline 
From 2000 to 2008, Piura and Tumbes reported a total of 62,893 malaria cases of which 
46,073 (73%) were due to P. vivax.  During this period Tumbes and Piura reported a mean API of 
8.74 and 3.21 malaria cases per 1,000 inhabitants, respectively.  The average age of the malaria 
positive cases was 31±7 years of age, with most of the cases adults (71%) or men (65%).  During 
this period, malaria cases due to P. falciparum cases dropped from 4,752 cases in 2000 to zero in 
2008 in Tumbes, and from 4675 down to zero in Piura, without any autochthonous P. falciparum 
malaria cases reported in the year 2007 and 2008.   
At study baseline (2008), Tumbes reported 2,479 P. vivax malaria cases and Piura reported 
4,016 cases, all P. vivax.  During that year, the mean weekly parasite incidence (WPI) estimated 
across surveillance reporting units in Tumbes was 28±93 malaria cases per 100,000 inhabitants 
and in Piura was 1±11 malaria cases per 100,000 inhabitants.  At the two districts that were selected 
to pilot the RCD/FMDA intervention the mean WPI estimated across their reporting units was 
significantly higher than among reporting units from the other eleven non-intervention districts 




(p<0.001), as well as compared to the 64 districts from Piura (81±167 cases per 100,000 inhabitants 
vs. 1±11 cases per 100,000 inhabitants; p<0.001). 
 
Malaria cases during Pilot study 
During pilot study (2009-2010) a total of 8,243 subjects, including 867 malaria cases and 
7,376 contacts (1:8.5 cases/contact ratio) were treated in Tumbes.  During the second year of the 
intervention, the mean WPIs dropped to 14.51 malaria cased per 100,000 inhabitants in Tumbes 
but increased to 3.83 malaria cases per 100,000 inhabitants in Piura. 
We estimated that comparing the baseline (2008) and the second year of the pilot study 
(2010), the Tumbes intervention sites registered a mean WPIs reduction of 95% (95%CI: 74−100), 
the Tumbes non-intervention sites a mean WPIs reduction of -39% (-75%−-3%), while across the 
Piura non-intervention sites the mean WPIs reduction was of -260% (-325%−-195%) (Table 11). 
Such reductions were statistically significant when comparing the intervention sites from Tumbes 
against the non-intervention sites from Tumbes (p<0.001) and Piura (p<0.001).  
During the pilot study the variability of the climate and environmental conditions across 
the Tumbes region was low (coefficient of variation [CV]:  <100%) for variables like pressure 
(CV<0.01), temperature (CV=0.04), humidity (CV=0.11), soil moisture (CV=0.27), vegetation 
(CV=0.16) and surface sea temperature (CV=0.10), and high (CV >1.00) for precipitation 
(CV=1.81).  Table 12 summarizes the estimates for each of the climate and environmental 
variables of interest of our study in 2009-2010 but lagged 10 weeks to better represent the malaria 
seasonality, including the wet months (November to April) and the dry months (May to October) 




Malaria cases during the scale-up study 
During scale-up, the WPIs dropped from 6.11 (95%CI: 5.30–6.43) cases per 100,000 
inhabitants in the year 2010 to 0.02 (95%CI: -0.00−0.05) in the year 2014 across Tumbes and Piura 
(Table 11). In 2015, Tumbes reported only three malaria imported cases, one from Ecuador, one 
from Iquitos, and one from Amazonas; and in 2016, two malaria imported cases were reported, 
one from Amazonas and one from Iquitos.  
 
Adverse events 
During both study phases health centers did not report any severe antimalarial adverse 
events (severe anemia, hemolysis, retinopathy, cardiomyopathy, myopathy, and neuromyopathy), 
and despite our specific protocol, the Tumbes hospital did not report any case of severe antimalarial 




The results of the correlation analysis between our variables of interest are summarized in 
Table 3.  Based on the estimates of the Pearson’s correlation coefficients we concluded that 
temperature was highly correlated (r>0.5000) with pressure (r=-0.6328; p<0.0001); that soil 
moisture was highly correlated with humidity (r=0.8087; p<0.0001); that precipitation was 
moderately correlated with humidity (r=0.4233; p<0.0001) and soil moisture (r=0.4547; 
p<0.0001); and that vegetation (NDVI) was moderately correlated with humidity (r=0.3575; 





Mixed-effects Poisson Regression Analysis for the Weekly Parasite Incidence during 
the pilot period 
The results from the mixed-effects Poisson regression analysis of the weekly parasite 
incidences of P. vivax cases across the 37 surveillance units from the Tumbes region are 
summarized in the Tables 14 and 15.  First, a basic two-level model was fixed to account for the 
distribution of the data and the effect of our intervention of interest (RCD/FMDA).  Second, a 
series of models were fixed to adjust for potential environmental and climate confounders.  To do 
so, the predictors were selected using the forward method and the AIC to decide which variables 
entered the model first.  The Table 14 summarizes the rationale behind the variable selection, while 
the table 15 summarizes the final model, which includes the following covariables as predictors of 
the malaria vivax counts:  RCD/FMDA, season’s trend, soil moisture, pressure, and vegetation.  
Based on this model we can conclude that the RCD/FMDA significantly contributed to decrease 
the weekly parasite incidence (Beta= -0.53; CI 95%: -0.9172, -0.1478; IRR=0.5866).    
 
4.5 Discussion 
Focalized interventions such as the RCD/FMDA represents an effective strategy to support 
malaria elimination initiatives in low endemic malaria regions such as the Peruvian north coast, a 
region with a predominance of vivax malaria.  In this study, we find evidence that suggest that the 
RCD/FMDA strategy besides contributed to control and later the elimination of malaria within the 
intervention areas of Tumbes; it further contributed to control and later elimination of malaria 




of the first reports of the value of the “spillover effect” in the scope of malaria elimination 
initiatives. 
The “spillover effect” (also known as “contamination”) is an often non-desired but well-
documented effect in clinical trials.  Is not desired because when the “spillover effect” is present 
it leads to the dilution of the treatment effect and an increase risk of a type II error (22).  As a 
consequence a truly effective intervention might be found ineffective because the observed effect 
size was neither statistically nor clinically significant due to an “spillover effect” (23).  Although 
there are several methods recommended to avoid and control for the “spillover effect”, in the case 
of a malaria elimination initiative the “spillover effect” is a desired rather than an undesired effect.    
In the previous chapter we described that during the pilot study we estimated a mean 
reduction in WPI across Tumbes intervention areas of 99% (97−100) and 85% (77−94) at 12 and 
24 months (m), respectively; and non-intervention areas of 34% (27−40) and 86% (76−93) at 12m 
and 24m, respectively.  During the same period, we estimated a mean reduction in WPI at the near, 
mid and far range Piura districts of 63%, -73%, and -420% at 12m, and 91%, -126% and 91% at 
24m, respectively.  After scaling-up the intervention to each of the 13 Tumbes districts, we found 
a negative association between the mean WPI reduction and proximity to intervention area across 
the Piura districts, at both 24m (p=0.04) and 48m (p<0.01).  Furthermore, during the following 
two years (2015 and 2016), the interruption of the transmission of malaria across Tumbes and 
Piura was reported as successful, without any autochthonous malaria cases reported.  
According to our study results the RCD/FMDA strategy represented an effective 
intervention to interrupt the transmission malaria along the north coast, but also is an intervention 
with a very valuable “spillover effect” in the Piura region and may support malaria elimination 




In the study 1 we found that ~90% of the total impact attributable to the RCD/FMDA at 
24-months of the pilot study occurred during the first year in the region of Tumbes.  Also, we 
observed that there were strong signals of an “spillover effect” from the intervention areas to the 
nearby non-intervention areas, both during the pilot study in Tumbes as well as during the scale 
up study in the nearby districts of Piura.  This observation might be explained in the case of 
Tumbes because of the relatively small territory as well as its strong road-connectivity due the 
Pan-American Highway.   So, it was plausible that the impact of the RCD/FMDA strategy in 
Tumbes was extended to Piura by an “spillover effect”.  Hence in this second study we tested that 
hypothesis finding that in fact, such might be the case.  
The study two results suggest that we can enhance the effect of a malaria elimination 
program selecting the proper intervention and by selecting the proper targets.  As for the 
intervention the RCD/FMDA was previously found to represent an effective strategy to support 
malaria elimination initiatives in Tumbes Peru, a region with a predominance of vivax malaria, 
while taking advantage of a clear understanding of the patterns of incidence of malaria at each site.  
And as for the target’s selection, the intervention sites were first selected strategically among the 
most endemic regions based on a clear understanding of the patterns of incidence across the region. 
By doing so, the intervention also produced a clear “spillover effect” that may have helped to 
interrupt the transmission of malaria along the Pan-American highway, which is the main road that 
connects both regions.  Additionally, several factors contributed to the success of the program, 
including the strong seasonality that characterize the pattern of the incidence of malaria along the 
Peruvian north coast, the lack of a vector with high vectorial capacity in the region, the 
sustainability of the Tumbes malaria elimination program, as the single road connectivity between 




During pilot study (2009-2010) a total of 8,243 subjects, of which around ~90% were 
asymptomatic subjects without any symptoms or signs of malaria received a complete course of 
antimalarials for P. vivax malaria.  Such numbers may be a sign that a significant fraction of the 
population at risk was treated for asymptomatic malaria and also receive a treatment a 
transmission-blocking drug such as primaquine. During this second year of the pilot study (2010), 
the Tumbes intervention sites registered a mean WPIs reduction of 95% (95%CI: 74−100), the 
Tumbes non-intervention sites a mean WPIs reduction of -39% (-75%−-3%), while across the 
Piura non-intervention sites the mean WPIs reduction was of -260% (-325%−-195%). Such 
reductions were statistically significant when comparing the intervention sites from Tumbes 
against the non-intervention sites from Tumbes (p<0.001) and Piura (p<0.001).  However, during 
the scale-up study, the WPIs dropped from 6.11 (95%CI: 5.30–6.43) cases per 100,000 inhabitants 
in the year 2010 to 0.53 (95%CI: -0.08−1.14) in the year 2014 across Tumbes and Piura. And since 
2015, Tumbes and Piura have reported only imported malaria cases, either from Ecuador or from 
the Peruvian Amazon.    
During both study phases participants did not report any antimalarial adverse events, and 
the regional hospitals from Piura and Tumbes did not state any case of antimalarial adverse 
events neither nor any fatal malaria case. 
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4.7 Tables for Chapter 5 
Table 11. Mean weekly parasite Incidence by year and proximity to the intervention districts 
District Population 
Mean Weekly Parasite Incidence ** (95% CI) 
  
Baseline Pilot Study Period Scale-Up Study Period 




(5.83 – 7.89) 
5.63 
(4.85 – 6.43) 
6.11 
(5.30 – 6.43) 
0.81 
(0.64 – 0.99) 
0. 12 
(0.06 – 0.18) 
0.02 
(-0.00 – 0.04) 
0.02 
(-0.00 – 0.05) 
By Intervention  
     
  
Intervention 42,922 81.00 
(63.74 – 98.26) 
36.15 
(25.84 – 46.45) 
3.34 
(1.60 – 5.09) 
0.13 
(0.03 – 0.24) 
0.09 
(0.01 – 0.18) 
0.00 
(0.00 – 0.00) 
0.00 
(0.00 – 0.00) 
Non-intervention 1,078,783 3.10 
(2.59 – 3.61) 
4.09 
(3.46 – 4.72) 
6.25 
(5.40 – 7.10) 
0.85 
(0.67 – 1.03) 
0.12 
(0.06 – 0.19) 
0.02 
(-0.00 – 0.04) 
0.02 
(-0.00 – 0.05) 
By proximity  
     
  
<100 Km 188,773 29.11 
(24.40 – 33.82) 
11.05 
(8.43 – 13.67) 
14.99 
(11.90 – 18.09) 
2.53 
(1.81 – 3.25) 
0.39 
(0.13 – 0.66) 
0.00 
(0.00 – 0.00) 
0.00 
(0.00 – 0.00) 
100-199 Km 54,174 0.25 
(-0.12 – 0.63) 
0.07 
(-0.01 – 0.17) 
0.17 
(-0.17 – 0.52) 
0.02 
(-0.02 – 0.08) 
0.02 
(-0.02 – 0.08) 
0.00 
(0.00 – 0.00) 
0.00 
(0.00 – 0.00) 
200-299 Km 182,329 1.97 
(1.13 – 2.81) 
14.75 
(12.24 – 17.27) 
13.52 
(10.92 – 16.12) 
1.19 
(0.79 – 1.59) 
0.12 
(0.02 – 0.21) 
0.10 
(-0.03 – 0.23) 
0.14 
(-0.04 – 0.32) 
300-399 Km 629,074 0.99 
(0.60 – 1.37) 
2.15 
(1.26 – 3.05) 
1.63 
(1.08 – 2.19) 
0.19 
(0.08 – 0.30) 
0.05 
(0.01 – 0.09) 
0.01 
(-0.01 – 0.02) 
0.00 
(0.00 – 0.00) 
400-499 Km 40,353 0.39 
(0.12 – 0.68) 
0.98 
(0.41 – 1.55) 
1.34 
(0.58 – 2.11) 
0.13 
(-0.13 – 0.40) 
0.00 
(0.00 – 0.00) 
0.00 
(0.00 – 0.00) 
0.00 
(0.00 – 0.00) 
>500 Km 27,002 0.95 
(-0.04 – 1.93) 
0.05 
(-0.02 – 0.12) 
1.00 
(-0.48 – 2.47) 
0.10 
(-0.09 – 0.29) 
0.00 
(0.00 – 0.00) 
0.00 
(0.00 – 0.00) 
0.00 
(0.00 – 0.00) 
* Population estimated at baseline (year 2008); ** Weekly Parasite Incidence = Total malaria cases per week/ 100,000 inhabitants; 




Table 12. Weekly means ±SD (95% CI) of the environmental and climate parameters during the scale-up study * 
District Pressure (kPa)a 
Humidity 
(kg vapor * 













All 94.4 ± 6.9 
(94.3 - 94.5) 
14.3 ± 4.9 
(14.3 - 14.4) 
24.2 ± 5.1 
(24.2 - 24.3) 
0.174 ± 0.127 
(0.172 - 0.176) 
5.1 ± 13.2 
(4.9 - 5.2) 
0.41 ± 0.23 
(0.41 - 0.42) 
19.1 ± 3.1 
(19.0 - 19.1) 
By Intervention        
Intervention 94.9 ± 2.3 
(94.8 - 95.1) 
14.8 ± 3.8 
(14.6 - 15.0) 
25.8 ± 2.2 
(25.7 - 25.9) 
0.184 ± 0.088 
(0.179 - 0.189) 
7.4 ± 16.8 
(6.5 - 8.3) 
0.46 ± 0.25 
(0.44 - 0.47) 
22.6 ± 1.7 
(22.5 - 22.7) 
Non-intervention 94.4 ± 7.1 
(94.3 - 94.5) 
14.3 ± 4.9 
(14.2 - 14.4) 
24.1 ± 5.2 
(24.0 - 24.2) 
0.174 ± 0.129 
(0.172 - 0.175) 
5.0 ± 13.2 
(4.9 - 5.2) 
0.41 ± 0.23 
(0.41 - 0.42) 
18.9 ± 3.1 
(18.8 - 19.0) 
By proximity 
       
<100 Km 98.8 ± 2.8 
(98.7 - 98.9) 
15.6 ± 4.9 
(15.5 - 15.7) 
26.0 ± 3.0 
(25.9 - 26.1) 
0.212 ± 0.178 
(0.207 - 0.217) 
6.8 ± 16.3 
(6.4 - 7.2) 
0.4 ± 0.2 
(0.4 - 0.5) 
22.6 ± 1.7 
(22.5 - 22.6) 
100-199 Km 93.5 ± 8.6 
(92.8 - 94.2) 
14.4 ± 4.6 
(14.1 - 14.8) 
23.0 ± 5.8 
(22.5 - 23.4) 
0.171 ± 0.084 
(0.170 - 0.181) 
5.6 ± 11.6 
(4.7 - 6.5) 
0.3 ± 0.2 
(0.2 - 0.3) 
19.6 ± 3.2 
(19.4 - 19.9) 
200-299 Km 96.6 ± 4.4 
(96.4 - 96.7) 
14.3 ± 5.4 
(14.2 - 14.5) 
25.4 ± 4.4 
(25.2 - 25.5) 
0.153 ± 0.104 
(0.150 - 0.156) 
4.0 ± 11.9 
(3.6 - 4.3) 
0.4 ± 0.2 
(0.4 - 0.4) 
18.1 ± 2.7 
(18.0 - 18.2) 
300-399 Km 93.3 ± 7.1 
(93.1 - 93.4) 
14.0 ± 4.8 
(13.9 - 14.1) 
23.9 ± 5.4 
(23.8 - 24.0) 
0.164 ± 0.113 
(0.162 - 0.165) 
4.4 ± 12.0 
(4.2 - 4.6) 
0.4 ± 0.2 
(0.4 - 0.4) 
18.1 ± 2.7 
(18.0 - 18.2) 
400-499 Km 91.6 ± 7.5 
(91.4 - 91.8) 
13.8 ± 4.4 
(13.7 - 13.9) 
23.0 ± 5.5 
(22.8 - 23.2) 
0.167 ± 0.113 
(0.164 - 0.170) 
5.5 ± 13.0 
(5.1 - 5.8) 
0.4 ± 0.3 
(0.4 - 0.4) 
18.1 ± 2.7 
(18.1 - 18.2) 
>500 Km 83.6 ± 5.2 
(83.3 - 83.9) 
13.2 ± 2.8 
(13.0 - 13.4) 
18.6 ± 4.4 
(18.3 - 18.8) 
0.194 ± 0.077 
(0.190 - 0.199) 
8.2 ± 14.0 
(7.3 - 9.0) 
0.4 ± 0.3 
(0.4 - 0.4) 
18.1 ± 2.7 
(18.0 - 18.2) 
* Weekly estimates averaged at year 2009-2010; SD, Standard deviation; 95% CI = 95% Confidence Interval; Pressure (kPa), kilopascals 
of pressure estimated per km2; Humidity (kg vapor * kg-1 air * 103),  103 kg of water vapor per kg of air measured daily at 2 m above 
the displacement height; Temperature (°C), degree Celsius of temperature at 2 m above the displacement height; Soil moisture (m3*m-
3), cubic meters of water per square meter of soil; Precipitation (mm water * m-2), mm of rain per square meter per hour; Vegetation 





Table 13. Correlation matrix of the variables used in the multivariate analysis for the P. vivax-weekly parasite counts model 
  WPIa Distance Pressure Humidity Temp. Moisture Precip. Vegetation 
RCD/FMDA Pearson (r) -0.0609* 1.0000       
 p value 0.0000        
Pressure Pearson (r) 0.0411* -0.4258* 1.0000      
 p value 0.0000 0.0000       
Humidity Pearson (r) -0.0144* -0.1375* 0.0475* 1.0000     
 p value 0.0124 0.0000 0.0000      
Temperature Pearson (r) 0.0029 -0.2467* 0.6980* 0.2812* 1.0000    
 p value 0.6135 0.0000 0.0000 0.0000     
Moisture Pearson (r) -0.0143* -0.1122* -0.3027* 0.7186* -0.1666* 1.0000   
 p value 0.0128 0.0000 0.0000 0.0000 0.0000    
Precipitation Pearson (r) 0.0062 -0.0330* -0.1234* 0.0203* -0.1139* 0.1270* 1.0000  
 p value 0.2795 0.0000 0.0000 0.0004 0.0000 0.0000   
Vegetation Pearson (r) 0.0029 -0.0414* -0.2593* -0.0502* -0.2341* 0.1007* 0.2548* 1.0000 
 p value 0.6186 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000  
Sea Surface Pearson (r) 0.0493* -0.5089* 0.2161* -0.3708* -0.0312* -0.1121* 0.1029* 0.0645* 
Temperature p value 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
a Weekly Parasite Incidence (WPI)= Total malaria cases per week/ 1,000 inhabitants; b RCD/FMDA = Reactive Case Detection with 




Table 14. Forward selection of variables for the Mixed-Effects Poisson Regression Model 
Models AIC 
I. Setting the basic model  
Empty Model 71468.4 
Empty Model + Distance 69547.5 
II. Modeling the effect of proximity towards the intervention sites  
Basic model 61411.5 
Basic model + Sea Surface Temperature (SST) 61167.0 
Basic model + Precipitation 61106.7 
Basic model + Temperature 60588.9 
Basic model + Pressure 60550.1 
Basic model + Soil Moisture 60038.2 
Basic model + Humidity 59276.6 
Basic model + Dry Season 57542.9 
Basic model + Dry Season + SST 57494.3 
Basic model + Dry Season + Vegetation 57484.1 
Basic model + Dry Season + Precipitation 57475.7 
Basic model + Dry Season + Temperature 57184.8 
Basic model + Dry Season + Pressure 57010.2 
Basic model + Dry Season + Soil Moisture 56542.0 
Basic model + Dry Season + Humidity 56177.9 
Basic model + Dry Season + Humidity + Precipitation 56179.8 
Basic model + Dry Season + Humidity + Soil Moisture 56157.3 
Basic model + Dry Season + Humidity + Vegetation 56152.0 
Basic model + Dry Season + Humidity + SST 56076.6 
Basic model + Dry Season + Humidity + Pressure  55730.1 
Basic model + Dry Season + Humidity + Temperature 49936.8 
Basic model + Dry Season + Humidity + Temperature + Precipitation 56168.4 
Basic model + Dry Season + Humidity + Temperature + Vegetation 56136.7 
Basic model + Dry Season + Humidity + Temperature + Soil Moisture 56133.4 
Basic model + Dry Season + Humidity + Temperature + SST 56047.8 
Basic model + Dry Season + Humidity + Temperature + Pressure  55560.1 





Basic model + Dry Season + Humidity + Temperature + Pressure + Soil Moisture 55495.3 
Basic model + Dry Season + Humidity + Temperature + Pressure + SST 55374.1 
Basic model + Dry Season + Humidity + Temperature + Pressure + SST + 
Vegetation 
55374.2 
Basic model + Dry Season + Humidity + Temperature + Pressure + SST + 
Soil Moisture * 
55229.4 
Basic model + Dry Season + Humidity + Temperature + Pressure + SST + 
Soil Moisture + Vegetation 
55228.7 
*  Final model; AIC = Akaike's information criterion; RCD/FMDA = Reactive case Detection 





Table 15. Mixed-Effects Poisson Regression Model for the P. vivax weekly parasite incidence 
 
Estimate 95% CI IRR-Fixed 
Effects 
95% CI 
Constant -6.0745 -7.5784 to -4.5706 0.0023 0.0005 to 0.0104 
Distance a -1.0342 -1.1378 to -0.9307 0.3555 0.3205 to 0.3943 
Dry Season b -1.7065 -1.7873 to -1.6256 0.1815 0.1674 to 0.1968 
Pressure c 0.1228 0.1122 to 0.1335 1.1307 1.1188 to 1.1428 
Temperature d -0.1323 -0.1460 to -0.1187 0.8760 0.8641 to 0.8881 
Precipitation e -0.0124 -0.0142 to -0.0106 0.9877 0.9859 to 0.9895 
SST f -0.1447 -0.1611 to -0.1283 0.8653 0.8512 to 0.8796 
Vegetation g -0.7177 -0.9041 to -0.5312 0.4879 0.4049 to 0.5879 
Soil Moisture h 0.0016 0.0010 to 0.0023 1.0016 1.0010 to 1.0023 
RE (Network) 7.2098 3.8490 to 13.5054   
* IRR = Incidence-Rate Ratio; AIC = Akaike's information criterion; 95% IC = 95% Interval of 
Confidence; RE = Random effects; a, distance by road to the sites intervened with the Reactive 
case Detection with Focal Mass Drug Administration strategy (positive/negative); b, dry season or 
season´s trend with a value of zero for the wet season and a value of one for the dry season; c, 
pressure (kPa) or kilopascals of surface pressure estimated per km2; d, temperature (°C) or degree 
Celsius of temperature at 2 m above the displacement height; e, precipitation (mm water * m-2) or 
mm of rain per square meter per hour; f, SST (°C), or degree Celsius of Sea Surface Temperature 
at the locations’ latitude; g, Vegetation or normalized difference vegetation index (NDVI); h, soil 












4.8 Figures for Chapter 5 
Figure 11. Annual parasite incidence by surveillance units in Tumbes and Piura. 
 2011 
















* The precipitation value in mm is referring to the amount of rain per square meter per hour 
averaged per week; the soil moisture value of m3/m-3 is referring to the mean quantity of cubic 
meters of water per square meter of soil averaged per week; the precipitation value in kPa is 
referring to the number of kilopascals of pressure estimated per km2 averaged per week; the 
humidity value in kg/kg is referring to the number of kg of water vapor per kg of air measured 
daily at 2 m above the displacement height; the temperature value in degrees centigrade is referring 
to the temperature at 2 m above the displacement height averaged per week; and, NDVI is referring 




Chapter 5.  “The heterogeneity of patterns of malaria incidence 
in the Peruvian Amazon and the opportunity of 
interrupting malaria transmission with focal 
interventions” 
5.1 Abstract 
The elimination of malaria demands a clear understanding of the patterns of malaria 
incidence that characterize each of the settings chosen as intervention targets. Typically, each 
malaria endemic country presents different regions where malaria transmission is sustainable in 
time and space.  Such foci represent targets for maximizing the effect of current available malaria 
control intervention.  Thus, in this study we aim to characterize the different patterns of incidence 
of malaria in the Peruvian Amazon to guide the decision making about where, how and which 
intervention should be chosen to maximize the effect of prospect interventions. Overall, we 
observed that the distribution of the human malaria reservoir in Loreto follows the natural 
boundaries of 14 Amazon river navigable tributaries.  At each of these rivers we identify a different 
pattern of malaria incidence, some of which seems to represent a good target to implement focal 
interventions such as reactive case detection with focal mass drug administration.  Across the 
Loreto region each of these 14 river networks seems to behave like an independent and well 
interconnected system with a human malaria reservoir larger enough to sustain the transmission of 
malaria from one season to the following.   In this study we tested such hypothesis by fitting a 
multivariate mixed-effect negative binomial Poisson regression model, with the following 




seasonality, traveling distance to the regional hospital, the type of health care offered at each health 
facility, as well as by altitude, vegetation and precipitation.  Although further assessments will be 
needed to probe such hypothesis, our results indicated that in the Peruvian Amazon there exist 
several different patterns of malaria incidence, including some (those with few communities 
carrying larger fractions of the human malaria reservoir) that offered optimal targets for focal 
interventions while other will other (those with an over dispersed human malaria reservoir) might 
need more permanent interventions. 
 
5.2 Introduction 
The elimination of malaria represents a hard to reach outcome but a necessary global health 
goal (1). Unfortunately, after a period of substantial gains in global malaria control, progress has 
slowed and in some regions reversed (2). In this context, the efforts must continue to resolve the 
major technical, operational and financial challenges that have not yet been addressed in order to 
achieve the goal of regional elimination.  Research continues to be an important driver in the future 
eradication scenario (3). A key point for malaria elimination is to design strategies to reduce 
transmission; effective identification and malaria case management may help to reduce the pool 
of parasites that contribute to further transmission (2). Transmission is a dynamic and variable 
process with different patterns according to each affected region. It involves many interlinked 
factors, from natural environmental conditions to man-made disturbances (4).  For example, where 
malaria transmission is seasonal, optimal timing of control becomes particularly crucial regarding 
planning control strategies.  With such information, health officers may plan to maximize the 
impact of Indoor Residual Spraying (IRS) by prioritizing rounds before the onset of the malaria 




Out of the five Plasmodium species that are capable of infecting humans, P. falciparum and 
P. vivax are the most common.  Although both species are ubiquitous in tropical and sub-tropical 
endemic regions around the world, most of the mortality and burden attributable to malaria is due 
to P. falciparum cases from Sub-Saharan Africa where such species is hyperendemic (6).  Similar 
to P. falciparum, P. vivax has also been occasionally associated with fatal and severe malaria (7).  
These cases are commonly reported in regions where P. vivax represents the dominant malaria 
species circulating like in the Americas (except in the Dominican Republic, Haiti and Colombia 
where P. falciparum is responsible for most cases) (2).  This is a reason of increasing concern 
given that several countries in the region are registering an increasing number of their severe and 
non-severe vivax malaria cases (8, 9).  Moreover, in some countries such as Venezuela and Peru, 
the cases of malaria, particularly P. falciparum malaria cases, have reemerged since 2010 (10).  
Such increasing malaria trends may threaten the regional progress was given that the contribute 
~50% of malaria cases in the region (10, 11).  
Around the world, most malaria endemic settings have "seasonal peaks" of malaria cases, 
which are described as associated with the rainy months or wet months.  However, this varies from 
year-to-year giving a variety of factors such as the lack of standard definition of seasonality (12) 
or disrupting effects such as the El Niño–Southern Oscillation (13, 14).  For example, in Manhiça 
(Mozambique) malaria seasons have been classified in different publications as being perennial 
either with "some" (15), "substantial" (16), or "marked" (17) seasonality, all of which are difficult 
to measure.  As a result, the intensity and seasonality of malaria transmission varies widely within 
and between countries in sub-Saharan Africa. The same occurs in other regions of the worlds where 




during the El Niño years intensifying transmission or during La Niña over dispersing malaria 
transmission across endemic areas (18).   
Assessing the distribution of the human malaria reservoir is essential to prioritize 
interventions and decide on resource allocation.  To do so, we can use mathematical models to 
assess the distribution of the human malaria reservoir across a range of transmission intensities 
by using the malaria symptomatic cases as its most strong signal.  Thus, in Peru, there is a need 
for models that consider the effects of seasonality, health-care coverage and access, transmission 
dynamics patters, among other factors, across its distinct epidemiological contexts to guide the 
choice and timing of control interventions.  
This paper aims to assess the variability of patterns of malaria incidence in the Peruvian 
Amazon and use that information to identify opportunities to interrupt malaria transmission with 




The study design corresponds with a time series study, where we analyze surveillance data 
routinely collected by the Health Directorate of Loreto covering a total of 342 surveillance 
reporting units.  Such units include 282 health posts, 50 health centers, and 10 clinics/hospitals, 






The study was conducted in the Loreto region, which is the largest region in the Peruvian 
Amazon (Figure 13).  Loreto's territory represents almost one-third of the country territory 
(368,851 km²), but with a population of ~1M inhabitants; it also represents one of the regions with 
the lowest population density in Peru (2.7 persons per Sq. km).  Geographically, Loreto comprises 
lands that are either at high (between 500 and 1500 meters or “upper jungle”) or low (bellow 500 
meters or “lower jungle”) altitude, which are humid and largely covered with thick vegetation.  
Loreto is one of the richest regions of Peru in terms of natural, gas and oil resources, but 
contradictorily, it is also one of the poorest regions in Peru with 70% of its population below the 
poverty line.  Consequently, the MoH represents the main healthcare provider in the region with a 
small fraction of Loreto inhabitants receiving healthcare from the social security system, the 
military health care system or private clinics.  Politically, Loreto is divided into eight provinces 
and 53 districts, connected mainly by the Amazon river tributaries.  The main Amazon river 
tributaries are navigable, so they naturally restrict the propagation of anopheline vectors 
(primarily An. darlingi) as well as the human migration for labor or commerce activities (19).  The 
region weather is typical of a humid and warm rainforest, with an average daily high temperature 
of 31 °C and an average temperature of 28 °C.  During the hottest months (December-March), 
temperatures range typically from 26 °C (79 °F) to 36 °C (97 °F), while coolest months from 17 
°C (63 °F) to 20 °C (68 °F).  The average humidity level is 84%, with tropical rain all year round. 
Malaria in Loreto is over-dispersed and exhibits high heterogeneity with an increasing 
burden in some regions.  Overall, the Loreto region alone counts for over 90% of the burden of 
malaria in Peru, showing an increasing trend since 2010 (Figures 15 and 16).  Symptomatic malaria 




at a ratio of 4:1 with an estimated ratio of symptomatic per asymptomatic malaria cases of 1:4-5 
(20, 21).  In 2017, Loreto reported an annual parasite incidence of were 57 cases per 1,000 
inhabitants, corresponding to 39,372 P. vivax malaria cases and 12,905 P. malaria cases, 
respectively, in 2017 (22).  The seasonality of malaria across the Loreto regions is marked with 
perennial malaria cases peaking during the rainy season (February–July), but with high 
heterogeneity across districts (23). 
 
Study Population 
For this study, we analyzed all surveillance reporting units from Loreto using traveling 
times by standard boats to the Regional hospital in Iquitos, as a proxy for connectivity across 
navigable rivers and accessibility to tertiary health-care.  Considering that susceptible subjects 
mainly commute across communities by navigable rivers, we hypothesized that each of the main 
Amazon rivers behaves as endemic malaria region independent and large enough to sustain malaria 
transmission from one season to the next season. 
The study period was limited to the 2010-2015 period because of three reasons.  First, 
before 2010 the Loreto region was actively exposed to several rounds of malaria control 
intervention within the scope of the PAMAFRO (malaria control in the border areas of the Andean 
region) project.  Briefly, at intervention areas, the project enhanced community participation with 
local health workers to implement educational campaigns, passive surveillance, implementing 
rapid diagnostic tests, and distributing over 250,000 long-lasting impregnated bed nets (24).  
Second, starting in 2016 the MoH officers raised awareness for malaria elimination due to the 




Program 2017-2021”) (25).  Moreover, third, NASA recently released new projects and algorithms 




Across Loreto, during the study period surveillance activities continued taking advantage 
of previous system enhancement either by active case detection (ACD) or passive case detection 
(PCD).  Briefly, under ACD eligible communities were visited to test and treat every subject either 
using a rapid diagnostic test or microscopy, followed by observed treatment by local health 
workers or community health workers if testing positive.  Under PCD every febrile subject 
presenting to a health center was tested for malaria using either a rapid diagnostic test or 
microscopy and treated by local health workers.  In both cases, following the Peruvian National 
Malaria guideline (25), subjects were treated uniformly as uncomplicated vivax malaria cases.  
During the PAMAFRO project surveillance protocols and case management were improved and 
standardized across regional reporting units and the personnel responsible for the local malaria 
program were trained to collect and report malaria surveillance in weekly reports.  Once collected 
the data are reported to the health network reference center and from there to the Regional Health 
Directorate, which entered the data into the Electronic Online Surveillance System (NOTI System) 
and issuing weekly epidemiological bulletins reporting the malaria incidence together with the 
counts from other diseases under mandatory surveillance.  For this study, the data was downloaded 





Malaria Treatment  
As previously reported and according to the Peruvian malaria treatment guidelines, all 
malaria cases received treatment uniformly and free of charge (26).  The treatment of choice for 
uncomplicated vivax malaria cases in adults and children was oral chloroquine (10 mg/kg) over 72 
hours, plus oral primaquine (0.5 mg/kg), daily, for seven days.  In the case of pregnant women, 
the treatment of choice was oral chloroquine (10 mg/kg) over 72 hours followed by a weekly dose 
of 5 mg/kg until delivery, and then primaquine phosphate (0.5 mg/kg) daily for seven days< while 
in the case of Infants under six months of age the treatment was chloroquine only.  And for 
unconscious patients, the treatment of choice was quinine sulfate (10 mg salt/kg/day) three times 
daily and intravenously clindamycin (20 mg base/kg/day) until subjects can initiate standard oral 
treatment.  The treatment of choice for uncomplicated falciparum malaria cases in adults and 
children was artesunate + mefloquine (adopted 2001) + primaquine 0.75 mg/kg single dose on last 
day of ACT (adopted 2015).  For complicated falciparum malaria, the treatment of choice was 
quinine sulfate (10 mg salt/kg/day) three times daily and intravenously clindamycin (10 mg 
base/kg/day) twice daily until subjects can initiate standard oral treatment.  In the case of pregnant 
women, the treatment of choice was oral quinine (10 mg/kg) three times daily for seven days, + 
oral clindamycin (10 mg/kg) twice daily for five days starting at the third day of treatment, + oral 
primaquine 0.75 mg/kg single dose at the third day of treatment. 
 
Study outcomes 
As a primary outcome, we assessed and compared the variability of the malaria weekly 




separately.  Weekly parasite incidence was calculated by dividing the total weekly count of malaria 
cases, as reported by the national surveillance system, per 1,000 inhabitants of each community as 
estimated by the Peruvian Ministry of Health at each surveillance reporting unit. 
 
Climate and environmental variables 
For the purpose of characterizing the patterns of transmission, we assessed a set potential 
climate and environmental associated factors with our outcome of interest.  These variables 
included temperature (MERRA-T2M), humidity (MERRA-QV2M), soil moisture (MERRA-
SFMC), elevation (ASTER-GDEM), precipitation (TRMM-TMPA 3B42V7), and NDVI (MODIS 
MOD13C1).  Each of these variables was assessed using their weekly averages estimated at the 
coordinates of each the Loreto surveillance reporting units for the 2010–2015 period.  Due to the 
different resolution, each variable was estimated by averaging their hourly estimates using the 
protocols standardized by NASA for each of their satellite products.  In the case of the MERRA 
products data was available at hourly steps and with a 1/2°×2/3° resolution, TMPA precipitation 
estimates were available at 3-hourly time steps and with a 0.25°×0.25° resolution; while the 
MODIS NDVI estimates were available at 0.05°x 0.05° resolution and the ASTER GDEM was 
available with a resolution of 1° × 1° tiles for land surface regions between 83° N-S. 
  
Data Collection 
Weekly parasite incidences (malaria cases per 1,000 inhabitants) was estimated at each 
surveillance reporting unit by dividing their weekly malaria counts over the government estimates 




surveillance system to obtain the weekly counts from each of its 342 surveillance reporting units 
during the 2010-2015 period.  Briefly, for each epidemiological week all the surveillance reporting 
units reported their malaria counts to the regional health directorate, which uses the surveillance 
software NOTI for data entry and quality control.  We maintained the main datasets without 
identifiers in a secure computer system as prevention to maintain confidentiality and avoid loss of 
data.  Then, we directly analyzed the CSV files using STATA/MP v14.0 (Stata Corporation, 
College Station, TX, 2011) with the Excel import command for data management, including 
further checks and reviewing for consistency and completeness.  
 
Data Analysis 
First, we performed an exploratory analysis to describe and compare the baseline 
characteristics within and between reporting units by region.  Baseline characteristics and 
outcomes were described with summary statistics, using frequency and percentage for categorical 
variables and mean and standard deviation for continuous variables.  To estimate the effect of the 
RCD/FMDA on interrupting malaria transmission in Piura, we first the fit a bivariate model with 
the WPI as a function of the road proximity to closer intervention districts during the pilot study.  
Then we fit a multivariate model using a mixed-effects Poisson regression model to adjust for the 
climate and weather variables as potential confounders and account for the structure of the data.  
The forward selection was used to determine the variables for the multivariate model using the 
Akaike Information Criteria (AIC) and the likelihood ratio test (LRT) to compare nested models.  
Pearson’s correlation coefficients are also computed for each variable to assess and prevent 
multicollinearity.  All the analyses were conducted with Stata/MP 14.0 (Stata Corporation, College 






During study planning, the study protocol was approved by the Tumbes and Piura Regional 
Health Directorate authorities, which approved the study as a project of public health relevance 
for their regions.  Both regions designated a lead epidemiologist to collaborate during data 
collection.  Both Regional Health Directorate epidemiologist participated actively in all the 
interventions related activities, so they had a broad knowledge about the quality and limitations of 
the data, and were the first recipients of the study results for decision-making purposes.   
 
5.4 Results  
Malaria incidence in Loreto  
In 2010 Loreto reported a total of 11,512 malaria cases, including 9,162 cases positive for 
P. vivax, 2,312 for P. falciparum, and 55 to both species. With this count, we estimated an annual 
parasite incidence of 13.3 cases per 1,000 people (95% Confidence Interval [CI]: 13.1 to 13.6 cases 
per 1,000 people), representing a record low since 1994 (Figure 14). Across surveillance units, we 
estimated that in 2010 the average weekly parasite incidence (WPI) was about 32.5 cases per 
100,000 people (95% CI: 29.2 to 35.7 cases per 100,000 people), with a range of 0 to 10,259 cases 





Malaria incidence in Loreto’s Health Networks 
Loreto showed a high heterogeneity variability of WPI among health networks (Table 15).  
During the period 2010-2017 (Figure 15-16), the health networks with the high mean WPI were 
Datem del Marañon with 331.6 cases per 100,000 people (95% CI: 305.5 to 358.1 cases per 
100,000 people), Loreto with 241.5 cases per 100,000 people (95% CI: 226.5 to 256.5 cases per 
100,000 people), Maynas City with 145.5 cases per 100,000 people (95% CI: 226.5 to 256.5 cases 
per 100,000 people), Maynas Periphery with 114.8 cases per 100,000 people (95% CI: 109.7 to 
120.1 cases per 100,000 people) and Ramon Castilla with 112.4 cases per 100,000 people (95% 
CI: 102.8 to 122.1 cases per 100,000 people).  During the same period the health networks with 
the lowest WPI were Requena with 81.2 cases per 100,000 people (95% CI: 81.2 to 122.1 cases 
per 100,000 people), Alto Amazonas with 53.9 cases per 100,000 people (95% CI: 50.0 to 57.8 
cases per 100,000 people), and Ucayali with 13.6 cases per 100,000 people (95% CI: 10.5 to 16.7 
cases per 100,000 people).  Among clinics and hospitals, which do not belong to any health 
network the mean WPI during 2010-2017 also low compared to most health networks with 17.5 
cases per 100,000 people (95% CI: 15.7 to 19.2 cases per 100,000 people).  
 
Malaria incidence across Amazon river tributaries  
For the purpose of testing the hypothesis that each of the main Amazon river tributaries 
behaves as independent ecosystems large enough to sustain the transmission of malaria from one 
season to the following, we assessed the patterns of incidence along them.  To do so, first, we 
explore the variability of the WPI among the health networks, which was already disaggregated 
following the Loreto map using the rivers as the natural boundaries.  Second, using guidance from 




managing and directing the malaria program in Loreto) we split the largest health networks into 
smaller river systems following the path of the main Amazon river tributaries as well as by splitting 
the Amazon river into as small as possible units but administratively independent sections. 
Consequently, we started with the eight health networks from the health infrastructure map of 
Loreto and then decided to disaggregate the Loreto map into 14 riverine systems.  
The process started by disaggregating the health network Datem del Marañon, which is 
crossed by the Marañon river and its two main tributaries, the Pastaza and the Morona rivers 
(Figure 17). Here the decision was to disaggregate the health network into three river systems 
allocating all the surveillance units from the Andoas and Pastaza districts to the Pastaza river, the 
ones from the Manseriche, Barranca and Cahuapanas districts to the Marañon river, and the ones 
from the Morona district to the Morona river. In doing so we observed significant differences 
(ANOVA p-value <0.001) in the mean WPI during the 2010-2017 period among the rivers 
Marañon (24.5 ± 2.1 malaria cases per 1,000 people), Morona (54.0 ± 6.1 malaria cases per 1,000 
people) and Pastaza (904.3 ± 38.7 malaria cases per 1,000 people) both, during the whole period 
or observations as well as from year to year (Figures 17 and 18).  
In the case of the Maynas Periphery and Ramon Castilla health networks, which are two of 
the largest health networks in Loreto, we allocated all the surveillance units from the Yaquerana 
district -Maynas Periphery together with ones from the Yavari district – Ramos Castilla, all located 
along the along the Yavari River (Figure 18). Second, similarly, we allocated all the surveillance 
units along the Peru-Colombia border, all located along the Putumayo River.  Third, we split the 
Amazon river into three sections, the first allocating the surveillance units from the Belen and 
Fernando Lores districts (both from Maynas Periphery health network), the second combining 




linking those from Pevas and San Pablo districts (Ramon Castilla health network). Third, we 
combined all the surveillance units along the Napo River, including the ones located at Torres 
Causasana, Napo, and Mazan districts (all from the Maynas Periphery health network) (Figure 19).  
By doing so we observed significant differences (ANOVA p-value <0.001) in the mean WPI 
during the 2010-2017 period among the Putumayo river (53.9 ± 4.2 malaria cases per 1,000 
people), Yavari river (279.6 ± 9.4 malaria cases per 1,000 people), Amazonas section Fernando 
Lores (24.5 ± 2.1 malaria cases per 1,000 people), and Amazonas section Las Amazonas (54.0 ± 
6.1 malaria cases per 1,000 people), Amazonas section Ramón Castilla (904.3 ± 38.7 malaria cases 
per 1,000 people). Such differences varied widely year by year as well (Figures 20 and 21). 
In the case of the Loreto health network, we allocated all of the surveillance units from the 
Tigre district with the Tigre river, while all other surveillance units were allocated to the Marañon 
River.  We observed significant differences (t-test p-value <0.001) in the mean WPI during the 
2010-2017 period for both rivers (339.7 ± 10.9 vs. 148.5 ± 10.6 malaria cases per 1,000 people; p-
value <0.001). Such differences also varied widely year by year (Figures 20 and 21). 
 
Modeling the risk of malaria in time and space  
To model the malaria counts in time and space, first we fit a mixed-effects Poisson regression 
model using health centers as a first level and the rivers system as a second level, and by adjusting 
the malaria counts by population, seasonality, time, and traveling time to the Loreto Regional 
Hospital as a surrogate of connectivity.  Second, we improved the fit of the model by adding key 
administrative, weather and climate covariates (Figures 22-28). At the end of the process, the main 




28), and the level of care offered at each surveillance unit or Health Center type (Tables 19 and 
20).  
Once the mixed-effects multivariate Poisson regression model was fitted we addressed the 
issue of the many weekly zero counts, which represent 25.1% of all weekly malaria counts in our 
dataset. To do so, we fitted a mixed-effect negative binomial Poisson regression model with the 
same covariates (Table 21). To compare the fit of both models, we used the Likelihood-ratio test 
and observed that indeed, the mixed-effect negative binomial Poisson regression model fitted the 
data significantly better than the mixed-effect negative binomial Poisson regression model (p-
value <0.0001). That being said, we also observed that precipitation lost its significance as a 
predictor of the malaria risk, so we ran a new model without precipitation. Comparing both models 
with the Likelihood-ratio test the one without precipitation fitted malaria counts better.   
Table 21 shows the regression coefficients of the final model where it can be seen that the 
risk of malaria increases with time, traveling distances from Iquitos, and vegetation, but decreases 
with higher altitude. Also, the model supports the hypothesis that the rivers behaves as independent 
networks with different patterns of malaria transmission.  
 
Modeling the risk of vivax and falciparum malaria  
When assessing the predictability of the model by malaria species, we noticed that 
precipitation seems to compete with traveling distance as a predictor of the risk of malaria.  By 
comparing the coefficients in both models, we observed that the risk of falciparum malaria seems 
to be more associated with the variability of the river systems than the risk of vivax malaria, as 






In the path to eliminate and eradicate malaria, there is a clear and urgent need for 
improvement of the data analysis used to inform decision makers.  By doing so, malaria-endemic 
countries certainly can take the best of their surveillance data to track their human malaria reservoir 
and characterize its patterns of malaria transmission.  In our study, we assessed the surveillance 
data from the Peruvian Amazon, which a low endemic malaria region, and were able to identify 
different patterns of malaria incidence across Loreto.  In the study region, the distribution of 
malaria cases seems to follow the Amazon river tributaries, which are areas competent to sustain 
the transmission of malaria from one season to the following. Furthermore, we observed that the 
main predictors of malaria in the region are low altitude and the density of the vegetation, which 
together seems to characterize well the variability of ecosystems across the region.  Additionally, 
we found some differences in the distribution of falciparum malaria which seems to be more 
associated with the density of the vegetation than the distribution of vivax malaria.  
The problem of zero counts of cases of malaria in epidemiological weeks resulted in a major 
challenge during the analytical process of our study. This is normally addressed by switching from 
a mixed-effects Poisson regression model to a mixed-effects Zero-Inflated Poisson regression, but 
mixed-effects negative binomial Poisson regression seems to represent a more appropriate 
alternative to deal with the over dispersion of the data. 
The pattern of incidence of malaria showed a high variability across river systems as well as 
year by year. While in some regions the incidence of malaria grew rapidly early in the study period, 
others seem to expand later in the study period.  In contrast, while some rivers exhibit some 
stability in time with a softened seasonality, others exhibited instability and with a strong 




Once characterized the information gathered about the patterns of incidence along the river 
system can be used to guide focalized intervention that helps to interrupt the transmission of 
malaria in a more cost-effective manner.  A reasonable explanation for these results could be the 
relative stability of the human malaria reservoir as well as of the mosquitoes breeding sites along 
each of the river systems in the Amazon basin. However, here we can only be conservative with 
these findings because of the lack of more rigorous study design and the fact that the signal we 
analyzed was based on diagnosis obtained by microscopy. This means the human reservoir we are 
assessing in only the tip of an iceberg of asymptomatic malaria below the limit of detection of 
microscopy like as previously described (27). 
This study showed that the combination of altitude and vegetation predict the risk of malaria 
in the Loreto region better that other climate and weather predictors such as temperature, 
precipitation, humidity, soil moisture or pressure.  The negative association with altitude could 
indicate a need for warmer temperatures for malaria transmission, which increases in the lower 
jungle compared with the high jungle. Furthermore, the combination of altitude and vegetation 
may better characterize better the conditions necessary for the appearance of mosquitoes breeding 
sites and guaranteed the Anopheles mosquitoes survival. 
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5.7 Tables for Chapter 6 
Table 16. Malaria mean weekly parasite Incidence by year and health network 
  Mean Weekly Parasite Incidence ** (95% CI) 
2010 2011 2012 2013 2014 2015 2016 2017 
Overall 32.5 30.9 69.6 111.9 145.9 181.7 247.8 295.5 
 (29.2 - 35.7) (28.5 - 33.3) (64.0 - 75.1) (104.7 - 119.1) (136.3 - 155.5) (170.7 - 192.8) (229.0 - 266.5) (273.4 - 317.6) 
Health Network         
  Clinics/Hospitals 3.8 1.6 5.4 19.5 32.1 23.7 30.8 22.8 
 (1.8 - 5.7) (1.0 - 2.3) (3.6 - 7.2) (14.2 - 24.7) (25.2 - 39.0) (18.6 - 28.8) (23.2 - 38.3) (17.9 - 27.7) 
  Maynas City 41.4 70.6 154.0 225.5 228.2 173.3 146.0 125.0 
 (35.3 - 47.4) (62.4 - 78.9) (131.5 - 176.5) (206.1 - 244.9) (209.6 - 246.8) (158.7 - 187.9) (133.7 - 158.3) (107.4 - 142.7) 
  Maynas Periphery 43.0 45.1 60.4 101.4 114.4 190.3 160.6 203.6 
 (32.9 - 53.1) (38.5 - 51.7) (52.9 - 67.8) (90.4 - 112.4) (98.3 - 130.4) (170.0 - 210.6) (143.7 - 177.5) (183.4 - 223.8) 
  Ramon Castilla 52.1 34.1 139.9 220.6 104.1 184.7 68.9 95.1 
 (38.0 - 66.2) (24.9 - 43.2) (113.8 - 166.0) (163.9 - 277.2) (88.1 - 120.0) (153.5 - 216.0) (54.2 - 83.5) (78.1 - 112.2) 
  Loreto 40.9 16.6 53.0 138.8 313.3 369.0 543.8 456.7 
 (28.2 - 53.5) (12.4 - 20.9) (41.4 - 64.6) (112.1 - 165.5) (259.5 - 367.1) (325.9 - 412.0) (473.2 - 614.3) (401.8 - 511.5) 
  Requena 86.7 29.3 94.2 130.8 113.1 70.0 73.2 51.9 
 (62.5 - 111.0) (20.3 - 38.3) (71.6 - 116.8) (100.1 - 161.6) (88.0 - 138.2) (55.6 - 84.5) (55.3 - 91.1) (37.6 - 66.3) 
  Ucayali 12.6 13.4 8.2 23.9 10.7 19.6 13.0 7.5 
 (3.4 - 21.8) (8.5 - 18.3) (4.3 - 12.0) (10.6 - 37.1) (5.5 - 15.9) (9.8 - 29.5) (-0.3 - 26.3) (4.3 - 10.7) 
  Alto Amazonas 10.5 16.9 38.8 35.4 65.1 82.1 72.1 110.6 
 (6.9 - 14.1) (11.6 - 22.1) (25.8 - 51.7) (27.4 - 43.4) (52.1 - 78.1) (67.0 - 97.2) (62.6 - 81.5) (96.0 - 125.2) 
  Datem del Marañon 13.7 11.2 27.5 73.8 192.2 325.3 837.9 1170.8 
   (8.9 - 18.5) (8.5 - 14.0) (21.5 - 33.5) (59.5 - 88.1) (152.0 - 232.5) (265.7 - 384.8) (715.8 - 960.0) (1020.5 - 1321.1) 




Table 17. Malaria mean weekly parasite Incidence by year and river system 
River System 
(Units) 
Mean Weekly Parasite Incidence ** (95% CI) 
2010 2011 2012 2013 2014 2015 2016 2017 
Amazonas 1 3.5 2.9 17.4 51.4 17.4 11.7 7.1 7.1 
(12 Units) (2.2 - 4.9) (1.8 - 3.9) (11.1 - 23.6) (36.0 - 66.7) (11.8 - 22.9) (8.7 - 14.8) (5.0 - 9.2) (4.7 - 9.6) 
Amazonas 2 8.5 31.2 87.6 73.1 38.8 27.3 15.4 28.1 
(11 Units) (6.0 - 10.9) (21.6 - 40.8) (61.8 - 113.4) (55.4 - 90.7) (30.2 - 47.3) (20.7 - 34.0) (10.5 - 20.2) (17.0 - 39.3) 
Amazonas 3 11.5 9.6 71.0 148.6 40.4 150.8 61.8 52.0 
(20 Units) (8.9 - 14.1) (7.0 - 12.1) (48.0 - 94.0) (79.2 - 217.9) (33.2 - 47.7) (113.2 - 188.5) (43.6 - 80.1) (37.1 - 66.9) 
Huallaga 1.3 0.3 1.3 6.2 4.9 46.7 61.2 120.4 
(37 Units) (0.7 - 1.9) (0.1 - 0.5) (0.6 - 2.1) (3.3 - 9.1) (2.6 - 7.3) (38.6 - 54.8) (51.9 - 70.6) (103.6 - 137.2) 
Marañon 13.9 1.1 7.6 28.9 116.6 115.9 161.0 220.3 
(52 Units) (8.1 - 19.7) (0.8 - 1.4) (5.5 - 9.7) (19.5 - 38.2) (82.8 - 150.5) (99.3 - 132.4) (126.4 - 195.6) (170.5 - 270.1) 
Morona 1.5 0.1 2.4 19.1 49.3 24.6 17.2 82.5 
(9 Units) (0.4 - 2.6) (-0.1 - 0.3) (1.2 - 3.6) (9.8 - 28.3) (32.2 - 66.5) (13.6 - 35.6) (8.6 - 25.8) (58.8 - 106.2) 
Nanay 41.4 70.7 154.0 225.4 228.2 173.3 145.9 125.0 
(62 Units) (35.3 - 47.4) (62.4 - 78.9) (131.5 - 176.5) (206.0 - 244.8) (209.6 - 246.8) (158.7 - 187.9) (133.6 - 158.2) (107.4 - 142.7) 
Napo 53.5 84.5 89.3 179.9 263.6 361.2 349.7 459.0 
(22 Units) (43.2 - 63.7) (69.0 - 99.9) (76.0 - 102.6) (154.1 - 205.7) (221.5 - 305.7) (311.7 - 410.6) (308.9 - 390.6) (408.3 - 509.7) 
Pastaza 19.5 31.4 78.2 201.3 518.0 885.2 2371.3 3130.0 
(15 Units) (14.3 - 24.6) (23.4 - 39.4) (60.7 - 95.7) (160.3 - 242.3) (401.2 - 634.7) (713.9 - 1056.4) (2030.0 - 2712.5) (2731.4 - 3528.5) 
Putumayo 1.4 0.0 0.0 0.0 0.1 195.3 128.7 105.3 
(10 Units) (-0.7 - 3.6) (0.0 - 0.0) (0.0 - 0.0) (0.0 - 0.0) (-0.1 - 0.3) (151.1 - 239.5) (91.3 - 166.2) (81.0 - 129.6) 
Tigre 61.4 32.9 94.1 234.8 362.7 535.1 784.6 611.7 
(18 Units) (38.6 - 84.1) (24.3 - 41.5) (71.1 - 117.0) (186.7 - 283.0) (307.6 - 417.7) (458.8 - 611.3) (678.4 - 890.7) (554.2 - 669.3) 
Ucayali 62.8 24.2 66.5 96.3 80.1 53.8 53.8 37.6 
(32 Units) (46.0 - 79.6) (17.8 - 30.5) (51.0 - 81.9) (74.9 - 117.7) (62.8 - 97.3) (43.4 - 64.1) (40.9 - 66.7) (27.8 - 47.4) 
Yavari 303.1 151.2 345.3 447.0 304.8 307.3 119.0 259.4 
(8 Units) (222.4 - 383.8) (117.0 - 185.5) (283.8 - 406.9) (386.3 - 507.7) (257.6 - 352.1) (265.7 - 348.8) (99.7 - 138.3) (218.0 - 300.9) 
Yurimaguas 23.6 40.1 89.2 63.5 133.3 135.0 95.4 116.3 
(34 Units) (15.1 - 32.1) (27.5 - 52.7) (58.2 - 120.1) (45.5 - 81.5) (103.3 - 163.4) (100.6 - 169.4) (75.7 - 115.0) (87.5 - 145.0) 




Table 18. Weekly means of the environmental and climate parameters during the scale-up study * 
Location 
 
















All 99.03  17.09 26.01 0.34 194.8 0.74 139.8 
 (90.02 - 94.03) (17.07 - 17.10) (26.00 - 26.02) (0.34- 0.34) (193.9 - 195.6) (0.74 - 0.74) (139.6 - 140.0) 
By river         
    Amazonas1 99.81 19.4 25.4 0.40 252.0 0.74 107.8 
 (99.81 - 99.82) (19.4 - 19.4) (25.4 - 25.5) (0.40 - 0.40) (247.9 - 256.1) (0.74 - 0.74) (107.8 - 107.9) 
Amazonas2 99.52 18.8 25.4 0.39 252.5 0.69 110.2 
 (99.48 - 99.55) (18.7 - 18.8) (25.3 - 25.4) (0.38 - 0.39) (248.2 - 256.9) (0.69 - 0.70) (109.6 - 110.8) 
Amazonas3 99.91 19.2 25.4 0.40 299.5 0.74 94.5 
 (99.90 - 99.91) (19.2 - 19.2) (25.4 - 25.4) (0.40 - 0.40) (296.1 - 302.9) (0.74 - 0.74) (94.2 - 94.7) 
Huallaga 97.68 14.9 26.5 0.28 139.0 0.76 188.1 
 (97.65 - 97.70) (14.9 - 15.0) (26.5 - 26.5) (0.28 - 0.29) (136.8 - 141.1) (0.76 - 0.76) (187.4 - 188.7) 
Marañon 98.58 15.9 26.6 0.29 154.0 0.72 140.4 
 (98.56 - 98.60) (15.8 - 15.9) (26.6 - 26.7) (0.29 - 0.29) (152.1 - 155.9) (0.72 - 0.72) (140.0 - 140.8) 
Morona 97.70 15.7 26.0 0.29 164.6 0.76 150.0 
 (97.68 - 97.72) (15.6 - 15.8) (25.9 - 26.1) (0.29 - 0.30) (160.1 - 169.0) (0.76 - 0.76) (150.0 - 150.0) 
Nanay 99.78 19.1 25.3 0.39 243.2 0.75 116.7 
 (99.78 - 99.78) (19.1 - 19.1) (25.3 - 25.3) (0.39 - 0.39) (241.4 - 244.9) (0.74 - 0.75) (116.5 - 116.9) 
Napo 99.54 18.8 25.0 0.40 254.9 0.75 169.4 
 (99.53 - 99.55) (18.8 - 18.8) (25.0 - 25.0) (0.40 - 0.40) (252.0 - 257.8) (0.75 - 0.75) (168.1 - 170.7) 
Pastaza 98.60 16.1 26.4 0.32 165.0 0.75 190.4 
 (98.58 - 98.61) (16.0 - 16.2) (26.3 - 26.5) (0.32 - 0.32) (161.4 - 168.6) (0.75 - 0.76) (189.8 - 191.0) 
Putumayo 99.82 18.7 24.9 0.41 292.1 0.73 108.3 
 (99.81 - 99.83) (18.7 - 18.8) (24.9 - 25.0) (0.41 - 0.41) (287.8 - 296.4) (0.73 - 0.74) (108.0 - 108.6) 
Tigre 99.36 16.9 26.0 0.35 167.6 0.73 125.0 
 (99.35 - 99.37) (16.9 - 17.0) (25.9 - 26.0) (0.35 - 0.36) (164.4 - 170.9) (0.73 - 0.74) (125.0 - 125.0) 
Ucayali 99.16 16.6 26.2 0.31 163.9 0.75 120.9 
 (99.15 - 99.18) (16.5 - 16.6) (26.2 - 26.2) (0.31 - 0.32) (161.5 - 166.4) (0.74 - 0.75) (120.7 - 121.0) 
Yavari 99.79 18.4 25.5 0.38 257.2 0.74 88.6 
 (99.78 - 99.80) (18.4 - 18.5) (25.4 - 25.5) (0.38 - 0.38) (251.3 - 263.0) (0.74 - 0.75) (87.4 - 89.8) 
Yurimaguas 98.33 14.4 27.4 0.26 111.2 0.75 178.7 
 (98.32 - 98.34) (14.4 - 14.5) (27.4 - 27.4) (0.26 - 0.26) (109.3 - 113.2) (0.75 - 0.75) (178.5 - 179.0) 
* Weekly estimates averaged at year 2009-2010; SD, Standard deviation; 95% CI = 95% Confidence Interval; Pressure (kPa), kilopascals of pressure 
estimated per km2; Humidity (kg vapor * kg-1 air * 103),  103 kg of water vapor per kg of air measured daily at 2 m above the displacement height; 
Temperature (°C), degree Celsius of temperature at 2 m above the displacement height; Soil moisture (m3*m-3), cubic meters of water per square 










Pressure Humidity Temp. Moisture Precip. Veget. 
Traveling  Pearson (r) 0.0330* 1.0000       
Time p value <0.0001        
Pressure Pearson (r) 0.0626* -0.5064* 1.0000      
 p value <0.0001 <0.0001       
Humidity Pearson (r) 0.0163* -0.4274* 0.5812* 1.0000     
 p value <0.0001 <0.0001 <0.0001      
Temperature Pearson (r) -0.0164* 0.1724* -0.2564* -0.6275* 1.0000    
 p value <0.0001 <0.0001 <0.0001 <0.0001     
Moisture Pearson (r) 0.0434* -0.4005* 0.6390* 0.7848* -0.6409* 1.0000   
 p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001    
Precipitation Pearson (r) 0.0054 -0.1778* 0.3146* 0.6486* -0.5085* 0.5701* 1.0000  
 p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001   
Vegetation Pearson (r) 0.0167* 0.0735* -0.0483* -0.0185* 0.0113* 0.0038 0.0113* 1.0000 
 p value 0.0000 0.0000 0.0000 0.0000 0.0002 0.2117 0.0002  
Altitude Pearson (r) 0.0518* 0.4406* -0.6548* -0.5089* 0.2288* -0.5134* -0.3068* 0.0719* 
 p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 






Table 20. Forward selection of variables for the Mixed-Effects Poisson Regression Model 
Models AIC 
I. Setting the basic model  
Empty Model 893556.8 
Empty Model + Population 881416.5 
Empty Model + Population + Traveling time 875501.2 
Empty Model + Population + Traveling time + Week 804957.0 
Empty Model + Population + Traveling time + Week + Sin1 + Cos1 792122.4 
Empty Model + Population + Traveling time + Week + Sin1 + Cos1 + Sin2 + 
Cos2 
791474.7 
II. Modeling the effect of proximity towards the intervention sites  
Basic model 791474.7 
Basic model + Pressure Correlated 
Basic model + Precipitation NC 
Basic model + Temperature NC 
Basic model + Altitude + Health Center Type NC 
Basic model + Vegetation 791399.8 
Basic model + Soil Moisture 791210.0 
Basic model + Humidity 791169.4 
Basic model + Altitude 789304.1 
Basic model + Altitude + Humidity Correlated 
Basic model + Altitude + Soil Moisture Correlated 
Basic model + Altitude + Temperature NC 
Basic model + Altitude + Health Center Type NC 
Basic model + Altitude + Vegetation 789257.1 
Basic model + Altitude + Precipitation 789208.6 
Basic model + Altitude + Precipitation + Health Center Type NC 
Basic model + Altitude + Precipitation + Vegetation 786192.7 
Basic model + Altitude + Precipitation + Vegetation + Health Center Type 789166.6 
*  Final model; AIC = Akaike's information criterion; RCD/FMDA = Reactive case Detection 





Table 21. Mixed-Effects Poisson Regression Model for the overall weekly Parasite Incidence 
 
Estimate 95% CI IRR-Fixed 
Effects 
95% CI 
Constant -0.7826 -1.3960, -0.1692 0.4572 0.2476, 0.8443 
Population 0.0000 0.0000, 0.0000 1.0000 1.0000, 1.0000 
Time traveling a -0.0070 -0.0074, -0.0066 0.9931 0.9927, 0.9935 
Time in weeks b 0.0068 0.0067, 0.0069 1.0068 1.0068, 1.0069 
Sine 1 c -0.0064 -0.0145, 0.0017 0.9936 0.9856, 1.0017 
Cosine 1 c  -0.3568 -0.3633, -0.3503 0.6999 0.6954, 0.7045 
Sine 2 c -0.0446 -0.0508, -0.0384 0.9564 0.9505, 0.9623 
Cosine 2 c 0.0649 0.0588, 0.0710 1.0671 1.0605, 1.0736 
Altitude d -0.0050 -0.0052, -0.0048 0.9950 0.9948, 0.9952 
Precipitation e 0.0003 0.0003, 0.0003 1.0003 1.0003, 1.0003 
Vegetation f 0.1142 0.0721, 0.1562 1.1209 1.0748, 1.1690 
Center Type      
   Health Post Ref.  Ref.  
   Health Center 1.2497 1.2401, 1.2594 3.4894 3.4559, 3.5232 
   Clinic/Hospital -0.5551 -0.5889, -0.5213 0.5740 0.5549, 0.5937 
RE (Network) 1.3638 0.6501, 2.8612 1.3638 0.6501, 2.8612 
* IRR = Incidence-Rate Ratio; AIC = Akaike's information criterion; 95% IC = 95% Interval of 
Confidence; RE = Random effects; a, Traveling time to Iquitos city by river; time in 
epidemiological weeks; sine and cosine functions to characterize the seasonality of the weekly 
parasite incidence; d, altitude in meter over the sea level; e, precipitation (mm water * m-2) or mm 













95% CI IRR without 
Precipitation 
95% CI 
Constant 0.7355 0.6275, 0.8622 0.7355 0.4219, 0.5647 
Population 1.0000 1.0000, 1.0001 1.0000 1.0000, 1.0000 
Time traveling a 0.9979 0.9969, 0.9989 1.0028 1.0017, 1.0039 
Time in weeks b 1.0084 1.0082, 1.0086 1.0085 1.0083, 1.0087 
Sine 1 c 1.1089 1.0727, 1.1463 1.1131 1.0831, 1.1441 
Cosine 1 c  0.7658 0.7452, 0.7870 0.7649 0.7447, 0.7857 
Sine 2 c 1.0174 0.9903, 1.0451 1.0250 0.9978, 1.0529 
Cosine 2 c 1.0893 1.0607, 1.1186 1.0878 1.0593, 1.1170 
Altitude d 0.9870 0.9864, 0.9876 0.9882 0.9877, 0.9888 
Precipitation e 1.0001 0.9999, 1.0003   
Vegetation f 1.2652 1.0677, 1.4992 1.2149 1.0250, 1.4399 
Center Type      
   Health Post Ref.  Ref.  
   Health Center 3.6913 3.5026, 3.8901 4.0858 3.8755, 4.3075 
   
Clinic/Hospital 0.1350 0.1095, 0.1664 0.1378 0.1112, 0.1708 
Ln(alpha) 1.9954 1.9784, 2.0125 2.0040 1.9784, 2.0125 





* IRR = Incidence-Rate Ratio; AIC = Akaike's information criterion; 95% IC = 95% Interval of 
Confidence; RE = Random effects; a, Traveling time to Iquitos city by river; time in 
epidemiological weeks; sine and cosine functions to characterize the seasonality of the weekly 
parasite incidence; d, altitude in meter over the sea level; e, precipitation (mm water * m-2) or mm 











95% CI IRR without 
Precipitation 
95% CI 
Constant 0.3394 0.2898, 0.3975 0.3651 0.3160, 0.4219 
Population 1.0000 1.0000, 1.0000 1.0000 1.0000, 1.0000 
Time traveling a 1.0010 1.0000, 1.0021 1.0010 1.0000, 1.0021 
Time in weeks b 1.0085 1.0083, 1.0088 1.0085 1.0083, 1.0088 
Sine 1 c 1.1150 1.0789, 1.1523 1.1391 1.1084, 1.1706 
Cosine 1 c  0.7347 0.7149, 0.7549 0.7393 0.7198, 0.7593 
Sine 2 c 1.0315 1.0042, 1.0596 1.0291 1.0020, 1.0570 
Cosine 2 c 1.0653 1.0375, 1.0939 1.0647 1.0369, 1.0933 
Altitude d 0.9898 0.9893, 0.9904 0.9897 0.9891, 0.9902 
Precipitation e 1.0002 1.0000, 1.0004   
Vegetation f 1.1119 0.9374, 1.3189 1.0949 0.9238, 1.2976 
Center Type      
   Health Post Ref.  Ref.  
   Health Center 4.2299 4.0135, 4.4581 4.2288 4.0114, 4.4580 
   
Clinic/Hospital 0.1366 0.1104, 0.1691 0.1348 0.1089, 0.1669 
Ln(alpha) 1.9546 1.9369, 1.9724 1.9550 1.9372, 1.9727 





* IRR = Incidence-Rate Ratio; AIC = Akaike's information criterion; 95% IC = 95% Interval of 
Confidence; RE = Random effects; a, Traveling time to Iquitos city by river; time in 
epidemiological weeks; sine and cosine functions to characterize the seasonality of the weekly 
parasite incidence; d, altitude in meter over the sea level; e, precipitation (mm water * m-2) or mm 






Table 24. Mixed-Effects Negative Binomial Regression Model for the Falciparum Malaria 









Constant 0.0370 0.0288, 0.0476 0.0487 0.0385, 0.0617 
Population 1.0000 1.0000, 1.0000 1.0000 1.0000, 1.0000 
Time traveling* 0.9984 0.9966, 1.0001 0.9972 0.9955, 0.9990 
Time in weeks+ 1.0088 1.0084, 1.0092 1.0089 1.0085, 1.0092 
Sine 1 0.8336 0.7891, 0.8807 0.9249 0.8847, 0.9669 
Cosine 1 0.8574 0.8200, 0.8965 0.8828 0.8450, 0.9223 
Sine 2 0.9464 0.9056, 0.9891 0.9356 0.8953, 0.9777 
Cosine 2 1.1580 1.1089, 1.2093 1.1516 1.1028, 1.2025 
Altitude 0.9936 0.9926, 0.9946 0.9932 0.9923, 0.9942 
Precipitation 1.0010 1.0007, 1.0013   
Vegetation 4.1567 3.1370, 5.5079 4.1300 3.1173, 5.4716 
Center Type     
   Health Post Ref.  Ref.  
   Health Center 4.4154 4.0650, 4.7961 4.2288 4.0114, 4.4580 
   
Clinic/Hospital 0.3035 0.2247, 0.4101 0.1348 0.1089, 0.1669 
lnalpha 2.8321 2.8040, 2.8602 2.8353 2.8072, 2.8634 
RE (Network) 14.450 3.6399, 57.368 14.227 3.5835, 56.484 
* IRR = Incidence-Rate Ratio; AIC = Akaike's information criterion; 95% IC = 95% Interval of 
Confidence; RE = Random effects; a, Traveling time to Iquitos city by river; time in 
epidemiological weeks; sine and cosine functions to characterize the seasonality of the weekly 
parasite incidence; d, altitude in meter over the sea level; e, precipitation (mm water * m-2) or mm 









5.9 Figures for Chapter 6 
Figure 13. Loreto location and provinces 
 
Source: Adapted from Ferruci HR, Razuri H, Casapia M, Rahme E, Silva H, Ault S, Blouin B, 
Mofid LS, Montresor A, Gyorkos TW. Governance, organization, accountability and sustainability 





Figure 14. Annual Malaria Parasite Incidences in Peru 
 
Legend: Annual Parasite Index (total of subjects that tested smear positives to malaria per 1,000 
inhabitants per year) in Peru since 1939 to 2017.  Here, the red dash shows that the threshold of 1 
case per 1,000 inhabitants has been overcome only twice (in the latest 1960’s and in the latest 






Figure 15. Annual Malaria Parasite Incidences in Loreto, 1994-2017 
 
Legend: Annual Parasite Index (total of subjects that tested smear positives to malaria per 1,000 
inhabitants per year) in Loreto since 1994 to 2017.  Here, the red dash shows that the threshold of 
1 case per 1,000 inhabitants has been overcome only once (late in 2010), but malaria increased 





Figure 16. Weekly Malaria Parasite Incidences by epidemiological week in Loreto, 2010-17 
 
Legend: Weekly Parasite Index (total of subjects that tested smear positives to malaria per 1,000 





Figure 17. Health infrastructure at the Datem del Marañon health networks 
 








Figure 18. Health infrastructure at the health networks Maynas City, Maynas 
Periphery and Ramon Castilla 
 





Figure 19. Districts allocated to the river networks Maynas City (“Ciudad”), Maynas (“Periferia”), and Ramon Castilla. 
 




Figure 20. Mean Weekly Malaria Parasite Incidences among Loreto Surveillance Units by year and River System 
 




Figure 21. Weekly Malaria Parasite Incidences among Loreto Surveillance Units by epidemiological weeks and River Systems 
 
* Y by X Axis: Weekly parasite incidence (malaria cases x 100,000 inhabitants) across Loreto’s surveillance units by river network 




Figure 22. Pressure (KPa) among Loreto Surveillance Units by epidemiological weeks and River Systems 
 




Figure 23. Humidity (kg vapor * kg1 air * 103) among Loreto Surveillance Units by epidemiological weeks and River Systems 
 





Figure 24. Temperature (°C) among Loreto Surveillance Units by epidemiological weeks and River Systems 
 




Figure 25. Soil Moisture (kg/m2) among Loreto Surveillance Units by epidemiological weeks and River Systems 
 




Figure 26. Precipitation (mm-1 water * m2) among Loreto Surveillance Units by epidemiological weeks and River Systems 
 




Figure 27. Vegetation (NDVI) among Loreto Surveillance Units by epidemiological weeks and River Systems 
 




Figure 28. Altitude (m) among Loreto Surveillance Units by epidemiological weeks and River Systems 
 




Chapter 6. Synthesis and Implications 
6.1 Introduction 
Malaria eradication is an ambitious but necessary global health goal. In the path towards 
purposely and permanently reducing the worldwide incidence of malaria to zero (the definition of 
eradication), each endemic malaria country must first do the same within their borders (which is 
the definition of elimination) (1). Moreover, as an intermediary step towards elimination, each 
endemic malaria country must set and achieve the control of malaria by deploying interventions 
to interrupt its transmission and reduce the malaria incidence to a previously and locally acceptable 
level (which is the definition of control). So, this is where the "think global but act local" mentality 
plays a key role in the fight against malaria. 
To act local, we need to understand the local patterns of transmission of malaria.  This will 
help to develop the means to interrupt such transmission sustainably. However, that is not an easy 
task given the many scenarios and combination of factors that interact to sustain the transmission 
of malaria. In that sense, it is easy to understand why is so important to fit a variety of models and 
analytical approaches to effectively guide each elimination effort (2).  
This dissertation aims to contribute to key pieces of knowledge necessary to support current 
Peru's malaria elimination program.  First, we determined the impact of reactive case detection 
with focal mass drug administration (RCD/FMDA) as compared to passive case detection on 
reducing the regional annual parasite incidence in Tumbes, Peru (Chapter 3).  Second, we 
determined the impact of the malaria elimination program implemented in Tumbes on interrupting 
the transmission of malaria beyond the intervention area and along the Peruvian north coast 




offer a variety of strategical targets for the malaria elimination program that was recently launched 
in Loreto (Chapter 5). 
 
6.2 Key results  
Specific Aim 1 
We observed that the malaria elimination program implemented in Tumbes, which was 
based on replacing passive case detection with RCD/FMDA strategy, did have a significant effect 
on reducing the regional annual parasite incidence within the intervention areas (2/13 districts) 
during the first two years of the program (pilot project).  Furthermore, that strategy most likely 
contributed to eliminate malaria from the Tumbes region after the strategy was scaled up across 
each of the 13 districts three years after.  
From this study we learned that malaria can be eliminated from low-endemic regions with 
high predominance of P. vivax by using focal interventions if some critical conditions align up to 
increase its likelihood of success.  First, as was the case of Tumbes, the human malaria reservoir 
should be relatively steady in time and space, meaning that the foci of malaria can be identified 
and have a predictable pattern of incidence that can be used to inform the selection of both the 
intervention and the targets for prioritization, with a low chance of error.  For this purpose, we 
must use data driven analytical strategies and take the best of the all the geographical, remote 
sensing, and administrative data available.  Furthermore, another key factor that was took in 
consideration during this decision-making process was the connectivity between communities and 
the patterns of human mobility in the region.  In the case of Tumbes, it was clear from the beginning 




become also a major driver of the human mobility due the intense commercial traffic across the 
Peru-Ecuador border.  This knowledge offered Peruvian MoH officers a great advantage to 
properly select the districts that were targeted during the pilot study, be successful, and later one 
to take advantage of this successful experience to later on obtain the clearance necessary to scale 
up the project to the whole region of Tumbes by the central government.   
Another important lesson from this study was recognizing the high relevance of accounting 
for the social structure of the communities when deploying interventions to interrupt malaria 
transmission.  In the case of Tumbes, within the FMDA component of the strategy besides 
including eligible contacts within the boundaries of the household of the index cases (identified 
with RCD) the officers also intervened on the contacts who worked or  studied with the index case 
in the previous 24 hours.  This key adaptation of the RCD strategy allowed Peruvian officers to 
expand the effect of the intervention beyond the limits of the index case household without 
sacrificing the sustainability of the program.  Actually, this modification might one of the main 
reasons for the success of the Tumbes malaria elimination program.  That been said, it is important 
to remember that in most RCD documented experiences the population at risk was delimited by a 
perimeter distance around the index case household either 1 km like in Sri Lanka (3) and Swaziland 
(4), 500 m as in southern Zambia (5), or 100 m used in the Peruvian Amazon (6).  Consequently, 
as the perimeter is expanded, the coverage becomes more expensive and less sustainable given the 
relatively higher cost (7). 
Another result of high interest from our study was the fact than the selected intervention 
included a transmission blocking drug like primaquine, which have huge implications from the 
stand point of a FMDA strategy.  First, there was the risk of severe adverse events due the massive 




dehydrogenase deficiency (G6PDd).  And second, primaquine is a long-time recognized 
transmission-blocking drug that can prevent relapses of malaria (8), but such effects varies 
significantly from region to region and is not exempt of risks.  The odds of relapse in the absence 
of primaquine therapy varies by geographic origin from 1 to 4, being higher in tropical regions 
like Tumbes (9).  Prior to the pilot project the malaria incidence was increasing consistently across 
Tumbes as well as the number of doses of chloroquine-primaquine used to treat every vivax 
malaria case, so clearly primaquine was not helping to interrupt the transmission of malaria nor 
deterring adverse events due the massive use of doses of primaquine.  Yet it was a matter of great 
concern that so many precautions were taken to account for the remote possibility of a severe 
adverse event due G6PD deficiency, including active surveillance and capacity building.  That 
been said, Peru have a decades of experience using primaquine to treat malaria cases with close to 
none fatal adverse event cases reported (10) and a very low prevalence (prevalence range: 0-0.7%) 
of G6PD deficiency reported  by a small, historical study (11).  Regardless, Peru recently approved 
the use of primaquine to interrupt falciparum malaria cases in the Peruvian Amazon so primaquine 
is considered a safe drug in low doses regardless of the G6PD deficiency risk in the country now.  
Another finding that deserves mention is the relevance of proper funding, strong political 
will, community acceptability and a successful pilot experience.  In Tumbes, we had each of them 
from the beginning of the project which was essential for the success of the project.  First, the 
financial aid from Ecuador’s government warrantying the availability of 20,000 complete malaria 
treatments, which were sufficient to pilot and then scale the intervention to the 13 Tumbes districts, 
was essential for the whole project.  This exceptional donation had a major impact in the political 
will from the regional authorities facilitating the decision making from the beginning.  Another 




from the central government requested a second year of data to approve the scale up project due 
the initial and reasonable doubts about the safety and community acceptability of the RCD/FMDA 
intervention.  And last but not least, one observation we cannot neglect was the impact of a 
successful pilot study in the scope of a long-term, large, labor and resource intensive project.  The 
pilot experience helped a lot in terms of gaining experience, community acceptance and 
sustainability, all which were validated and reaffirm after the very first year of the scale up study 
giving the fact that each of the newly intervention districts starting reverting their malaria incidence 
trends. 
To sum up we reported the first successful malaria elimination initiative based on RCD with 
FMDA in a region with a high predominance of vivax malaria worldwide.  Such strategy may be 
useful to achieve the control and further elimination of malaria without significant adverse events.   
 
Specific Aim 2 
In our previous study we found that ~90% of the total impact attributable to the 
RCD/FMDA at 24-months of the pilot study occurred during the first year in the region of Tumbes.  
Also, we observed that there were strong signals of an “spillover effect” from the intervention 
communities to the nearby non-intervention communities, both during the pilot study in Tumbes 
as well as during the scale up study in the nearby districts of Piura.  This observation might be 
explained in the case of Tumbes because of the relatively small geographic area as well as its 
strong road-connectivity due the Pan-American Highway.   So, it was plausible that the impact of 
the RCD/FMDA strategy in Tumbes was extended to Piura by an “spillover effect”.  Hence in this 




The study two results suggest that we can enhance the effect of a malaria elimination 
program by both selecting the proper intervention and by selecting the proper targets.  As for the 
intervention the RCD/FMDA was previously found to represent an effective strategy to support 
malaria elimination initiatives in Tumbes Peru, a region with a predominance of vivax malaria, 
while taking advantage of a clear understanding of the patterns of incidence of malaria at each site.  
As for the target’s selection, the intervention sites were first selected strategically among the most 
endemic regions based on a clear understanding of the patterns of incidence across the region. By 
doing so, the intervention also produced a possible “spillover effect” that could help to interrupt 
the transmission of malaria along the Pan-American Highway, which is the main road that connects 
both regions.  Additionally, several factors contributed to the success of the program, including 
the strong seasonality that characterize the pattern of the incidence of malaria along the Peruvian 
north coast, the lack of a vector with high vectorial capacity in the region, the sustainability of the 
Tumbes malaria elimination program, and the single road connectivity between both regions that 
drives the economy of both regions.  
During the pilot study (2009-2010) a total of 8,243 subjects, of whom around ~90% where 
asymptomatic subjects without any symptoms or signs of malaria received a complete course of 
antimalarials for P. vivax malaria.  Such numbers may be an indication that a significant fraction 
of the population at risk was treated for asymptomatic malaria and also received treatment of a 
transmission-blocking drug such as primaquine.  During this second year of the pilot study (2010), 
the Tumbes intervention sites registered a mean WPIs reduction of 95% (95%CI: 74−100), the 
Tumbes non-intervention sites a mean WPIs reduction of -39% (-75%−-3%), while across the 
Piura non-intervention sites the mean WPIs reduction was of -260% (-325%−-195%).  Such 




against the non-intervention sites from Tumbes (p<0.001) and Piura (p<0.001).  However, during 
the scale-up study, the WPIs dropped from 6.11 (95%CI: 5.30–6.43) cases per 100,000 inhabitants 
in the year 2010 to 0.53 (95%CI: -0.08−1.14) in the year 2014 across Tumbes and Piura.  Since 
2015, Tumbes and Piura have reported only imported malaria cases, either from Ecuador or from 
the Peruvian Amazon.    
During both study phases participants did not report any antimalarial adverse events, and 
the regional hospitals from Piura and Tumbes did not state any case of antimalarial adverse 
events neither nor any fatal malaria case. 
 
Specific Aim 3 
The evidence from this study suggest that there are several different patterns of incidence 
of malaria across de Loreto Region and that such variability might be explained by the seasonality 
of malaria, its most important climate predictors, as well as by the connectivity and accessibility 
to health care.  Overall, it seems that the distribution of the human malaria reservoir follows the 
natural boundaries offered by each of the main Amazon river tributaries.  Hence, at each of these 
river networks we can observe a different pattern of malaria incidence, which represents an great 
opportunity for deploying focal interventions while taking advantage of the independence of each 
river system.  In our previous two studies we reported that is possible to interrupt the transmission 
of malaria in systems that are strongly connected by implemented focal strategies such as 
RCD/FMDA to target the main foci if the system behaves as such while considering the 
independent well interconnected system by only one main road.  In the case of the Peruvian 
Amazon, we believe that each of these factors that played a key role in the success of the malaria 




Briefly, out third study we found that Loreto is a low endemic area with an over-dispersed 
distribution of malaria cases and a high predominance of P. vivax malaria over P. falciparum 
malaria (4:1).  At the beginning of our study period, 2010, we estimated an annual parasite 
incidence of 13.3 cases per 1,000 people (95% Confidence Interval [CI]: 13.1 to 13.6 cases per 
1,000 people), but when we disaggregated the malaria incidence weekly and by surveillance units 
we estimated an average WPI of 32.5 cases per 100,000 people (95% CI: 29.2 to 35.7 cases per 
100,000 people).  By doing so we observed that across surveillance units there was a wide range 
of WPI (0 to 10,259 cases per 100,000 people). Furthermore, if we assessed the variability of the 
WPI in times we also observed that the pattern of incidence changed in time. 
There are different ways to disaggregate a large region like Loreto, but whatever 
disaggregation we may attempts may end useless if they are not be functional for the purpose of 
facilitating the distribution of interventions in a cost-effective manner.  In the case of the Loreto 
region, the main way to commute between communities, is along the Amazon river navigable 
tributaries.  Hence, it makes sense to use that knowledge as well as the administrative and MoH 
health infrastructure map, to assess the patterns of incidence across the rivers systems to inform 
the decision making behind a prospect malaria elimination program in Loreto.   
In this study we tested the hypothesis of our interest by disaggregating the Peruvian Amazon 
basin in the main Amazon river navigable tributaries and then explore which ones may behave as 
independent systems large enough to sustain the transmission of malaria from one season to the 
next.  To do so, first we explored the variability of the WPI among the health networks and then 
used key informants from the Loreto Health Directorate (each of them with over twenty years of 
experience managing and directing the malaria program in Loreto) to divide the largest health 




along the path of the navigable rivers. Consequently, we started with the eight health networks 
from the health infrastructure map of Loreto and ended with 14 riverine systems.   
 
6.3 Strengths and limitations 
There are several strengths and limitations that should highlighted in this dissertation 
research.  One important limitation we need to mention is that each of the studies uses malaria 
surveillance data with malaria febrile cases diagnosed trough microscopy.  There are important 
sources of bias, including selection, classification, instrument bias, interpretation, and reporting 
bias.  First, the surveillance of febrile syndrome implies that some fractions of the population will 
be less likely to be included in the study, including febrile infants, elders and adult young males.  
Also, there exist a high risk of over sampling communities closer to the surveillance units and 
those communities or populations that lives in close proximity to the city of Iquitos.  On the other 
hand, febrile indigenous populations and other minorities will less likely to be captured by the 
surveillance system.  Additionally, there is a high risk of misclassification and interpretation of the 
microscopic images of the malaria parasites due the poor accuracy attributed to microscopy and 
the high variability of competency among the microscopists (12).  In the same direction there was 
observed a high variability in the models and maintenance of microscopes used for malaria 
microscopy in Loreto (12), which increase the risk of instrument bias.  And lastly, there is a high 
risk of reporting bias due the remote location of some the surveillance units and the variety of 
methods (radio, telephone, text, e-mail and physical reports) used for the reporting of the data prior 
to data entry.  All of these biases affect the internal and external validity of our studies, but do not 
necessarily invalidate them because in malaria research surveillance data is highly informative to 




Furthermore, in the case of the Loreto region the surveillance system was enhanced in the context 
of the PAMAFRO project, which invested for over five years on capacity building and improving 
the quality of the data reporting, quality control and data entry processes.  However, we 
acknowledge that using surveillance data represents a major weakness in our series of studies 
which may be difficult to overcome. 
The aim of the study one was to determine the impact of RCD/FMDA as compared to passive 
case detection on reducing the regional annual parasite incidence in Tumbes, Peru, but we used a 
non-randomize community trial.  Consequently, the study has a high-risk of selection bias due the 
lack of randomization and a high-risk of an “spillover effect”.  To overcome this major limitation, 
we implemented a variety of measures to mitigate the effect of such bias by including standardized 
surveillance data with rigorous quality control and a rigorous collection of information on potential 
confounders including remote sensing data, traveling distances trough accessibility and friction 
maps, seasonality assessment and accounting for the over dispersion and aggregation of the data 
by using mixed-effects Poisson regression methods and negative binomial correction when 
necessary. 
 
6.4 Recommendations for future research 
This dissertation reports the first successful malaria elimination initiative based on RCD 
with FMDA in a region with a high predominance of vivax malaria worldwide.  However, there 
are some limitations related to the quality of the evidence generated by a non-randomized 
community trial through our first two studies, which demands further assessments to verify our 
results.  So, our first recommendation is to test our hypothesis using a community randomized trial 




passive case detection in settings with low malaria endemicity and a transmission pattern similar 
to the Peruvian north coast.  This strategy might be of great value particularly in the Peruvian 
Amazon where several of the factors that facilitated the success of the RCD/FMDA in the Peruvian 
north coast also characterize the Peruvian Amazon, including low endemicity, strong seasonality, 
long-term massive use of doses of primaquine without major adverse events, and high connectivity 
and clustering of susceptible subject within communities constrained by naturally limited networks 
with the Amazon river navigable tributaries behaving similar to the Pan-American highway in the 
Peruvian north coast.  That been said, it is unclear how such strategy might work in a region with 
so much variability in their pattern of incidence of malaria but certainly we believe such a strategy 
would be a very cost-effective alternative for most of the river networks where the human malaria 
reservoir behaves as stable foci in space and time. 
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Loza Concha R. Quispe AM. [Cost utility of renal transplant vs. hemodialysis in the treatment of end 
stage chronic kidney failure in a Peruvian hospital] Rev Per Med Exp Sal Pub 2011;28(3):432-9 (Pubmed 
ID: 22086622) 
 
Quispe AM, Santivañez-Pimentel A, Leyton-Valencia I, Pomasunco D. [Caesarean section among seven 
public hospitals at Lima: trend analysis during 2001-2008 period]. Rev Per Med Exp Sal Pub 2010; 27(1): 
45-50 (Pubmed ID:21072449). 
 
Quispe A, Santivañez-Pimentel A, Leyton-Valencia I, Olivos JC. [Analysis of clavicle fractures tendency 
in three Lima hospitals]. Rev Per Gin & Obst 2009;55:182-186  
 
Quispe AM, Segura ER, Salmon-Mulanovich G. [Clinical trials and the accomplishment of CONSORT 
guidelines in Peru]. An Fac Med 2010;71(1):62  
 
Danesi A, Quispe AM, Masías-Bustos L. [Correlation and concordance between the main stroke risks 
scores in patients with non-valvular auricular fibrillation]. Rev Per Card 2009;35(1):5-10 
 
TECHNICAL DOCUMENTS (Published in the last 10 years)   
IETSI-EsSalud. [Safety and efficacy of pembrolizumab in the treatment of patients with malignant 
melanoma with metastatic or unresectable disease without prior systemic treatment]. Preliminary Health 
Technology Assessment. N° 062—SDEPFyOTS-DETS-IETSI-2016, Lima, Peru. 2016. 
 
IETSI-EsSalud. [Efficacy and safety of simeprevir in combination with peginterferon alfa and ribavirin 
in the treatment of patients diagnosed with chronic hepatitis C genotype 1A negative to the Q80K or 
genotype 1B mutation with significant fibrosis]. Preliminary Health Technology Assessment. N° 060—





IETSI-EsSalud. [Efficacy and safety of sorafenib in the treatment of patients with differentiated, 
metastatic, unresectable thyroid carcinoma refractory to treatment with radioactive iodine]. Preliminary 
Health Technology Assessment. N° 056—SDEPFyOTS-DETS-IETSI-2016, Lima, Peru. 2016. 
 
IETSI-EsSalud. [Efficacy and safety of axitinib in patients with metastatic renal cancer treated with 
sunitinib]. Preliminary Health Technology Assessment. N° 048—SDEPFyOTS-DETS-IETSI-2016, 
Lima, Peru. 2016. 
 
IETSI-EsSalud. [Safety and efficacy of bevacizumab in combination with chemotherapies that do not 
contain platinum in the treatment of patients diagnosed with metastatic ovarian cancer]. Preliminary 
Health Technology Assessment N° 040—SDEPFyOTS-DETS-IETSI-2016, Lima, Peru. 2016. 
 
IETSI-EsSalud. [Safety and efficacy of bevacizumab in combination with fluoropyrimidine-based 
chemotherapy in first-line treatment for patients diagnosed with metastatic colorectal cancer]. Preliminary 
Health Technology Assessment N° 038—SDEPFyOTS-DETS-IETSI-2016, Lima, Peru. 2016. 
 
IETSI-EsSalud. [Torasemide safety and efficacy in treating patients diagnosed with congestive heart 
failure patients] Preliminary Health Technology Assessment. N° 037—SDEPFyOTS-DETS-IETSI-2016, 
Lima, Peru. 2016. 
 
IETSI-EsSalud. [Safety and efficacy of safety and efficacy of ipilimumab in treating patients diagnosed 
with malignant melanoma metastatic or unresectable disease with no prior systemic therapy]. Preliminary 
Health Technology Assessment N° 035—SDEPFyOTS-DETS-IETSI-2016, Lima, Peru. 2016. 
 
IETSI-EsSalud. [Crizotinib safety and efficacy in treating patients with lung cancer diagnosis of 
metastatic non-small cell positive ALK fusion gene]. Preliminary Health Technology Assessment N° 
019—SDEPFyOTS-DETS-IETSI-2016, Lima, Peru. 2016.   
  
IETSI-EsSalud. [Safety and efficacy of vildagliptin in the treatment of elderly patients diagnosed with 
diabetes mellitus type 2, with risk of hypoglycemia and limitations for use of insulin (with high degree of 
dependence), without adequate metabolic control (as HbA1C) despite treatment with metformin and 
glyburide maximum dose]. Preliminary Health Technology Assessment N° 012—SDEPFYOTS-DETS-
IETS1-2016, Lima, Peru. 2016.  
 
IETSI-EsSalud. [Safety and efficacy of metreleptin in the first-line treatment of patients with congenital 
generalized lipodystrophy]. Preliminary Health Technology Assessment N° 009—SDEPFYOTS-DETS-
IETSI-2016, Lima, Peru. 2016.  
 
ABSTRACTS AT INTERNATIONAL CONFERENCES (Published in the last 10 years) 
Quispe AM, Arróspide A, Valladares M, Huapaya C, Acosta J. [Risk of tuberculosis in hospital 
environments in a country with high endemicity]. Second Place and oral presentation at the XI 
International Scientific Congress organized by the National Institute of Health, Lima, Peru – November 
2017. 
 
Quispe AM, Quintana F, Pozo E, Kosek MN, Gotuzzo E. Reactive detection of cases with targeted mass 
treatment: Interrupting transmission of malaria and achieving its elimination beyond intervened areas in 
Northwestern Peru. Oral presentation presented at the 65th ASTMH Annual Meeting, Baltimore, MD – 
November 2017. 
 
Quispe AM, Quintana F, Pozo E, Risco R, Hernandez RH, Cabezas C, Esipov S. Spreading of Dengue 
and Chikungunya in Northwestern Peru: from Waves to Coinfection. Poster presented at the 2016 





Wagner K, Mousam A, Kephart JL, Aquila V, Maggioni V, Cabezas C, Quispe AM. El Niño as a threat 
to regions progressing toward malaria elimination in Peru. Poster at the Epidemiology Congress of the 
Americas, Miami, FL – June 2016. 
 
Quispe AM, Campos J, Cruz R, Fernandez J, Chavez E, Ore, M. Responding to Infectious diseases 
outbreaks in the Peruvian military: 10-year review using an electronic disease surveillance system. Poster 
presented at the 64th ASTMH Annual Meeting, Philadelphia – October 2015, and at the International 
congress at the Peruvian National Health Institute, Lima, Peru – November 2015. 
 
Quintana FA, Mendoza EL, Gonzales RV, Arrasco J, Herrera YO, Quispe AM. Reactive case detection 
with targeted mass drug administration for malaria elimination in northwestern Peru. Poster presented at 
the 64th ASTMH Annual Meeting, Philadelphia – October 2015, and at the International congress at the 
Peruvian National Health Institute, Lima, Peru – November 2015. 
   
Mousam A, Maggioni V, Delamater P, Kephart JL, Quispe AM. The impact of climate variability on 
malaria prevalence rates in Loreto, Peru. Poster presented at the 64th ASTMH Annual Meeting, 
Philadelphia – October 2015, and at the International congress at the Peruvian National Health Institute, 
Lima, Peru – November 2015. 
 
Quispe AM, Khepart JL, Lescano AG, Thields TM, Shiff CJ. A free surveillance app for planning malaria 
interventions and outbreak responses at the community level in malaria endemic countries. Poster 
presented at the; at the Malaria World Day, Baltimore, Maryland – April 2014; at the Second Conference 
in Scientific Research in tropical Medicine and Public Health “Amy C Morrison”, Iquitos, Peru – August 
2014; and at the Young Investigators Awards at the 63rd ASTMH Annual Meeting, New Orleans – 
November 2014. 
  
Quispe AM, Aquila V, Khepart JL, Lescano AG. Latitude and microclimate associated with malaria 
incidence at the district level in a low endemic area. Poster presented at the 63rd ASTMH Annual Meeting, 
New Orleans, Louisiana – November 2014.  
  
Smith-Nuñez ES, Durand S, Baldeviano GC, Quispe AM, Jequeiros F, Sihuincha M, Celis JC, Tapia LL, 
Campos K, Edgel KA, Lescano AG. WHO criteria for severe malaria in identifying severe vivax malaria 
Preliminary data from a study in Iquitos, Peru. Poster presented at the 62th ASTMH Annual Meeting, 
Washington, DC – November 2013.  
  
Baldeviano GC, Leiva KP, Quispe AM, Ventocilla J, Tapia LL, Durand S, Santolalla ML, Ricopa L, 
Campos K, Sihuincha M, Smith-Nuñez ES, Edgel KA, Lescano AG. Serum markers of severe clinical 
complications during Plasmodium vivax malaria mono-infection in the Peruvian Amazon basin. Poster 
presented at the 62th ASTMH Annual Meeting, Washington – November 2013.  
  
Quispe AM, Santolalla ML, Tapia LL, Maguiña EA, Guerrero E, Pozo E, Baldeviano GC, Graf PCF, 
Edgel KA, Lescano AG. Malaria risk in a vivax mono-endemic area nearing elimination. Poster presented 
at the 61th ASTMH Annual Meeting, Atlanta, Georgia – November 2012.  
  
Baldeviano GC, Quispe AM, Llacua LA, Santolalla ML, Tapia LL, Maguiña EA, Pozo E, Guerrero E, 
Palacios AM, Loncarich V, Graf PCF, Edgel KA, Lescano AG. Naturally acquired immunity in an area 
of low Plasmodium vivax transmission in the North Coast of Peru. Poster presented at the 60th ASTMH 
Annual Meeting, Washington, DC – December 2011.  
 
Quispe AM, Pozo E, Campos P, Guerrero E, Durand S, Jimenez L, Palacios AM, Edgel KA, Graf PCF, 
Lescano AG. Severe malaria in a nearly exclusive Plasmodium vivax endemic area. Poster presented at 





Quispe AM, Sanchez JF, Bayer AM, Beltran M, Halsey ES, Gonzaga VE, Razuri HR, Zavaleta C, Maves 
R, Sanders JW, Montgomery JM, Lescano AG. Self-reported health status and wellbeing in the rural 
Peruvian rainforest. Oral presentation presented at the 58th ASTMH Annual Meeting, Washington, DC – 
November 2009.  
  
Quispe AM, Santivanez A, Pomasunco D. Clavicle fractures rates among three Peruvian Ministry of 
Health Hospitals. Oral presentation presented at the 18th Annual Meeting of the International Congress of 
Gynecology and Obstetrics Peruvian Society, Lima, Peru – February 2009.  
   
RESEARCH SUPPORT  
CONCYTEC 136-2017-FONDECYT, Beltran (PI), Role: co-PI                        11/15/2017 al 
11/14/2019 
Validation of panels for the detection of somatic mutations in solid tumors and their prognostic value in 
the management of lung, colon and melanoma cancers in the Peruvian population        
US$125,000 
• Grant awarded with the objective of validating panels for the detection of somatic mutations and their 
prognostic value in cancers of the lung, colon and melanoma that affect the Peruvian population. 
 
Bill and Melinda Gates Foundation OPP1099774, Gotuzzo (PI), Role: Co-PI 10/01/2013 to 
03/31/2016 
Accelerating to zero: Strategies to Eliminate Malaria in the Amazon            
US$50,000 
• Conference grant, which aim to convey the goals of a malaria elimination project in the Peruvian 
Amazon. 
  
US DoD-AFHSC/GEIS, Quispe (PI), Role: PI            11/01/2010 to 
10/30/2012 
Risk factors for severe Plasmodium vivax malaria in Peru           
US$300,000 
• Study that assessed the clinical and epidemiological markers associated with severe malaria secondary 
to Plasmodium vivax in Peru, and the potential role of Plasmodium falciparum co-infection and other 
co-morbidities. 
  
US DoD-AFHSC/GEIS, Quispe (PI), Role: PI            10/01/2010 to 
09/30/2011 
Plasmodium Vivax malaria incidence in infants, children and adults in Northwestern Peru.  US$150,000              
• Study that evaluated the incidence of vivax malaria in different age groups in low endemic settings. 
  
NIH/FIC 2D43 TW007393, Lescano (PI), Role: Coordinator              10/01/2005 to 
09/30/2015 
Peru Infectious Diseases Epidemiology Research Training Consortium               $ 
961,200 
• This program aims at building sustainable research capacity in Peru for studies on infectious 
diseases epidemiology 
  
OTHER EXPERIENCE, PROFESSIONAL MEMBERSHIPS 
2018 – Present: Grants Reviewer, Research Vice-rectorate, UNMSM, Lima, Peru.  
2017 – Present: Associate Member, American College of Epidemiology, Albany, NY.  
2017 – Present: Senior Advisor, National Medicine Students Scientific Society (SOCIMEP), Peru.  
2015 – Present: Member, Society for Epidemiologic Research, Clearfield, Utah.   
2014 – Present: Certification in Public Health (No 10442), National Board of Public Health 




2012 – Present: Mentor, GloCal Health Fellowship Program, University of California, Los Angeles, 
CA.   
2012 – Present: Grant proposal reviewer, Research Vice-Rectorate, UPCH  
2011 – Present: Advisor, Medicine Students Scientific Society, UNMSM), Peru. 
2010 – Present: Statistical Reviewer and Member, Institutional Animal Care and Use Committee, 
NAMRU-6 
2009 – Present: Member, American Society of Tropical Medicine and Hygiene, Oakbrook Terrace, IL  
  
PEER REVIEW 
• 2017 – Present: Reviewer, Revista CIMEL-Ciencia e Investigación Médica Latinoamericana, Perú. 
(ISSN 1680-8398) 
• 2017 – Present: Reviewer, Sky Journal of Journal of Microbiology Research, U.S. (ISSN 2315-876X) 
• 2016 – Present: Board Member, International Archives of Medicine, U.S. (ISSN: 1755-7682) 
• 2016 – Present: Reviewer, Peer J, U.S. (ISSN: 2167-8359) 
• 2016 – Present: Reviewer, American Journal of Tropical Medicine and Hygiene, U.S. (ISSN: 1476-
1645) 
• 2015 – Present: Reviewer, Tropical Diseases, Travel Medicine and Vaccines, U.S. (ISSN: 2055-
0936) 
• 2014 – Present: Reviewer, Journal of Women's Health Care, U.S. (ISSN: 1540-9996)  
• 2014 – Present: Reviewer, Hemodialysis International, U.S. (ISSN: 1542-4758) 
• 2011 – Present: Reviewer, Revista Peruana de Medicina Experimental y Salud Publica, Peru (ISSN: 
1726-4634) 
• 2011 – Present: Reviewer, Iranian Red Crescent Medical Journal, Iran (ISSN: 2074-1812) 
  
LANGUAGES AND COMPUTER SKILLS 
Languages: Spanish (Native language), English (TOEFL iBT 100), Italian (Basic), and Portuguese 
(Basic). 
Statistical Analysis Software: MatLab, STATA, R, ArcGIS, ATLAS.ti, PASS, PS, SPSS, and EpiInfo.  
Reference Manager Software: EndNote, Bibus, Mendeley, RefWorks, Zotero, and BibDesk (LATEX) 
Survey & Data Management Software: Surveygizmo, Surveymonkey, RedCap, MySQL, & MS Access 
 
 
Date of Birth: January 11, 1978  
Place of Birth: Lima, Perú 
